ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0036496;regulation of translational initiation by eIF2 alpha dephosphorylation;10.0;0.9326813400603323;0.8815816818910864;9.608321545174602;674.6262540571083;9.083926447120524;0.022579133599080606;0.8797934328124444;[PPP1R15A]
GO:0036498;IRE1-mediated unfolded protein response;6.0;1.0;0.8231203125901445;9.628524252492122;55.46397693329154;5.825829909099042;0.0018563293936187412;0.6210535250702663;[ZBTB17, XBP1, WFS1, EDEM1, SYVN1, ARFGAP1, YIF1A, ERN1, EXTL2, CTDSP2, LMNA, DNAJB11, SSR1, TPP1, HYOU1, TLN1, SULT1A3]
GO:0060123;regulation of growth hormone secretion;9.0;0.8933024483968273;0.8428918493787028;9.510741216835738;106.7634718148897;7.212124270218933;0.003573277320757824;0.7650689957573628;[CHD7]
GO:1902310;positive regulation of peptidyl-serine dephosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;773.3300010362153;9.083926447120524;0.02588265918286621;0.8797934328124444;[PPP1R15A]
GO:1990090;cellular response to nerve growth factor stimulus;6.0;0.9326813400603323;0.7894609826203107;9.5544162803384;97.48528473772916;5.9928839937622085;0.003262744749111514;0.6295966787287501;[USP8, EIF4A3, RAB35, RAPGEF1, PTEN, CIB1, BPTF]
GO:1901223;negative regulation of NIK/NF-kappaB signaling;8.0;1.0;0.875;9.628524252492122;239.1998693179246;6.686031174322154;0.008005804360164796;0.7169239451870815;[CYLD, NLRP12, RASSF2, CPNE1, NLRP3, RELA]
GO:1900138;negative regulation of phospholipase A2 activity;8.0;1.0;0.875;9.628524252492122;83.36451349999537;8.67846133901236;0.002790135243653613;0.8188169164668168;[ANXA1]
GO:1903408;positive regulation of sodium:potassium-exchanging ATPase activity;11.0;1.0;0.9324289523296623;9.628524252492122;1737.6104827170566;9.777073627680469;0.05815625910863255;0.9324289523296623;[DNM2]
GO:0002244;hematopoietic progenitor cell differentiation;4.0;0.811012628672052;0.655506314336026;8.935377071932177;21.066225782797595;5.395046993006588;7.050676185779127E-4;0.5259029541176994;[AGPAT5, SFRP1, COL24A1, XRCC5, SIN3A, HYAL2, KIT, HOXB4, PAPD4, PTPN6, MIXL1]
GO:0072583;clathrin-dependent endocytosis;7.0;0.8436909121759173;0.7727648213451592;9.223059144383958;30.046907922432062;6.558197802812269;0.0010056429677022863;0.6863059058804069;[GAK, AP2S1, CLTA, FNBP1L, PICALM]
GO:0071493;cellular response to UV-B;8.0;1.0;0.875;9.628524252492122;82.44278777713699;7.697632086000634;0.0027592859132088378;0.7686572628545723;[CDKN1A, HYAL2]
GO:0048489;synaptic vesicle transport;7.0;0.7671156992804218;0.7344772148974115;9.292052015870908;108.01043080855717;5.459585514144159;0.003615011916085639;0.6301228223472235;[TOR1A, SYT15, SYTL3, DNM2, RPH3A, P2RX7, AP3M1, TRIM9, SYNJ1, CDK5, BLOC1S1, AP3S2, SPG11]
GO:0098976;excitatory chemical synaptic transmission;8.0;1.0;0.875;9.628524252492122;25.73829654599903;7.697632086000634;8.61437622431563E-4;0.7686572628545723;[SSH1]
GO:0048488;synaptic vesicle endocytosis;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;55.00680757199006;6.599019797332524;0.0018410283465216937;0.6605944919115335;[KIAA1109, SYNJ1, CDK5, DENND1A]
GO:0071257;cellular response to electrical stimulus;5.0;1.0;0.7902410118609202;9.628524252492122;37.20981579086828;7.292166977892469;0.0012453790478602876;0.6631627702307852;[PTEN]
GO:0051402;neuron apoptotic process;5.0;0.8259837884571596;0.7032329060895001;9.022388448921806;23.44398779513952;6.113511981550823;7.846491732841165E-4;0.6028862989048107;[POLB, PIGT, CDK5, DIABLO, MAX, CASP3, BID, GAPDH, CIT]
GO:0034063;stress granule assembly;7.0;1.0;0.8509193652572005;9.628524252492122;107.30488678463786;7.069023426578259;0.0035913979925534566;0.7124295520356204;[ATXN2, EIF2S1, PUM2, C9orf72]
GO:0060591;chondroblast differentiation;4.0;1.0;0.75;9.628524252492122;21.066225782797595;8.16763571524637;7.050676185779127E-4;0.6676932703116032;[RARA]
GO:2000370;positive regulation of clathrin-dependent endocytosis;9.0;1.0;0.896240625180289;9.628524252492122;226.36966561352764;8.16763571524637;0.0075763889886123065;0.8139338954918922;[WASL, PICALM, DNM2]
GO:1903898;negative regulation of PERK-mediated unfolded protein response;9.0;1.0;0.896240625180289;9.628524252492122;384.78934721132015;8.16763571524637;0.012878553163233311;0.8139338954918922;[PPP1R15A]
GO:0048008;platelet-derived growth factor receptor signaling pathway;8.0;0.7763722522362496;0.7631861261181248;9.186691500213083;31.002284443533863;6.280566066213989;0.0010376185600805164;0.6961884407023742;[BCR, PDGFRB, SGPL1, ABL1, RAPGEF1, PTEN]
GO:0006612;protein targeting to membrane;10.0;0.811012628672052;0.8207473261969463;9.414950152194063;149.73401455281405;4.753193106834193;0.0050114627152184205;0.6583195283905053;[PEX16, TRAM1, RPS9, PEX19, RPL3, NCF1, RPS7, SSR2, RAB3IP, ZDHHC23, SRP54, ZDHHC12, ZDHHC24, ZDHHC6, RPL23A, RPS15, SEC61A2, TAOK2, CHMP4B, SSR1, RPL29, RAB8B, RPL19]
GO:0051895;negative regulation of focal adhesion assembly;8.0;1.0;0.875;9.628524252492122;270.76229412472316;7.069023426578259;0.009062170314110184;0.7365101867784198;[RCC2, PTEN, THBS1]
GO:0052501;positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction;10.0;0.8436909121759173;0.837086467948879;9.59953671561887;492.85104632609745;8.67846133901236;0.01649528098338966;0.8590579283277371;[GAPDH]
GO:0048010;vascular endothelial growth factor receptor signaling pathway;8.0;0.8259837884571596;0.7879918942285797;9.186691500213083;31.002284443533863;5.572381008289503;0.0010376185600805164;0.6599718239061428;[CYFIP2, NCKAP1, BMPR2, NCF1, ROCK2, NCF2, ITGB3, PDCD6, VAV1, VAV2, ELMO1, NCKAP1L, ITGAV]
GO:0005999;xylulose biosynthetic process;7.0;1.0;0.8509193652572005;9.628524252492122;171.81603384806527;9.083926447120524;0.005750528028503347;0.8154717862087246;[TALDO1]
GO:0071481;cellular response to X-ray;7.0;1.0;0.8509193652572005;9.628524252492122;60.39874674087868;7.379178354882098;0.0020214916980741903;0.728290889492758;[NIPBL, SFRP1, XRCC6, XRCC5, DNM2]
GO:0071245;cellular response to carbon monoxide;5.0;1.0;0.7902410118609202;9.628524252492122;234.8296146911994;9.777073627680469;0.007859535870782117;0.7902410118609202;[DNM2]
GO:0048015;phosphatidylinositol-mediated signaling;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;26.42836680105094;5.649939242635378;8.845336528452411E-4;0.6398575208746181;[PDGFRB, GSN, C1QBP, PIK3C3, SIRT2, PIK3CG, EXOC1, IGF1R]
GO:0006606;protein import into nucleus;9.0;0.8933024483968273;0.8428918493787028;9.551563211355994;277.5355368998559;5.288437257948329;0.009288864654271135;0.6666915524892495;[NUP107, SYK, NUP153, RGPD1, IPO4, NUP93, NCKIPSD, IPO8, IPO9, NUP62, LMNA, HEATR3, KPNA4, TNPO1, TNPO2, RAE1, KPNB1, TNPO3]
GO:0006607;NLS-bearing protein import into nucleus;10.0;1.0;0.9152410118609203;9.628524252492122;278.22868408041535;6.481236761676141;0.009312063666612497;0.7466917612613706;[NCKIPSD, KPNA4, TNPO1, TNPO2, RGPD1, KPNB1, IPO4]
GO:0051897;positive regulation of protein kinase B signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;4.7664383335842135;0.007979625599047746;0.6187558780415471;[PDGFRB, ITGB1, IGFBP5, ANGPT1, CD80, PARK7, THBS1, VAV1, PIK3CG, TGFBR1, STK3, MTDH, BAG4, C1QBP, KIT, CPNE1, CCL19, TEK, MET, HBEGF]
GO:0048490;anterograde synaptic vesicle transport;10.0;1.0;0.9152410118609203;9.628524252492122;439.1991285038257;7.004484905440688;0.014699599577469427;0.7734506956670166;[AP3M1, BLOC1S1, AP3S2]
GO:0051898;negative regulation of protein kinase B signaling;8.0;1.0;0.875;9.628524252492122;238.79440420981607;6.063501560976162;0.00799223380789131;0.6850877518099798;[FLCN, PDCD6, HYAL2, RAPGEF1, PTEN, CIB1, TRIB3, MTM1]
GO:0048017;inositol lipid-mediated signaling;6.0;0.8933024483968273;0.7697715367885581;9.4949928598676;26.42836680105094;5.602686357784832;8.845336528452411E-4;0.6096419534788213;[PDGFRB, GSN, C1QBP, PIK3C3, PLD1, SIRT2, PIK3CG, EXOC1, IGF1R]
GO:1904754;positive regulation of vascular associated smooth muscle cell migration;9.0;1.0;0.896240625180289;9.628524252492122;244.58802208207217;7.212124270218933;0.008186140984158152;0.7650689957573628;[IGFBP5, ATP7A, SSH1]
GO:0060389;pathway-restricted SMAD protein phosphorylation;8.0;1.0;0.875;9.628524252492122;180.75330000196035;7.212124270218933;0.006049650283656873;0.7438283705770736;[TGFBR1]
GO:0002223;stimulatory C-type lectin receptor signaling pathway;11.0;1.0;0.9324289523296623;9.628524252492122;628.1099736002739;5.618190544320798;0.02102227555412486;0.7197434780388068;[CREBBP, FCER1G, RPS6KA5, SYK, EP300, KRAS, HRAS, NFKB1, RELA, CARD11]
GO:0042953;lipoprotein transport;8.0;1.0;0.875;9.628524252492122;68.44752614357394;7.138016298065211;0.0022908771012512216;0.7400384854347593;[MIA3, ZDHHC17]
GO:0000045;autophagosome assembly;6.0;1.0;0.8231203125901445;9.628524252492122;62.10424204613046;5.769740442447999;0.0020785730910948433;0.618185107137305;[BECN1, NSFL1C, GABARAPL1, TP53INP2, TP53INP1, UBQLN1, PIK3C3, ULK1, ATG5]
GO:0046085;adenosine metabolic process;9.0;0.8653626801206646;0.8289219652406215;9.54514264355307;443.46863639021404;7.474488534686424;0.01484249616411921;0.7784863164434164;[ADK, ACPP]
GO:0071277;cellular response to calcium ion;6.0;1.0;0.8231203125901445;9.628524252492122;78.50383844342444;5.433268205826786;0.0026274528238337297;0.6009779013089371;[ITPKB, ENDOG, PPIF, CPNE1, CPNE3, CPNE2, ECT2, ARID1A, RASGRP2, TUBG1, PKD2]
GO:0098711;iron ion import across plasma membrane;10.0;0.8933024483968273;0.861892236059334;9.533214072687796;266.397951560906;7.697632086000634;0.008916099696152526;0.8088982747154926;[STEAP3, ARHGAP1, PICALM]
GO:0048268;clathrin coat assembly;6.0;0.8436909121759173;0.7449657686781032;9.310070521373587;44.51706700895919;6.781341354126479;0.0014899461700306506;0.6699184248047958;[CLTCL1, AP2S1, CLTA, PICALM]
GO:0071276;cellular response to cadmium ion;6.0;1.0;0.8231203125901445;9.628524252492122;78.50383844342444;6.139487467954083;0.0026274528238337297;0.6370939872166814;[GSN, NCF1, MT1G, ATP7A]
GO:2000134;negative regulation of G1/S transition of mitotic cell cycle;9.0;0.7980440201809971;0.7952626352707877;9.394909401310617;355.88113835876356;5.244474134527214;0.011911021428637128;0.6644432763129993;[BTG2, CDKN1A, PCNA, PTEN, PKD2, CCNB1, CASP2, EP300, GTSE1, E2F7, E2F8, DACT1, CNOT10, CNOT4, CNOT6, TFDP1, RBL1, CNOT7, TFDP2, CNOT1, CTDSP2, RFWD3, CNOT3, CDK2, CNOT8, EZH2]
GO:0060391;positive regulation of SMAD protein signal transduction;8.0;1.0;0.875;9.628524252492122;234.98809543662418;7.292166977892469;0.007864840078708074;0.747921758369865;[NUP93, TGFBR1]
GO:0098719;sodium ion import across plasma membrane;9.0;1.0;0.896240625180289;9.628524252492122;255.84958837647977;7.069023426578259;0.008563055473280314;0.757750811958709;[SLC9A6, SLC9A8]
GO:0048261;negative regulation of receptor-mediated endocytosis;8.0;0.8259837884571596;0.7879918942285797;9.392135474427892;175.26533825665737;6.832634648514029;0.005865973142886497;0.7244212536750128;[LRPAP1, ATXN2, PICALM]
GO:2000379;positive regulation of reactive oxygen species metabolic process;6.0;0.7763722522362496;0.7113064387082693;9.253830803050711;112.71770282919289;5.299736813202263;0.0037725600743465397;0.5941490996802742;[PDGFRB, CDKN1A, P2RX4, RIPK3, NNT, ITGB2, PTX3, RIPK1, PARK7, PKD2, THBS1, DNM2]
GO:2000378;negative regulation of reactive oxygen species metabolic process;6.0;0.7763722522362496;0.7113064387082693;9.253830803050711;113.12708673636307;5.905872616772578;0.003786261785297929;0.6251469128630576;[BCR, TFAP2A, BECN1, G6PD, CAV1, CTNS, BRCA1, PARK7, AATF, SIRT2, ATG5]
GO:0060134;prepulse inhibition;6.0;1.0;0.8231203125901445;9.628524252492122;45.20359748329822;7.212124270218933;0.0015129237271694644;0.6919486831672181;[ADORA2A, PTEN]
GO:1903432;regulation of TORC1 signaling;8.0;0.8933024483968273;0.8216512241984136;9.446202695698167;46.45640819702609;6.409777797693995;0.0015548541743014947;0.7027963346592216;[SEC13, SEH1L, CLEC16A, C9orf72]
GO:0033198;response to ATP;6.0;0.9326813400603323;0.7894609826203107;9.56398573135455;115.93137747960115;6.375876246018314;0.0038801188727762915;0.6491829203200885;[P2RX7, P2RX4, PTEN, HSP90B1, SSH1]
GO:0033197;response to vitamin E;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;57.68202331572161;7.292166977892469;0.00193056540992653;0.7238411236270654;[BECN1, CAT]
GO:1901017;negative regulation of potassium ion transmembrane transporter activity;10.0;0.7866048967936545;0.8085434602577476;9.418803721510052;728.707892328508;7.004484905440688;0.024389197361709854;0.7734506956670166;[CAV1, PTEN, OXSR1]
GO:0060378;regulation of brood size;3.0;0.8933024483968273;0.6447715367885581;9.427853557029971;52.655132693119924;9.083926447120524;0.0017623199046958948;0.6626727335416686;[SH3PXD2B]
GO:0071260;cellular response to mechanical stimulus;5.0;1.0;0.7902410118609202;9.628524252492122;56.1235610070294;5.420364800990877;0.00187840507897962;0.5674387198563348;[PTGER4, MTPN, CD40, MAP3K1, ITGA2, TNFRSF10B, TNFRSF10A, NFKB1, AQP1, BAG3, NPPA, CASP2, TLR7, LTBR]
GO:2000146;negative regulation of cell motility;6.0;0.5781283279524737;0.6121844765663813;8.01908634005802;116.39406446339459;4.247644540169047;0.0038956045897326065;0.5403450519100613;[PTGER4, MCTP1, PTEN, WAS, MIA3, WASL, PTPRK, THBS1, ABR, FLCN, RRAS, TBXA2R, ADORA3, HYAL2, TP53INP1, ARHGDIB, TIMP1, CLASP1, RNF20, STARD13, IGFBP5, JUP, SERPINF1, IDH2, RHOB, BCR, NISCH, SFRP1, EPHA1]
GO:2001237;negative regulation of extrinsic apoptotic signaling pathway;9.0;0.8436909121759173;0.8180860812682478;9.50592193039979;358.6811287979994;5.152100814396198;0.012004734588810557;0.6597193004257005;[FGA, EYA2, TRADD, FGG, TNFRSF10B, TNFRSF10A, BRCA1, PARK7, THBS1, RELA, TGFBR1, LMNA, TMBIM1, RIPK1, ITGAV, BIRC6, RFFL]
GO:2001238;positive regulation of extrinsic apoptotic signaling pathway;9.0;0.8653626801206646;0.8289219652406215;9.54514264355307;358.11284317915005;5.8650506222523235;0.011985714580571521;0.6961795867550195;[TNFRSF12A, CAV1, PTEN, G0S2, STK4, THBS1, STK3, CYLD, SFRP1, HYAL2, RIPK1, LTBR, BID]
GO:0033189;response to vitamin A;7.0;0.9326813400603323;0.8172600352873667;9.533214072687796;42.3983228833862;6.781341354126479;0.0014190337108936392;0.6977174774718518;[ABCB4, CAT, RARA]
GO:0046092;deoxycytidine metabolic process;9.0;0.8653626801206646;0.8289219652406215;9.541512875502493;399.2486070631531;9.777073627680469;0.013362491577985136;0.896240625180289;[TK2]
GO:2001235;positive regulation of apoptotic signaling pathway;8.0;0.6997970393407541;0.724898519670377;9.176539128749065;291.4603159253591;4.6590798152637145;0.009754914476767216;0.6132655584219551;[HRK, YWHAB, PTEN, PARK7, STK4, THBS1, BBC3, STK3, BCLAF1, HYAL2, TP53INP1, TP53BP2, CASP2, CTSH, PLAGL2, RIPK1, BID, GSN, FBXO18, RPS7, TNFRSF12A, RIPK3, CAV1, ATPIF1, PLAUR, G0S2, YWHAZ, TGFBR1, CYLD, SFRP1, TFDP1, TFDP2, ADORA2A, PPIF, LTBR, SERINC3]
GO:1902750;negative regulation of cell cycle G2/M phase transition;8.0;0.7763722522362496;0.7631861261181248;9.249034630787218;106.68287692346017;5.69953618377475;0.003570579882272371;0.6664745454937787;[FANCI, GPR132, FZR1, H2AFY, RAD21, TAOK2, DONSON, TOPBP1, BRCA1, CDK5RAP3]
GO:0002281;macrophage activation involved in immune response;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;81.79914540449643;7.379178354882098;0.0027377437822370863;0.7004918368257019;[SUCNR1, SYK, HAVCR2]
GO:0002283;neutrophil activation involved in immune response;7.0;0.9326813400603323;0.8172600352873667;9.548481544818586;82.20461051260416;3.594988720963838;0.002751314334510546;0.5347672556313635;[SERPINA3, PYGB, GPI, SIGLEC9, FRMPD3, RAB3D, ITGB2, HK3, PSMD7, ACTR1B, PSMD2, LAMP2, CPNE1, TIMP2, CTSH, ITGAV, CPNE3, CAPN1, GUSB, SNAP29, CAP1, ACTR2, SERPINB1, FCER1G, DBNL, SYK, PLAUR, COMMD3, RNASE3, TMEM173, SCAMP1, UNC13D, SERPINB6, VAMP8, ACLY, CAT, TMBIM1, ALDOC, DOCK2, ALDOA, ACPP, SLC27A2, DNASE1L3, KPNB1, CSTB, PDXK, RAB5C, CLEC12A, UBR4, IQGAP2, LILRA2, PLD1, C3, RAP1B, COMMD9, CYB5R3, ALDH3B1, PSMB1, NCKAP1L, RAB6A, AP1M1, CTSA, XRCC6, TMEM30A, RAB4B, GSN, JUP, XRCC5, HSPA6, SURF4, LILRB3, NFKB1, FABP5, VAPA, IMPDH1, IMPDH2, RAB18, PTX3, MNDA, DEGS1, MAN2B1, PTPN6]
GO:0006641;triglyceride metabolic process;7.0;0.8436909121759173;0.7727648213451592;9.318369324188282;85.59385656069774;5.500407508664414;0.0028647493496168257;0.6322104610454062;[FABP5, GPAM, CAV1, CAT, DDHD2, MGLL]
GO:0003374;dynamin family protein polymerization involved in mitochondrial fission;8.0;1.0;0.875;9.628524252492122;46.126504921393284;7.57984905034425;0.0015438126085597365;0.7626338329336335;[MX2, DNM2]
GO:0006886;intracellular protein transport;8.0;0.5537205960740763;0.6518602980370382;8.117066748418225;90.55259897265384;3.0436717358431102;0.0030307139955665606;0.5306535141162272;[RAB3B, VPS29, AHCYL1, RPL3, NUP107, NCF1, PDCD6, RAB3D, ZDHHC6, TBC1D3C, IPO4, RAB43, RPH3A, RPS15, IPO8, IPO9, LAMP2, LONP2, ARFIP1, HOMER3, KPNA4, TBC1D22A, SIL1, VPS18, GSTK1, RPS9, RPS7, COG3, AP1B1, TOMM34, TBC1D2B, MYO7A, SYTL3, BCR, NUP93, RAB35, CHMP4B, RAB38, RPL29, SLC27A2, KPNB1, ACOT4, RTN2, COPB2, COPA, RAB5C, VPS26B, HSP90B1, NCKIPSD, CLTCL1, VPS11, SSR1, RAB6A, TBC1D15, VPS16, AP1M1, CTSA, RAB4B, PMM1, RAB3IP, PMM2, NUP153, RAB27B, TIMM44, NFKBIA, POLA2, PAN3, NPLOC4, CDK5, BCL3, HYOU1, CD24, ARF3, ARF4, TRAM1, YWHAB, SRP54, CLTA, SEC61A2, AP1G2, AP1G1, NUP62, XPO5, KIF13B, TMED2, TMED1, AP3S2, EVI5L, TNPO1, TMED7, TNPO2, ARL5A, TNPO3, RAB8B, TMED4, GRIPAP1, TMED9, SEC13, SYK, SSR2, TBC1D8, ZDHHC12, RHOB, ACOX2, AGPS, CAT, SLU7, ARF5, RABGAP1, TOMM40, RAB1B, ZDHHC23, HSD17B4, ZDHHC24, DERL2, TRAK1, RGPD1, NAPG, STX11, ARNTL, RAB21, AP3M1, RAB20, GGA3, RAB40C, LMNA, AP2S1, HEATR3, STX5, MFN2, RAB28, BID, RAE1, RPL19, PEX16, TIMM8B, PEX19, AGK, SYVN1, RPL23A, RAB11A, ARCN1, SPCS2, SNX17, VPS41, RAB13, TAOK2, RAB18, RUNDC1, RAB3GAP2, VPS45, SEC24C]
GO:0006401;RNA catabolic process;7.0;0.5945822691631375;0.6482104998387692;8.775746926340293;532.6118641417924;4.304802954008995;0.01782603977326812;0.5710671885190304;[HBS1L, FEN1, SMG1, RPL3, RNH1, EIF4A3, PPP2R2A, CASC3, SMG5, PPP2CA, RPS15, DHX34, POLR2G, EXOSC3, DCPS, RPL19, UPF2, UPF1, RPS9, RPS7, PAPD4, CNOT10, RPL23A, RNASE3, LSM5, SND1, PNRC1, ERN1, CNOT4, CNOT6, PAN3, CNOT7, XRN1, CNOT1, CSDE1, CNOT3, MRTO4, XRN2, SKIV2L, ETF1, CNOT8, DCP1A, RPL29, DCP2]
GO:0032924;activin receptor signaling pathway;8.0;0.8436909121759173;0.7968454560879586;9.427853557029971;29.903672154863813;6.518977089658987;0.0010008489954655988;0.7083807915285978;[BMPR2, TGFBR1]
GO:0048681;negative regulation of axon regeneration;11.0;0.7866048967936545;0.8257314007264895;9.463444502132672;878.9066493445661;7.212124270218933;0.02941621458893199;0.8012573229067359;[PTEN, LRIG2]
GO:0032928;regulation of superoxide anion generation;7.0;0.8933024483968273;0.7975705894556142;9.405380701177911;29.554879433861746;6.781341354126479;9.891752169867288E-4;0.6977174774718518;[SYK, ITGB2, AATF]
GO:0070365;hepatocyte differentiation;5.0;1.0;0.7902410118609202;9.628524252492122;24.20171999872632;7.212124270218933;8.100097882234571E-4;0.659069382437994;[ANXA1, ITGA2, E2F7, E2F8]
GO:0051607;defense response to virus;6.0;0.8653626801206646;0.7558016526504768;9.485423408851448;78.89111305633469;4.573066940603674;0.0026404145566033123;0.5569871686019774;[BECN1, ZNF175, CD40, DDX41, ZC3HAV1, LYST, RELA, HYAL2, NLRP3, IFNAR2, DDX17, APOBEC3F, DTX3L, APOBEC3H, MX2, TMEM173, UNC13D, ITCH, ILF3, IL6, CNOT7, GPAM, POLR3B, POLR3C, IL23A, POLR3E, DDIT4, TLR7, SERINC3, APOBEC3A, EXOC1]
GO:0050999;regulation of nitric-oxide synthase activity;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;24.724602712185703;6.039404009397101;8.275102020790521E-4;0.6319757144917204;[SCARB1, CAV1, KRAS, WASL, CALM1, DNM2]
GO:0071456;cellular response to hypoxia;6.0;1.0;0.8231203125901445;9.628524252492122;103.24589989147204;5.104244793218563;0.0034555473540902374;0.5841516286869992;[ENDOG, SUV39H1, PTEN, RORA, AQP3, SIRT2, AQP1, NPEPPS, SFRP1, CCNB1, TBL2, MYC, LMNA, UBQLN1, HYOU1, ATP7A, KCNK3]
GO:0019722;calcium-mediated signaling;7.0;0.7192862368539868;0.710562483684194;8.712233520617966;27.814661162170232;4.835431205071165;9.309316775279788E-4;0.598203541955087;[PRNP, MCTP1, CCL20, SPHK1, EIF2AK3, ATP2A2, DEFB1, CALML4, P2RX4, RCAN3, NMUR1, CALM3, CALM1, CALM2, CCR10, SULT1A3, CCR2]
GO:0051603;proteolysis involved in cellular protein catabolic process;6.0;0.6519675769143192;0.6491041010473041;8.270400768338927;49.64990487012002;3.4509241545253704;0.001661737633989536;0.49960073433695684;[CCNF, BUB1B, UBE3A, UBE2Z, UBE2L3, PSMD8, PSMD7, PSMD4, PSMD2, CDC26, LONP2, SKP2, C18orf25, USP8, RNF44, FBXO18, ARRDC1, KCTD2, TRPC4AP, KCTD5, RNF40, KCTD10, TBL1XR1, CHMP4B, ANAPC5, UBR4, ANAPC11, HSP90B1, CCNB1, RNF213, UBD, UBR5, USP51, CTSA, XBP1, UBE2I, TOR1A, SDF2L1, UBE2B, KLHL25, WFS1, EDEM1, RHBDD1, ERLIN2, BTBD6, MARCH6, NSFL1C, CYLD, RNF103, NPLOC4, CDC16, FBXL3, USP36, USP37, USP38, PPP1R11, USP32, USP34, KIF14, OTUD7B, TRIM9, CTSO, CTSK, CTSH, USP46, SEC13, PDCD6IP, DTX3L, RAD23A, VPS37A, SIRT2, DDB1, PSMA1, MAN1B1, USP41, DERL3, VPS4B, RNF38, USP12, DERL2, NEDD8, PSMB10, PSMA7, ARNTL, FZR1, PSMB5, TP53INP2, PSMB1, UBQLN1, RFFL, RNF20, LRRC29, SYVN1, FBXL15, FBXL16, KBTBD4, ITCH, SPSB1, FAP, PSMC1, TRIM32, MAD2L1]
GO:2001244;positive regulation of intrinsic apoptotic signaling pathway;9.0;0.7671156992804218;0.7797984748205;9.413412872875176;596.4251749563025;5.75172193694532;0.019961813857978603;0.6903839525180965;[BCLAF1, FBXO18, RPS7, RIPK3, CAV1, PLAGL2, PARK7, SERINC3, BID]
GO:0030501;positive regulation of bone mineralization;7.0;0.9326813400603323;0.8172600352873667;9.55953138100517;171.85898464291293;6.221725566191056;0.005751965552953692;0.6690987000520388;[TFAP2A, P2RX7, BMPR2, TMEM119, FAM20C]
GO:2000158;positive regulation of ubiquitin-specific protease activity;10.0;1.0;0.9152410118609203;9.628524252492122;498.23042437157306;9.083926447120524;0.0166753239254458;0.8797934328124444;[TANK]
GO:0003382;epithelial cell morphogenesis;6.0;0.8653626801206646;0.7558016526504768;9.36615998802463;47.452274261266446;6.409777797693995;0.0015881849152503491;0.6509166472493662;[VSIG1, HRH2, COL4A4, MET]
GO:0006893;Golgi to plasma membrane transport;7.0;0.8933024483968273;0.7975705894556142;9.510741216835738;32.11060110714162;5.845247994956144;0.0010747129213912287;0.6498456195510879;[BBS2, ARF3, ARFGEF2, ARF4, SYS1, COMMD1, VAMP5, ARF5, EXOC1, DNM2]
GO:0060317;cardiac epithelial to mesenchymal transition;6.0;0.7980440201809971;0.722142322680643;9.0094850440859;24.75510523691153;6.481236761676141;8.285310941311355E-4;0.6545710619905948;[OLFM1, SPRY1, TGFBR1]
GO:0006897;endocytosis;5.0;0.6324783794010864;0.6064802015614634;8.088079211544972;26.35802846831835;3.582668236575797;8.821794921490709E-4;0.47345883209051776;[ITGB1, SCARB1, DGKD, TFRC, SH3KBP1, NCF2, WIPF2, ITGB3, DENND1A, ITGB2, STON1, CLTA, UBE3A, WASL, FNBP1L, RABEPK, PIK3CG, KIAA1109, ANKFY1, ITGAV, SCARF1, HRAS, CAP1, FCER1G, DBNL, ANXA1, SYK, FNBP1, UNC13D, NME1, DNM2, RUFY1, GAK, ADORA2A, RARA, PIK3C3, RIN3, AMPH, RHOU, DOCK2, MET, CSNK1G2, CSNK1G1, C9orf72, COLEC12, CD163L1, WAS, LRP8, CORO1A, AGER, TM9SF4, HSP90B1, CLN3, HSPH1, CLTCL1, AP2S1, APOL1, AMBP, CAV1, CDC7, MARCH3, MIB1, EHD4, SYNJ1, CDK5, SNX17, CD9, HYOU1, PICALM]
GO:1904706;negative regulation of vascular smooth muscle cell proliferation;7.0;1.0;0.8509193652572005;9.628524252492122;80.8833163751231;6.8867018697843045;0.0027070918088165762;0.7031056191423581;[CDKN1A, PTEN]
GO:0006898;receptor-mediated endocytosis;6.0;0.6799073451904818;0.6630739851853854;8.48339194818912;28.437470009997963;4.178651668682095;9.517765291732001E-4;0.536816753253722;[COLEC12, ITGB1, SCARB1, CD163L1, TFRC, ITGB2, CLTA, FNBP1L, RABEPK, LRP8, AGER, HSP90B1, CLN3, HSPH1, CLTCL1, AP2S1, APOL1, SCARF1, CAP1, FCER1G, DBNL, AMBP, SYK, CAV1, DNM2, GAK, SYNJ1, SNX17, CD9, HYOU1, PICALM]
GO:0006654;phosphatidic acid biosynthetic process;8.0;1.0;0.875;9.628524252492122;659.6112576846374;6.139487467954083;0.022076595183113425;0.6889736746265369;[AGPAT5, PLA2G12A, GPAM, DGKA, PLD1]
GO:0048208;COPII vesicle coating;6.0;1.0;0.8231203125901445;9.628524252492122;62.43707956725794;5.6339389012889365;0.0020897128633926582;0.6112402100070131;[TRAPPC2, TRAPPC3, SEC13, TRAPPC2L, PDCD6, RAB1B, KLHL12, PPP6C, TFG, TBC1D20, TRAPPC6B, COL7A1, TMED2, STX5, SEC24C]
GO:0006412;translation;7.0;0.8653626801206646;0.7836007053175329;9.510741216835738;402.5585345733233;4.39257856489138;0.01347327187300917;0.5755560373415389;[HBS1L, RPL3, MRPS16, MRPS36, RRBP1, MRPL37, RPS15, RPL36AL, HARS, RPL19, RPL39L, RPS9, NDUFA7, MRPS24, RPS7, MRPS18B, MRPS18A, SARS, RPL23A, RPL3L, COPS5, TNIP1, RPL7L1, RPL22L1, RPL29, MRRF, CPEB4]
GO:0006646;phosphatidylethanolamine biosynthetic process;8.0;0.8933024483968273;0.8216512241984136;9.54514264355307;660.9975520457573;7.004484905440688;0.022122993207796184;0.7332096838060964;[CHKB, CHKA]
GO:0006888;ER to Golgi vesicle-mediated transport;6.0;1.0;0.8231203125901445;9.628524252492122;49.13394272044514;4.493869898942481;0.001644468845175705;0.5529370282083849;[DCTN6, DCTN5, COPB2, ARF4, COPA, DCTN2, DCTN4, PDCD6, RAB1B, GOSR1, DCTN3, KLHL12, TEX261, MIA3, RAB43, ACTR1A, SPAST, TFG, CAPZB, TMED2, STX5, TMED1, TMED7, TMED4, TRAPPC2, TRAPPC3, TMED9, TRAPPC2L, COG4, COG3, DDHD2, COG1, DYNLL2, SPTB, ARFGAP1, YIF1A, ARCN1, TBC1D20, TMEM115, VAPA, TRAPPC6B, GOLGB1, COL7A1, HYOU1, SEC24C, SEC22C]
GO:0046034;ATP metabolic process;10.0;0.6519675769143192;0.7412248003180799;9.106334870075816;1262.3387643731025;4.99795013456894;0.04224934241243719;0.6708364141712261;[GPI, STOML2, TPI1, ADPGK, ATP5J, CTNS, ATP5I, BPGM, COX5B, ATP5O, ATP5F1, ATP5L, HK3, ATP6V0A2, FAM20C, ALDOC, CYC1, ALDOA, GAPDH]
GO:0050766;positive regulation of phagocytosis;8.0;0.7671156992804218;0.7585578496402109;9.34084218004034;175.32691305650852;5.825829909099042;0.005868033996023792;0.6729332124801218;[FCER1G, ITGA2, SIRPG, C2, DNM2, BCR, C3, ABR, RAPGEF1, PTX3, NCKAP1L, ITGAV, DOCK2, CD300LF]
GO:0050767;regulation of neurogenesis;6.0;0.47270034079162526;0.5594704829859571;7.335989495351577;60.464536800347794;3.1570004211501135;0.002023693632157412;0.4845694609432947;[BMPR2, WDR1, GFI1, CHD7, PTEN, CIB1, CYB5D2, EIF4ENIF1, PPP1CC, PREX1, NIPBL, CFL1, KIF13B, CPNE1, TIMP2, SOX8, SCARF1, CDK5RAP3, ZNF365, CCR2, SEMA6B, ACTR2, TNFRSF12A, SERPINF1, PAQR3, OMG, THOC2, SIRT2, NME1, DNM2, GAK, OLFM1, SFRP1, RUFY3, KIT, RAPGEF1, RARA, ADNP, FKBP4, PAFAH1B1, FOXG1, TWF2, TRAK1, LRP8, AGER, RELA, ARNTL, RAB21, FXR1, NCKIPSD, ABL1, DVL3, LRIG2, ECT2, MARK2, SPEN, TMEM30A, SEMA4D, XRCC5, SEMA4B, IDH2, SSH3, RAB11A, MIB1, SSH1, SETX, PER2, CCDC88A, SYNJ1, CDK5, FES, RHEB, CAPRIN1, CAMK1, TRIM32, EZH2]
GO:0098706;ferric iron import across plasma membrane;11.0;1.0;0.9324289523296623;9.628524252492122;329.4898826815344;7.9853141584524145;0.011027729851708358;0.8407982897480031;[STEAP3, ARHGAP1]
GO:0050764;regulation of phagocytosis;7.0;0.6873818243518346;0.6946102774331178;9.05316010758856;47.10255867462412;5.4730085344763;0.0015764802492890249;0.6308092762312435;[SCARB1, FCER1G, SYK, ITGA2, SIRPG, PTEN, C2, DNM2, BCR, C3, ABR, RAPGEF1, PTX3, NCKAP1L, CSK, ITGAV, DOCK2, CD300LF, ATG5]
GO:0050765;negative regulation of phagocytosis;8.0;0.8436909121759173;0.7968454560879586;9.503361109538115;175.4194889364855;7.069023426578259;0.005871132427413739;0.7365101867784198;[PTEN, CSK, CD300LF, ATG5]
GO:0014003;oligodendrocyte development;5.0;1.0;0.7902410118609202;9.628524252492122;34.09911675737102;6.558197802812269;0.001141266750656509;0.6256275524841266;[MED12, EIF2B4, GSN, CD9]
GO:0060586;multicellular organismal iron ion homeostasis;10.0;1.0;0.9152410118609203;9.628524252492122;58.33118610341119;7.57984905034425;0.0019522923042219213;0.8028748447945538;[HYAL2]
GO:1900116;extracellular negative regulation of signal transduction;7.0;0.811012628672052;0.7564256795932265;9.34084218004034;186.7212249151276;6.8867018697843045;0.0062493913597168604;0.7031056191423581;[LRPAP1]
GO:1904715;negative regulation of chaperone-mediated autophagy;8.0;1.0;0.875;9.628524252492122;775.6380740464814;8.67846133901236;0.025959908309388966;0.8188169164668168;[CTSA]
GO:0050773;regulation of dendrite development;9.0;0.7586651285174919;0.775573189439035;9.510741216835738;86.24077544028233;4.857092701852345;0.002886401142327329;0.6446325718309276;[ACTR2, SEMA4D, PTEN, LRP8, RAB21, FXR1, PREX1, CDK5, CAPRIN1, CFL1, CAMK1, PAFAH1B1, EZH2]
GO:0050771;negative regulation of axonogenesis;10.0;0.7436939687323844;0.7870879962271125;9.36383169826504;885.0968544383536;5.54296712308321;0.029623395182598163;0.6987086083097278;[SEMA6B, CDK5, SEMA4D, RUFY3, SEMA4B, OMG, PTEN]
GO:1904707;positive regulation of vascular smooth muscle cell proliferation;7.0;1.0;0.8509193652572005;9.628524252492122;80.75549718811011;6.444869117505266;0.0027028138156570515;0.6805102716434839;[ERN1, IGFBP5, MFN2, MAP3K5]
GO:0000086;G2/M transition of mitotic cell cycle;5.0;1.0;0.7902410118609202;9.628524252492122;43.44612409677276;4.981283082083729;0.0014541026745458175;0.5449840603320351;[CDKN1A, DCTN2, DCTN3, FBXL15, PPP2R2A, PKMYT1, MASTL, TUBG1, CKAP5, CDC25A, CIT, DNM2, CCNB1, WEE1, ACTR1A, PPME1, CENPJ, CEP70, CDK2, FGFR1OP, SKP2, MAPRE1, CLASP1, PAFAH1B1]
GO:0050770;regulation of axonogenesis;9.0;0.6324783794010864;0.7124798148808322;8.859391164954255;152.1280667645758;4.606589632642318;0.005091589488238978;0.6318218332219429;[SEMA6B, BMPR2, SEMA4D, TNFRSF12A, SEMA4B, OMG, TWF2, PTEN, TRAK1, SSH3, RAB11A, SSH1, DNM2, RAB21, OLFM1, CDK5, RUFY3, KIF13B, ABL1, ADNP, MARK2, PAFAH1B1]
GO:0045198;establishment of epithelial cell apical/basal polarity;6.0;0.8933024483968273;0.7697715367885581;9.510741216835738;84.74551277475317;7.212124270218933;0.0028363560465611;0.6919486831672181;[MSN]
GO:0000082;G1/S transition of mitotic cell cycle;5.0;1.0;0.7902410118609202;9.628524252492122;42.752976916212816;5.142344639450834;0.0014309036622044387;0.5532207558659172;[ITGB1, CDKN1A, USP37, MAX, GMNN, MCM10, PPP6C, GPR132, PPAT, MYC, SKP2, CDKN2D, CDKN2C, CDC7, CDC25A, POLE4, WEE1, POLA2, CDK6, CCNE2, CCNE1, POLE2, CDK2, POLE3, MCM5, RHOU, MCM6, MNAT1, MCM2]
GO:0071479;cellular response to ionizing radiation;6.0;0.8933024483968273;0.7697715367885581;9.446202695698167;48.660440229648614;5.602686357784832;0.0016286211429333208;0.6096419534788213;[CDKN1A, XRCC6, XRCC5, ELK1, TANK, RHOB, DNM2, RAD51AP1, NIPBL, SFRP1, WRN, RAD51, POLE3, INTS7, ECT2, HRAS]
GO:2001269;positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway;13.0;0.9326813400603323;0.9288956347978027;9.609476057521427;1176.1232083486047;7.474488534686424;0.03936378534126017;0.8448006560307637;[GSN]
GO:0035176;social behavior;3.0;1.0;0.6981203125901445;9.628524252492122;22.58175877758554;5.8067817141283475;7.557911440223213E-4;0.49507939949363344;[TBX1, OXTR, PTEN, CIC]
GO:2001044;regulation of integrin-mediated signaling pathway;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;41.8512380110395;7.212124270218933;0.0014007232725606145;0.6919486831672181;[TIMP1]
GO:0060338;regulation of type I interferon-mediated signaling pathway;7.0;0.8653626801206646;0.7836007053175329;9.503361109538115;103.51609522721039;6.481236761676141;0.003464590548817385;0.6823701146576509;[IFNAR2, CNOT7, PTPN6, LSM14A]
GO:0002031;G-protein coupled receptor internalization;8.0;0.9326813400603323;0.8413406700301662;9.567899630675686;66.79409571189065;7.379178354882098;0.0022355382726935618;0.7523715242355574;[DNM2]
GO:1901216;positive regulation of neuron death;6.0;0.811012628672052;0.7286266269261705;9.260799472366804;58.38287487682085;5.370354380416217;0.001954022280951067;0.5977604853516485;[TFAP2A, PRNP, ITGB2, ELK1, EIF2S1, SSH1, CDK5, CASP3, DDIT4, TP53BP2, ABL1, CASP2, MAP3K5, PICALM]
GO:0006874;cellular calcium ion homeostasis;9.0;0.6324783794010864;0.7124798148808322;8.83001655627435;287.08247441589424;3.7781370657337865;0.009608392061246992;0.5894547304232562;[PTGER4, OXTR, STOML2, CD40, ITPR2, ATP2A2, PKD2, PIK3CG, CLN3, GNAT2, TBXA2R, CCL5, ABL1, PDE6B, ITGAV, CCL19, NTSR1, CCR10, GTF2I, CCR2, ATP13A1, WFS1, CAV1, SWAP70, GPR55, P2RX7, CD4, P2RX4, CALM3, ATP13A3, CALM1, CD24, CALM2, KCNK3]
GO:0051873;killing by host of symbiont cells;7.0;0.811012628672052;0.7564256795932265;9.454170865347344;141.48138775290343;7.57984905034425;0.004735254723107338;0.738553198190834;[GAPDH]
GO:0006626;protein targeting to mitochondrion;10.0;1.0;0.9152410118609203;9.628524252492122;196.80778803422263;6.250713103064308;0.006586979549995513;0.734902770639515;[TIMM8B, TOMM40, TOMM34, MFN2, TIMM44, BID]
GO:0070372;regulation of ERK1 and ERK2 cascade;10.0;0.8653626801206646;0.8479223519212526;9.541512875502493;158.98679164778278;4.069963362931594;0.0053211448376282704;0.623379127513894;[ERRFI1, PTEN, CIB1, PTPN22, AGER, IGF1R, RAP1B, FLCN, RRAS, CCL5, ABL1, CSK, CCL19, FAM83D, HRAS, EPHB4, HAVCR2, PDGFRB, FGA, ANGPT1, SYK, CCL20, RYK, FGG, GPR55, CD4, NLRP12, KARS, TNIP1, KIT, RAPGEF1, SPRY1, PTPN6, TEK, EPHA1, MET]
GO:1904719;positive regulation of AMPA glutamate receptor clustering;10.0;1.0;0.9152410118609203;9.628524252492122;255.30246384087266;9.777073627680469;0.008544743707453659;0.9152410118609203;[SSH1]
GO:0006625;protein targeting to peroxisome;10.0;0.8933024483968273;0.861892236059334;9.56183287799345;237.37488197280172;5.572381008289503;0.007944723676105511;0.7002128357670632;[PEX16, GSTK1, PEX19, ACOX2, AGPS, CAT, HSD17B4, LONP2, SLC27A2, ACOT4, RAB8B]
GO:0071222;cellular response to lipopolysaccharide;6.0;1.0;0.8231203125901445;9.628524252492122;237.99812851129587;4.786641040901733;0.007965583176863442;0.5679093580234316;[UPF1, CXCL6, XBP1, CD40, ABCC2, CCL20, GFI1, CD80, PDCD1LG2, NFKB1, RELA, BCR, IL6, PABPN1, TNIP1, NLRP7, TBXA2R, TNIP2, ABL1, RARA, NLRP3, IL12A, HAVCR2, NFKBIB]
GO:0070373;negative regulation of ERK1 and ERK2 cascade;11.0;1.0;0.9324289523296623;9.628524252492122;1180.902522994834;5.6339389012889365;0.039523744701365535;0.7205488497465309;[FLCN, ERRFI1, NLRP12, TNIP1, ABL1, RAPGEF1, PTEN, CSK, SPRY1]
GO:0070374;positive regulation of ERK1 and ERK2 cascade;11.0;0.9326813400603323;0.8987696223598284;9.604993755081928;1178.864923326294;4.330336256014159;0.03945554807418015;0.6538825498434562;[PTEN, CIB1, PTPN22, AGER, IGF1R, RAP1B, CCL5, ABL1, CCL19, HRAS, EPHB4, HAVCR2, PDGFRB, FGA, ANGPT1, CCL20, RYK, FGG, GPR55, CD4, KARS, KIT, RAPGEF1, TEK, EPHA1, MET]
GO:0071226;cellular response to molecule of fungal origin;5.0;1.0;0.7902410118609202;9.628524252492122;58.24779613319063;9.083926447120524;0.00194950131696474;0.7547934328124444;[SYK]
GO:0014068;positive regulation of phosphatidylinositol 3-kinase signaling;8.0;1.0;0.875;9.628524252492122;238.41769229280743;5.602686357784832;0.007979625599047746;0.6615216408886768;[PDGFRB, BECN1, NCF1, ANGPT1, SEMA4D, CCL5, KIT, CAT, UBE3A, PTPN6, TEK]
GO:0014067;negative regulation of phosphatidylinositol 3-kinase signaling;8.0;1.0;0.875;9.628524252492122;238.79440420981607;7.292166977892469;0.00799223380789131;0.747921758369865;[PIK3IP1, PTEN]
GO:0061052;negative regulation of cell growth involved in cardiac muscle cell development;10.0;1.0;0.9152410118609203;9.628524252492122;1870.595370074125;8.16763571524637;0.0626071436098452;0.8329342821725234;[G6PD]
GO:1903003;positive regulation of protein deubiquitination;10.0;0.8653626801206646;0.8479223519212526;9.5544162803384;912.3518242519174;7.8311634786251565;0.030535594494377795;0.8157270763441555;[WDR48, TNIP1, TANK]
GO:0051491;positive regulation of filopodium assembly;9.0;1.0;0.896240625180289;9.628524252492122;200.30665838708023;6.409777797693995;0.006704083591926775;0.7240369598395108;[DOCK11, WASL, FNBP1L, TGFBR1]
GO:0051490;negative regulation of filopodium assembly;9.0;1.0;0.896240625180289;9.628524252492122;173.84791521056468;8.67846133901236;0.005818533269131697;0.8400575416471059;[CAPZB]
GO:0008625;extrinsic apoptotic signaling pathway via death domain receptors;7.0;0.9326813400603323;0.8172600352873667;9.523163736834295;52.44533375847466;6.311337724880743;0.0017552981231601008;0.6736814700148209;[DIABLO, BAG3, TRADD, TNFRSF10B, TNFRSF10A, BID, DEDD]
GO:0042775;mitochondrial ATP synthesis coupled electron transport;7.0;1.0;0.8509193652572005;9.628524252492122;33.34232067890278;7.57984905034425;0.0011159374669824286;0.738553198190834;[BID, TAZ]
GO:0097494;regulation of vesicle size;5.0;1.0;0.7902410118609202;9.628524252492122;28.02071028012121;8.390779266560578;9.378279560736312E-4;0.7193458537639684;[RAB3B, PICALM]
GO:0006687;glycosphingolipid metabolic process;7.0;0.6763753087927167;0.6891070196535589;9.040737587590003;147.45961877692685;5.734022359845919;0.004935340735422783;0.64415753539903;[GALC, GLTP, CTSA, UGT8, CLN3, ALDH5A1, KIT, GBA2, SUMF1]
GO:0030307;positive regulation of cell growth;6.0;0.6954798709641801;0.6708602480722345;8.712233520617966;80.64681300048527;4.733648510761223;0.0026991762537066665;0.5651993175676412;[MTPN, BMPR2, CSNK2A1, SEMA4D, TNFRSF12A, PARP2, SPHK1, H3F3A, TWF2, DERL2, CIB1, RAB11A, TGFBR1, SFRP1, RUFY3, FGFR1OP, ADNP, TRIM32, EIF4G2, PAFAH1B1, HBEGF]
GO:0030308;negative regulation of cell growth;6.0;0.6913464685778243;0.6687935468790567;8.673012807464685;80.89021177018715;4.623782033182691;0.0027073225914839173;0.5595807407949613;[SEMA6B, CDKN2D, CDKN1A, G6PD, CDKN2C, BMPR2, BTG1, SEMA4D, EI24, SEMA4B, EAF2, ADIPOR2, PPP2CA, FLCN, SERTAD3, SFRP1, GAL, CDK5, SERTAD2, HYAL2, NPPA, SCGB3A1, RBBP7]
GO:0032728;positive regulation of interferon-beta production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;84.40547105694755;6.343086423195323;0.0028249751562838235;0.6753050999230941;[RNF135, POLR3B, POLR3C, ZBTB20, TLR7]
GO:0030540;female genitalia development;5.0;0.8933024483968273;0.736892236059334;9.405380701177911;51.25239902994334;7.004484905440688;0.001715371671367711;0.6484506956670166;[CHD7]
GO:0032720;negative regulation of tumor necrosis factor production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;85.92712208559752;5.926926025970411;0.002875903446815721;0.6540226378555745;[ERRFI1, BCL3, RARA, PTPN22, HAVCR2]
GO:0016239;positive regulation of macroautophagy;8.0;0.7671156992804218;0.7585578496402109;9.242861771680136;266.06548500403863;5.666199763507158;0.008904972339694651;0.6647697194109919;[BECN1, CALCOCO2, CLEC16A, RAB3GAP2, MFN2, ULK1, RAB3GAP1, C9orf72]
GO:0042307;positive regulation of protein import into nucleus;9.0;0.9326813400603323;0.8625812952104552;9.592156608321247;778.7460608588023;6.063501560976162;0.02606392983099081;0.706328376990269;[HDAC3, JUP, BAG3, HYAL2, TPR, UBR5, ECT2, TMEM173]
GO:0085032;modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade;8.0;0.9326813400603323;0.8413406700301662;9.57973408832269;107.52635477412818;9.777073627680469;0.0035988103268534475;0.875;[TNIP1]
GO:0045815;positive regulation of gene expression, epigenetic;7.0;0.7763722522362496;0.7391054913753253;9.081980546124052;79.85422672196849;5.8650506222523235;0.0026726491042460506;0.6508583268319309;[TBP, H2AFY, WBP2, ATAD2, TAF1A, POLR2E, EP300, POLR1E, DEK, ARID1A, SF3B1]
GO:0002091;negative regulation of receptor internalization;9.0;0.9326813400603323;0.8625812952104552;9.585964638073326;394.0818765588627;7.57984905034425;0.013189565757762102;0.7838744581139225;[LRPAP1, ATXN2]
GO:0002092;positive regulation of receptor internalization;9.0;0.9326813400603323;0.8625812952104552;9.585964638073326;393.55365953464764;6.599019797332524;0.013171886809326083;0.7337148045016781;[ANGPT1, SYK]
GO:0000902;cell morphogenesis;4.0;0.6260725219892441;0.563036260994622;7.923776160253697;43.26261951924051;4.420487353008457;0.0014479609414792109;0.47606392880653703;[CYFIP2, ITGB1, NCKAP1, ITGB3, LST1, KIF14, STK4, VSIG1, CAPZB, HRH2, ABL1, NCKAP1L, ITGAV, ECT2, SOX6, CAP1, TBCCD1, THOC2, SSH1, P2RX7, BIN3, PARVG, TBC1D20, COL4A4, COL7A1, TEK, EPHA1, MET]
GO:1903012;positive regulation of bone development;6.0;0.8653626801206646;0.7558016526504768;9.36615998802463;85.25827669706136;7.697632086000634;0.0028535177935831856;0.7167775754447168;[TMEM119]
GO:0006695;cholesterol biosynthetic process;7.0;0.8653626801206646;0.7836007053175329;9.50592193039979;430.3580998185219;6.039404009397101;0.014403698303781551;0.6597747671587765;[ACLY, SQLE, EBP, NSDHL, G6PD, CYB5R3, GGPS1]
GO:0051260;protein homooligomerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;4.056761851073058;0.00140677858073304;0.5305833023127396;[COLEC12, KCNG1, CRTC2, DGKD, ITLN1, KCNA3, PKD2L1, NLRC4, PKD2, CLYBL, ACACA, GLS, SPAST, RXRA, RNF213, PPAT, RIPK1, ECT2, BID, VASP, POLQ, PRNP, PDCD6IP, KCND1, FCER1G, TOR1A, RIPK3, GPX3, CAV1, DCXR, ATPIF1, EIF2AK3, KCTD2, KCTD5, MARCKS, ALDH5A1, RAD51, P2RX4, EHD4, KCTD10, IMPDH2, CAT, KCTD14, CHMP4B, ALDOA, ACPP, PAM]
GO:0008631;intrinsic apoptotic signaling pathway in response to oxidative stress;7.0;0.8653626801206646;0.7836007053175329;9.523163736834295;52.930841574252625;6.943860283624253;0.001771547632825523;0.7060287030842711;[DIABLO, ARL6IP5, ZNF622, PDK1, MAP3K5]
GO:0006212;uracil catabolic process;9.0;1.0;0.896240625180289;9.628524252492122;1126.0761526232816;9.083926447120524;0.03768875542555955;0.8607930461318132;[DPYD]
GO:0042542;response to hydrogen peroxide;5.0;0.9326813400603323;0.7565816818910864;9.541512875502493;79.2907140195247;5.09494240055625;0.0026537888412237636;0.5507966031644187;[PDGFRB, BECN1, PCNA, ANXA1, PARK7, RELA, AQP1, RHOB, MAPK13, SETX, IL6, CASP3, CAT, PPIF, ABL1, SDC1, KPNA4, ECT2, EZH2, MAP3K5]
GO:0006210;thymine catabolic process;9.0;1.0;0.896240625180289;9.628524252492122;1047.620013338454;8.67846133901236;0.03506289904963761;0.8400575416471059;[DPYD]
GO:0009725;response to hormone;4.0;0.5257808277979137;0.5128904138989568;7.033269545535256;21.85620986101781;3.280298637494607;7.315076747364311E-4;0.41775462487096104;[ERRFI1, BTG2, OXTR, CDKN1A, BTG1, PTEN, UBE3A, ELK1, AACS, UBE2L3, AQP1, YY1, PPAT, CASP3, NPPA, TIMP2, CTSH, TIMP1, RAB8B, PDGFRB, USP8, PAQR6, ABCC2, ENDOG, ANXA1, IGFBP5, NCOA6, ITGA2, SERPINF1, CAD, RNF40, NME1, SFRP1, GAL, XRN1, DDIT4, KIT, CAT, RARA, TRIB3, PTGER4, PCNA, WBP2, MAX, ROCK2, ABCB4, ADCY4, THBS1, CRHR1, RELA, ACACA, RAP1B, GNG2, TBXA2R, SCAP, CSK, CYC1, CCL19, RBBP7, EIF2B4, XBP1, ABCA3, CAV1, MSN, CRLS1, TSHR, NFKB1, SOX30, CD4, IL6, SP1, MARS, RAB13, SDC1, KRAS, TEK, PAM, EZH2]
GO:0009967;positive regulation of signal transduction;6.0;0.44130843764162375;0.5437745314109563;6.712834686611667;140.23187634019237;2.4492930892588385;0.004693434700611163;0.44837727507861835;[CYFIP2, MAML1, GFI1, RASSF2, TFG, ARL6IP5, CPNE1, IL12A, SKP2, EPHB4, CDK5RAP3, CSNK2A1, SLC35C2, MAPK8IP3, RC3H2, NUP93, DEPDC1B, SFRP1, TWSG1, KARS, IL23A, EPHA1, SEH1L, MTDH, C3, TP53BP2, NTSR1, CREBBP, XBP1, JUP, STARD10, PUM2, CYLD, ARL2BP, TREML4, CALM3, CALM1, CD24, CALM2, EZH2, CDKN1C, HRK, CD40, ARHGAP1, BBC3, AKAP13, ING2, C1QBP, HYAL2, TIMP2, CTSH, HRAS, HAVCR2, TMED4, DUSP5, MAP4K2, SEC13, DBNL, TNFRSF12A, RIPK3, SYK, SPHK1, FCRL3, ATPIF1, ZDHHC13, RHOC, ZDHHC17, VAV1, ITPKB, KIT, RAPGEF1, TLR7, ARHGEF5, PAFAH1B1, HBEGF, SLC20A1, TUBD1, GPS2, RELA, ARNTL, BCLAF1, PLAGL2, CCL19, BID, MAP3K3, MAP3K1, GSN, CCL20, RYK, GPR55, G0S2, NLRP12, TAOK2, LIMS1, NCF1, CD80, CIB1, UBE3A, PARK7, IGF1R, EP300, MAP3K5, PDGFRB, USP8, FBXO18, IGFBP5, RPS7, ERN1, TBL1XR1, MADD, PPIF, CARD11, ANKRD17, CLEC16A, STK4, AGER, RASGRP4, STK3, RAP1B, BAG4, UBD, UBR5, ABL1, DVL3, RIPK1, ECT2, CD300LF, UBE2I, CAV1, TNFRSF10B, TNFRSF10A, NFKB1, SSH1, IL6, CDK5, RHEB, SERINC3, LSM14A, BCAR3, ITGB1, BMPR2, YWHAB, ITGB3, TRADD, USP34, PTEN, PTPN22, PKD2, PIK3CG, FLCN, PTBP1, RASGEF1A, NUP62, CASP2, ITGAV, DACT1, FGA, KSR1, BUD31, FGG, PLAUR, ZFP91, ARNT, IRAK4, YWHAZ, TGFBR1, DUSP22, TFDP1, ALS2, TFDP2, ADORA2A, CAT, ACPP, MET, BECN1, HDAC3, WBP2, THBS1, CCL5, TP53INP1, CSK, ZNF622, SH2B3, SH2B2, TBX1, PDE6H, ANGPT1, SEMA4D, FBXL15, P2RX7, CD4, P2RX4, VAPA, TNIP2, TSPAN17, ASXL2, KRAS, PTPN6, TEK, LTBR, TRIM32]
GO:0006214;thymidine catabolic process;10.0;1.0;0.9152410118609203;9.628524252492122;2915.381228856312;9.777073627680469;0.09757518605705806;0.9152410118609203;[DPYD]
GO:0051016;barbed-end actin filament capping;13.0;1.0;0.9625549647676366;9.628524252492122;827.5885363368888;7.069023426578259;0.027698643529868262;0.8240651515460564;[VIL1, GSN, CAPZB, TWF2]
GO:0051497;negative regulation of stress fiber assembly;11.0;1.0;0.9324289523296623;9.628524252492122;338.83785420150645;6.781341354126479;0.01134059804585365;0.7792270645443136;[PPFIA1, WAS, MET, CLASP1]
GO:0032956;regulation of actin cytoskeleton organization;7.0;0.559792591703537;0.630815661108969;7.718981747607684;34.11626247365944;3.9689311377000256;0.0011418406023505395;0.553890688213353;[NCKAP1, GMFB, WDR1, WIPF2, ARPC1A, WASL, AKAP13, PREX1, CAPZB, ARHGDIB, CFL1, SH3PXD2B, PPFIA1, ARFIP1, HRAS, PDGFRB, ACTR2, SWAP70, RHOC, SPTB, TGFBR1, CIT, RHOB, SFRP1, CDC42EP4, MYADM, RHOU, EPHA1, MET, ARHGEF5, C9orf72, PTGER4, MTPN, ROCK2, TWF2, WAS, IQGAP2, CORO1A, BAG4, ABL1, NCKAP1L, CLASP1, S100A10, VASP, GSN, SSH3, SSH1, VIL1, CCDC88A, ARPC2, CDK5, FES, TAOK2, TEK, PAM]
GO:0051496;positive regulation of stress fiber assembly;11.0;1.0;0.9324289523296623;9.628524252492122;365.07497849775285;5.926926025970411;0.012218730984170163;0.735532224928036;[SFRP1, BAG4, SH3PXD2B, ABL1, EPHA1, ARHGEF5, TGFBR1, S100A10]
GO:0016241;regulation of macroautophagy;7.0;0.6729672293956388;0.6874029799550199;8.606873004960141;45.30384692040349;4.7081694254602375;0.0015162789856107417;0.5916953686275062;[BECN1, USP36, CALCOCO2, RAB1B, CLEC16A, VPS26B, MTM1, ERN1, CDK5, RHEB, CASP3, ATP6V0A2, CHMP4B, RAB3GAP2, MFN2, ULK1, CAPN1, GAPDH, RAB3GAP1, EXOC1, C9orf72]
GO:0031623;receptor internalization;7.0;0.7248374789738407;0.7133381047441208;9.201080237665183;64.84818556283533;5.682729065458369;0.0021704104112101165;0.6415343939386686;[ITGB1, FCER1G, SYNJ1, TFRC, SYK, CAV1, ITGB2, CD9, PICALM, DNM2]
GO:1902174;positive regulation of keratinocyte apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;129.82178199018807;8.67846133901236;0.00434501821119318;0.8400575416471059;[GSN]
GO:0043407;negative regulation of MAP kinase activity;12.0;0.811012628672052;0.8536266269261705;9.539970855150678;2610.1786565788484;5.4730085344763;0.08736033062741366;0.7280102235641875;[DUSP5, CAV1, GPS1, PAQR3, GPS2, PTPN22, DUSP14, PPP2CA, DUSP22, SFRP1, HYAL2, NUP62, STK38, SPRY1, PTPN6, CDK5RAP3]
GO:1903020;positive regulation of glycoprotein metabolic process;7.0;0.7369933605727446;0.7194160455435727;9.186691500213083;287.9044849027368;6.7325511899570465;0.009635904012480203;0.6952223462072524;[SOAT1, RAB1B, CCL19]
GO:0014044;Schwann cell development;5.0;1.0;0.7902410118609202;9.628524252492122;34.09911675737102;8.390779266560578;0.001141266750656509;0.7193458537639684;[MED12, CDK5]
GO:1903265;positive regulation of tumor necrosis factor-mediated signaling pathway;8.0;1.0;0.875;9.628524252492122;305.68887294206377;7.57984905034425;0.01023113147524637;0.7626338329336335;[CPNE1, TRIM32]
GO:0002062;chondrocyte differentiation;4.0;0.8933024483968273;0.6966512241984136;9.446202695698167;21.066225782797595;6.039404009397101;7.050676185779127E-4;0.5588554019015759;[SNX19, NFIB, CYTL1, RUNX2, RUNX1]
GO:0022900;electron transport chain;4.0;0.7140352122741334;0.6070176061370667;8.475844742553736;29.758801740447502;4.623782033182691;9.96000313069993E-4;0.48646042820481683;[NDUFB7, NDUFB10, NCF1, COX15, NCF2, COX4I1, NDUFA10, ETFA, GLRX, ETFB, COX5B, COX6A1, TAZ, AKR7A2, IDH3B, PMPCB, CYC1, BID, NDUFA7, TXNRD1, COQ9, UGDH, COX7A2L, ALDH5A1, NDUFS8, NDUFS7, UQCRQ, NDUFS6, DEGS1]
GO:0006661;phosphatidylinositol biosynthetic process;8.0;0.7508913569872202;0.7504456784936101;9.237657943805111;661.808482261977;4.917261223318797;0.022150134312343243;0.6264689676365554;[ARF3, VAC14, PIGU, PLEKHA2, PTEN, PIK3CG, MTMR6, MTM1, RUFY1, DPM3, SYNJ1, PIGA, PIK3C3, SBF1]
GO:0043401;steroid hormone mediated signaling pathway;6.0;0.7508913569872202;0.6985659910837546;8.801845679307654;25.735219620490994;4.909539177224887;8.613346405038622E-4;0.5741943744303455;[DDX17, PAQR6, EGLN2, NCOA6, WBP2, RORA, UBE3A, BRCA1, SAFB, ARID1A, PIAS2, MED12, RXRA, MED30, CCNE1, UBR5, RARA, TAF7, FKBP4]
GO:0002068;glandular epithelial cell development;6.0;0.8259837884571596;0.7361122068187242;9.143016436710422;35.73672554677016;7.069023426578259;0.0011960760430854717;0.6846304993685643;[CDK6, RARA]
GO:0006423;cysteinyl-tRNA aminoacylation;11.0;0.9326813400603323;0.8987696223598284;9.590783924509275;205.4345073903719;9.083926447120524;0.006875708083302461;0.8969813732811862;[CARS]
GO:0010916;negative regulation of very-low-density lipoprotein particle clearance;6.0;1.0;0.8231203125901445;9.628524252492122;56.919357069360565;8.390779266560578;0.0019050396570158856;0.7522251544931926;[LRPAP1]
GO:1990266;neutrophil migration;8.0;0.8933024483968273;0.8216512241984136;9.446202695698167;32.18154458361247;5.277263957350204;0.0010770873357037246;0.6448795241967606;[CXCL6, FCER1G, WDR1, SYK, CCL20, ITGB2, IRAK4, VAV1, PIK3CG, PREX1, CCL5, NCKAP1L, CCL19]
GO:0006657;CDP-choline pathway;9.0;1.0;0.896240625180289;9.628524252492122;751.2326363803086;7.8311634786251565;0.025143080274170074;0.7967266896635242;[CHKB, CHKA]
GO:1902170;cellular response to reactive nitrogen species;5.0;0.8653626801206646;0.7229223519212526;9.310070521373587;43.014841799506705;6.832634648514029;0.0014396680441851907;0.639662265535933;[CDK2, AQP1, MAP3K5, DNM2]
GO:0030521;androgen receptor signaling pathway;8.0;0.8933024483968273;0.8216512241984136;9.446202695698167;54.01143535742291;5.948432231191374;0.0018077141342769656;0.6792031009335148;[DDX17, MED12, MED30, CCNE1, UBE3A, BRCA1, ARID1A, FKBP4, PIAS2]
GO:0016236;macroautophagy;5.0;0.7671156992804218;0.6737988615011312;8.935377071932177;39.83166466328102;5.244474134527214;0.0013331299701091492;0.5584436629936305;[BECN1, GABARAPL1, CALCOCO2, VTA1, EI24, VPS4B, ATG10, VPS37A, VPS37B, DYNLL2, PRKAB1, CLN3, FUNDC1, UBQLN1, C6orf106, CHMP4B, MFN2, PIK3C3, ULK1, CHMP6, ATG5]
GO:0043410;positive regulation of MAPK cascade;10.0;0.6634067003016617;0.7469443620117512;9.174268980214526;1017.2390743488962;3.4929394666096676;0.03404607636272706;0.5938700986216354;[CD40, NCF1, PTEN, CIB1, PTPN22, PIK3CG, IGF1R, AKAP13, RASSF2, ARL6IP5, TIMP2, ITGAV, HRAS, EPHB4, HAVCR2, MAP3K5, PDGFRB, FGA, DUSP5, MAP4K2, DBNL, KSR1, SYK, FCRL3, FGG, MAPK8IP3, TGFBR1, ERN1, DUSP22, KARS, KIT, MADD, RAPGEF1, EPHA1, MET, ARHGEF5, THBS1, AGER, STK3, RAP1B, CCL5, ABL1, DVL3, RIPK1, CSK, ZNF622, CCL19, TBX1, MAP3K3, MAP3K1, PDE6H, ANGPT1, CCL20, RYK, GPR55, P2RX7, CD4, IL6, TAOK2, KRAS, TEK, LTBR, CD24, EZH2]
GO:0051279;regulation of release of sequestered calcium ion into cytosol;9.0;0.7369933605727446;0.7647373054666613;9.242861771680136;148.50473241193134;5.486614186532078;0.004970319748245178;0.676826329833192;[CHD7, ABL1, CALM3, PTPN6, CALM1, PKD2, CALM2, CORO1A, NTSR1, ATG5]
GO:0030516;regulation of axon extension;10.0;0.7866048967936545;0.8085434602577476;9.474373572664863;209.02857457674645;5.244474134527214;0.0069959982775799475;0.6834436629936306;[SEMA6B, BMPR2, SEMA4D, TNFRSF12A, SEMA4B, TWF2, RAB11A, DNM2, RAB21, OLFM1, CDK5, RUFY3, ABL1, ADNP, PAFAH1B1]
GO:0010923;negative regulation of phosphatase activity;9.0;0.7866048967936545;0.7895430735771163;9.362821086759116;265.75489588375854;5.142344639450834;0.008894577201350937;0.659220369185286;[PPP1R15A, PPP1R14B, PPP1R12A, ELL, PPP1R11, SEMA4D, ROCK2, PKMYT1, MASTL, MYO1D, BAG4, PPME1, CD2BP2, PHACTR2, NCKAP1L]
GO:0010922;positive regulation of phosphatase activity;9.0;0.7586651285174919;0.775573189439035;9.267510906954792;265.2783726737478;6.311337724880743;0.008878628398354923;0.7190027299379095;[PDGFRB, PPP1R15A, PPP1R12A, RIPK3, ITGA2, FCRL3, CALM3, CALM1, CALM2]
GO:0030512;negative regulation of transforming growth factor beta receptor signaling pathway;8.0;0.8933024483968273;0.8216512241984136;9.537552474286395;374.7458266990886;5.54296712308321;0.012542405570270547;0.6584675964488075;[ONECUT2, SNX25, CAV1, LEMD3, GLG1, TGFBR1, DNM2]
GO:0060168;positive regulation of adenosine receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;237.90608858864195;8.67846133901236;0.007962502683482768;0.8188169164668168;[ACPP]
GO:0006002;fructose 6-phosphate metabolic process;5.0;0.8653626801206646;0.7229223519212526;9.34084218004034;72.82688802824934;7.57984905034425;0.0024374504023614934;0.6778748447945537;[TALDO1]
GO:0006486;protein glycosylation;7.0;0.6181399273706679;0.6599893289425345;8.590536585640447;174.0766208890209;4.3090134865453384;0.005826187842367879;0.5712825153487487;[GALNT12, DPAGT1, GALNT11, DERL3, FUT11, RPN1, TRAK1, GALNT10, FUT4, FUT8, PGM3, MGAT3, MGAT1, MGEA5, ST6GAL1, SDF2L1, PMM1, SLC35C2, GALNT1, COG3, SLC35C1, PMM2, SYVN1, ALG2, DOLK, ALG1, GBGT1, DPM3, TMEM115, DOLPP1, MGAT4B, STT3A, MAN1B1, B4GALT7]
GO:0006006;glucose metabolic process;6.0;0.7090535922965819;0.6776471087384355;8.572471578242808;34.676020684410545;5.040875179285974;0.0011605752059146955;0.5809109036834981;[GPI, CRTC2, G6PD, TPI1, IGFBP5, ADPGK, DCXR, BPGM, PER2, NISCH, HK3, G6PC3, ALDH5A1, FABP5, SLC25A10, ALDOC, ALDOA, GAPDH, PDK1]
GO:0009749;response to glucose;7.0;0.8933024483968273;0.7975705894556142;9.405380701177911;32.95598622603122;4.917261223318797;0.001103007200523252;0.6023883328937558;[ERN1, EIF2B4, XBP1, ENDOG, GPAM, SIN3A, SERPINF1, CASP3, PTEN, THBS1, AACS, NME1]
GO:0032526;response to retinoic acid;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;43.78950961223322;5.123113277522946;0.0014655954787213788;0.5522372631225753;[TBX1, PDGFRB, CDKN2D, SERPINF1, TWF2, ZNF35, AQP3, AQP1, SETX, RXRA, SYNJ1, RARA, CTSH, TEAD2]
GO:0010738;regulation of protein kinase A signaling;7.0;0.9326813400603323;0.8172600352873667;9.523163736834295;45.070113835906206;6.599019797332524;0.001508456149618737;0.6883935445785896;[AKAP11, AKAP7, PJA2]
GO:0018230;peptidyl-L-cysteine S-palmitoylation;10.0;1.0;0.9152410118609203;9.628524252492122;467.1984371929297;6.686031174322154;0.015636711241551894;0.7571649570480019;[ZDHHC23, ZDHHC12, ZDHHC24, ZDHHC6]
GO:0019322;pentose biosynthetic process;6.0;0.8259837884571596;0.7361122068187242;9.360260265897443;135.4172465659101;8.390779266560578;0.004532293374951417;0.7522251544931926;[G6PD, TALDO1]
GO:0016055;Wnt signaling pathway;7.0;0.5916390046238794;0.6467388675691402;7.647522783625538;28.581916314885376;4.0633408221711;9.566110170045473E-4;0.558718803867703;[VPS29, CHD8, USP34, PTEN, KLHL12, APCDD1, MED12, GNG2, GNAT2, RNF138, MYC, GRK6, AP2S1, DVL3, MARK2, DACT1, TLE4, CSNK2A1, UBE2B, RYK, SENP2, DDB1, CYLD, SFRP1, CCNE1, SDC1, TAX1BP3, CALM1, CD24, MET, CSNK1G2, TNRC6A, CSNK1G1]
GO:0010734;negative regulation of protein glutathionylation;9.0;1.0;0.896240625180289;9.628524252492122;446.489693504691;9.083926447120524;0.014943608226965869;0.8607930461318132;[G6PD]
GO:0030100;regulation of endocytosis;6.0;0.5902001590945054;0.6182203921373972;8.152617732682543;44.90533409728707;4.321752512322768;0.0015029411200592913;0.5441349370523758;[SCARB1, LRPAP1, CD151, MCTP1, RAB5C, SIRPG, STON1, PTEN, WASL, C2, RAB21, C3, ABR, ATXN2, RAB20, AP2S1, ABL1, ANKFY1, NCKAP1L, CSK, ITGAV, CCL19, CD300LF, SH3GL1, ATG5, FCER1G, TOR1A, RAB4B, ANGPT1, SYK, ITGA2, CAV1, ARFGAP1, MIB1, DNM2, BCR, RUFY1, EHD4, SYNJ1, SNX17, RAPGEF1, PTX3, DOCK2, SMAP1, CBLL1, PICALM]
GO:0048041;focal adhesion assembly;8.0;1.0;0.875;9.628524252492122;92.53238439646684;6.599019797332524;0.0030969756320103773;0.712474179321389;[ITGA2, RCC2, TAOK2, TESK2, PTPRK]
GO:0017148;negative regulation of translation;8.0;0.6493065804076676;0.6996532902038338;9.081980546124052;1114.6737408694362;4.99795013456894;0.03730712696566269;0.6305954023103058;[UPF1, BTG2, IGFBP5, YTHDF3, EIF4A3, EIF2AK3, CNOT10, EIF2S1, FXR1, EIF4ENIF1, ILF3, CNOT7, XRN1, CNOT1, CAPRIN1, TPR, CNOT3, RARA, EIF4E2, CNOT8, GAPDH, TNRC6A, CPEB4]
GO:0060155;platelet dense granule organization;6.0;1.0;0.8231203125901445;9.628524252492122;22.861654980906852;7.697632086000634;7.651590180572567E-4;0.7167775754447168;[BLOC1S1, RAB38]
GO:0061002;negative regulation of dendritic spine morphogenesis;12.0;1.0;0.9481203125901445;9.628524252492122;1979.5057838953023;7.9853141584524145;0.06625227714743111;0.8564896500084854;[PTEN]
GO:0042989;sequestering of actin monomers;12.0;1.0;0.9481203125901445;9.628524252492122;480.51094201236833;7.474488534686424;0.016082268797382004;0.8303660038532719;[GSN, TWF2]
GO:1903690;negative regulation of wound healing, spreading of epidermal cells;8.0;1.0;0.875;9.628524252492122;396.72827980217687;8.390779266560578;0.013278138492707536;0.8041048419030481;[PTEN, CLASP1]
GO:0038066;p38MAPK cascade;11.0;1.0;0.9324289523296623;9.628524252492122;290.6144555783003;7.8311634786251565;0.009726604292176047;0.8329150168128974;[MAP3K5]
GO:0038061;NIK/NF-kappaB signaling;6.0;1.0;0.8231203125901445;9.628524252492122;26.42836680105094;6.8867018697843045;8.845336528452411E-4;0.6753065664753021;[PPP4C, RIPK3, NFKB1, RELA]
GO:0038063;collagen-activated tyrosine kinase receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;57.50475921673876;7.474488534686424;0.0019246325400609058;0.7572456912631272;[SYK]
GO:0042742;defense response to bacterium;6.0;0.7866048967936545;0.7164227609869718;9.193206181234276;69.6526388451159;4.021331414093558;0.0023312111388408135;0.5287713881179241;[ANKRD17, FGA, CXCL6, FCER1G, SEH1L, HIST1H2BJ, PPP1R11, SYK, CCL20, DEFB1, RNASE3, NLRC4, LYST, P2RX7, CD4, IL6, IL23A, BCL3, NLRP3, IL12A, HIST1H2BC, HAVCR2]
GO:0042744;hydrogen peroxide catabolic process;6.0;0.9326813400603323;0.7894609826203107;9.55953138100517;235.80375524332874;6.481236761676141;0.007892139478392308;0.6545710619905948;[HBZ, GPX3, PRDX1, CAT]
GO:0051453;regulation of intracellular pH;10.0;0.7192862368539868;0.7748841302879137;9.242861771680136;143.07278219841277;5.407625775213448;0.004788517263036519;0.6917872454856517;[CLN3, RAB20, SLC9A6, VPS33A, SLC9A8, ATP6V0A2, RAB38, CLCN3, GPR89B, TM9SF4]
GO:0032515;negative regulation of phosphoprotein phosphatase activity;10.0;0.8653626801206646;0.8479223519212526;9.5525383455142;1090.4524045737035;5.788089581116195;0.03649646063763195;0.7112441822128948;[PPP1R15A, PPP1R14B, PPP1R11, ROCK2, PPME1, PHACTR2, NCKAP1L, MASTL]
GO:0031669;cellular response to nutrient levels;5.0;0.5537205960740763;0.5671013098979585;7.6544432264701125;58.45336087306237;4.4540636485420615;0.0019563813838119923;0.5180220339825032;[BECN1, CDKN1A, SEH1L, BMPR2, MAX, ABCB4, CLEC16A, COMT, AQP3, HSP90B1, WRN, LAMP2, FADS1, ATG5, MAP3K5, GABARAPL1, XBP1, EIF2AK3, USF2, EIF2S1, SSH1, SFRP1, TBL2, P2RX4, MARS, PIK3C3, ULK1, CPEB4]
GO:0032516;positive regulation of phosphoprotein phosphatase activity;10.0;0.8653626801206646;0.8479223519212526;9.5525383455142;1089.2705050571928;6.832634648514029;0.036456903524454846;0.7646622655359331;[PDGFRB, PPP1R15A, PPP1R12A, FCRL3, CALM3, CALM1, CALM2]
GO:0016042;lipid catabolic process;4.0;0.5127202928476964;0.5063601464238482;6.883086519318291;43.14795622097559;4.114113147544524;0.0014441232640765526;0.4603959376912539;[SCARB1, ECHS1, ABCD3, HSD17B4, ETFA, GDPD3, ETFB, PLD1, GBA2, PLD3, SGPL1, CPT2, SCARF1, HIBCH, HSD3B7, PLA2G12A, ACOT7, SPHK1, DDHD2, SIRT2, GALC, ALDH3A2, BSCL2, ACOX2, FABP5, SNX17, TBL1XR1, PNPLA6, DAGLB, HRASLS, SLC27A2, MGLL, PAFAH1B1]
GO:0032753;positive regulation of interleukin-4 production;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;64.94897299966192;6.686031174322154;0.0021737836760178982;0.665044257777226;[IRF4, RARA, NLRP3, HAVCR2]
GO:0030335;positive regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.22453031427283;157.26390226612122;3.6656062881777913;0.005263481280523835;0.5383786413027378;[CXCL6, SCARB1, GPI, CD40, BMPR2, ONECUT2, DOCK8, ITGB3, PDCD6, CIB1, MIA3, CXCL14, IGF1R, PREX1, NIPBL, C1QBP, CTSH, IL12A, ITGAV, CPNE3, ATP7A, GTSE1, HRAS, GPSM3, CCR2, SEMA6B, PDGFRB, ANXA1, IGFBP5, ITGA2, SPHK1, SWAP70, TGFBR1, RHOB, PTP4A1, CREB3, KARS, IL23A, RUFY3, KIT, MYADM, EPHA1, MAPRE1, MET, CBLL1, HBEGF, CD151, ROCK2, CD99L2, THBS1, CORO1A, BAG4, CCL5, ABL1, NCKAP1L, CCL19, CLASP1, MAP3K3, XBP1, ANGPT1, SEMA4D, CCL20, SEMA4B, RAB11A, SSH1, VIL1, IL6, P2RX4, SP1, FGFR1OP, TEK, TRIM32]
GO:0032754;positive regulation of interleukin-5 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;7.212124270218933;0.002183412136085803;0.6919486831672181;[RARA, NLRP3]
GO:0061037;negative regulation of cartilage development;6.0;0.8259837884571596;0.7361122068187242;9.36615998802463;85.27219906913868;6.558197802812269;0.002853983762847292;0.6585068532133508;[RARA, TGFBR1]
GO:0006464;cellular protein modification process;6.0;0.33881133730344803;0.4925259812418685;5.842712558201993;147.0276183392271;1.7630686329010112;0.004920882069548126;0.41328372446777834;[GMFB, MAML1, TESK2, PSMD8, PSMD7, PSMD4, PSMD2, MYC, CDK5RAP3, CSNK2A1, ATG10, PRKAB1, RC3H2, BCR, PSME2, ANAPC13, CDCA3, RPN1, COPS7B, COPS7A, MTMR6, ANAPC11, C3, RHOT1, RNF213, PPP4C, BLOC1S1, SULT1A3, ATG5, CREBBP, PMM1, EDEM1, PMM2, EIF2AK3, LNPEP, CDC7, ERLIN2, SETX, CYLD, RNF103, PAM, EZH2, PIGS, ARF4, BTG2, SMG1, PIGU, WDR48, PIGT, SETD3, BTG1, SERPINA10, MED12, TRIM9, UBL5, TRIM7, PBK, TIMP1, PCMTD1, DUSP5, ANXA1, RIPK3, SIRT7, JOSD1, SIRT2, CIT, SUMF1, DDB1, ITPKB, PSMA1, PIGA, MED20, RARA, RNF166, HBEGF, GPS1, GPS2, PSMA7, RNF135, PSMB5, RNF138, PSMB1, APOL1, EGLN2, MBD6, SYVN1, GTF2H4, SPSB1, TTLL3, PSMC1, RFWD3, TAOK2, RAB3B, RAB3D, IL5RA, STK19, YEATS4, PARK7, YY1, PPP1CB, PPP1CC, NPEPPS, FNTB, CFL1, NEK1, C18orf25, MAP3K5, USP8, RNF44, FBXO18, IGFBP5, VPS33B, VRK1, VRK2, CDC25A, PIAS2, RNF40, MINPP1, ILF3, ANAPC5, RAB38, FKBP4, CSNK1G2, CSNK1G1, UBR4, PKMYT1, RLF, HSP90B1, MTM1, STK35, MED30, STK38, UBR5, ABL1, MBP, RAB6A, DR1, TOR1A, SDF2L1, AMBP, WFS1, BRPF3, BTBD6, MARCH6, NFKB1, MARCH3, CDK9, CNOT4, COPS5, CDK6, CDK5, UBLCP1, YEATS2, PTPRA, CDK2, FGFR1OP, MNAT1, BMPR2, PTEN, PTPN22, MSLN, PIK3CG, DUSP14, PPP6C, SIN3A, SUMO3, PGM3, TRIM69, ITGAV, HIF1AN, ATP7A, PPP1R12A, KSR1, DTX3L, ZFP91, DUSP28, RAD23A, SPTB, RABGGTA, PTP4A1, DUSP22, DUSP23, CTDSP2, PIK3C3, ETF1, BIRC6, MET, GAPDH, PPP1R15A, BECN1, HDAC3, ITIH2, HDAC1, ROCK2, MGRN1, RAB1B, RNF38, GLRX, NLRC4, IL2RG, PPM1G, FZR1, RBBP5, CCL5, SAP18, CSK, RBBP7, RFFL, RNF20, ANGPT1, FEM1B, FBXL15, FBXL16, P2RX7, SNRK, DOLPP1, TSPAN17, RAB13, MGAT4B, ASXL2, CCM2, PTPN6, TRIM32, TRIM33, METAP2, OXTR, CCNK, CCNH, CCNF, ZDHHC5, ZDHHC6, PPP2R2A, UBE2L3, RPS6KA4, HERC4, RPS6KA5, RASSF2, HERC1, RPS6KA2, CDC26, TRIM24, CPNE3, SKP2, SEPHS1, ATXN7L3, EPHB4, PDK1, ST6GAL1, ESCO1, ARRDC1, SLC35C2, COG3, NSMCE2, PAQR3, SLC35C1, ALG2, ALG1, GBGT1, KARS, KCTD10, TRIB3, ULK1, EPHA1, CBLL1, PAXIP1, FUT11, MYCBP2, LIAS, TGOLN2, NUAK1, HLTF, STK38L, ZBED1, SETDB1, BCL11A, MSRA, KLHDC8A, CDC16, CALU, FBXL3, CALM1, PPP1R11, FASTKD1, GPAA1, SUV39H1, OTUD7B, MIA3, BRCA1, PTPRK, AKAP13, ZMYM2, CTSH, HRAS, VKORC1, MAP4K2, SYK, PARP2, PRMT3, ZDHHC12, COMMD1, GFRA2, ZDHHC17, GAK, PDIK1L, KIT, FASTKD5, FAM20C, TLR7, PTGER4, CSTA, PCNA, DERL3, ZDHHC23, ZDHHC24, DERL2, NEDD8, TRAK1, PPP2CA, PDPR, MGAT3, MGAT1, UBL4A, MAP3K3, MAP3K1, DOHH, RAB11A, MIB1, PER2, ITCH, CAMK4, KBTBD2, CAMK1, KBTBD8, GALNT12, DPAGT1, GALNT11, CRTC2, ARID4A, BUB1B, UBE3A, UBE2Z, GALNT10, IGF1R, PPME1, EP300, TGM6, SBF1, PDGFRB, SSU72, TRPC4AP, ERN1, DPM3, BRMS1, TBL1XR1, CCNE1, PPIF, PPID, HIST1H2BC, DTX2, KLHL12, STK4, RASGRP4, FUT4, STK3, VCPIP1, CCNB1, FUT8, UBD, GRK6, NLRP3, USP51, RIPK1, SUDS3, MARK2, MGEA5, UBE2I, UBE2B, KLHL25, CBX4, RHBDD1, DOLK, KLHL24, CLK4, SSH3, EIF2S1, CLK3, SSH1, CLK1, NFKBIA, IL6, PAN3, TMEM115, MAN2B2, FES, UBE2T, STT3A, MAN2B1, USP36, USP37, USP38, PRKCSH, MAST3, USP32, YWHAB, USP34, USP39, GPHN, SENP6, POLB, RASGEF1A, USP46, FGA, FGG, CAD, PPP2R5D, OXSR1, IRAK4, SENP2, MASTL, TGFBR1, PJA2, IRF4, MAN1B1, USP41, B4GALT7, THOP1, HIST1H2BO, HIST1H2BJ, USP12, THBS1, PSMB10, TFPT, PABPN1, RAB40C, MKNK2, NCAM1, MTA2, EYA2, GALNT1, MAPK13, POLE4, WEE1, TNIP1, TNIP2, ASB8, POLE3, KRAS, FAM98A, TAF5, TEK, ASB3, OTUD1]
GO:0006468;protein phosphorylation;7.0;0.5708408884191841;0.6363398094667926;8.175090588534603;177.75756772840523;2.970244267288293;0.005949385820444992;0.5028177952168079;[OXTR, CCNK, GMFB, MAML1, CCNH, IL5RA, BUB1B, TESK2, STK19, IGF1R, RPS6KA4, RPS6KA5, RASSF2, RPS6KA2, MYC, CFL1, TRIM24, NEK1, CPNE3, EPHB4, PDK1, MAP3K5, PDGFRB, CSNK2A1, PAQR3, VRK1, VRK2, PRKAB1, ERN1, BCR, ILF3, KARS, CCNE1, TRIB3, ULK1, EPHA1, CSNK1G2, CSNK1G1, PKMYT1, STK4, RASGRP4, STK3, NUAK1, CCNB1, STK35, STK38, GRK6, ABL1, STK38L, MBP, RIPK1, MARK2, SULT1A3, EIF2AK3, CDC7, ERLIN2, CLK4, EIF2S1, CLK3, NFKB1, SETX, CLK1, CDK9, PAN3, CDK6, CDK5, PTPRA, FES, CDK2, FGFR1OP, CALM1, MNAT1, SMG1, BMPR2, FASTKD1, MAST3, YWHAB, PIK3CG, AKAP13, ZMYM2, RASGEF1A, PBK, CTSH, ITGAV, HRAS, DUSP5, MAP4K2, KSR1, RIPK3, SYK, CAD, OXSR1, IRAK4, MASTL, GFRA2, SPTB, TGFBR1, CIT, GAK, ITPKB, PDIK1L, KIT, FASTKD5, RARA, FAM20C, PIK3C3, TLR7, BIRC6, MET, HBEGF, PTGER4, ROCK2, GPS1, GPS2, IL2RG, PABPN1, CCL5, MKNK2, NCAM1, CSK, MAP3K3, MAP3K1, ANGPT1, GTF2H4, MAPK13, P2RX7, SNRK, WEE1, TNIP2, CAMK4, TAOK2, CCM2, KRAS, PTPN6, CAMK1, TEK]
GO:0006469;negative regulation of protein kinase activity;10.0;0.6835726970475526;0.7570273603846966;9.223059144383958;1097.0598301796;4.243684138952949;0.03671760522636433;0.6322632160784685;[CDKN1C, ERRFI1, CDKN1A, GMFB, GPS1, PTEN, GPS2, CIB1, PTPN22, PARK7, DUSP14, IGF1R, PPP2CA, PREX1, CASP3, HYAL2, NUP62, STK38, ABL1, CDK5RAP3, CDKN2D, DUSP5, CDKN2C, H2AFY, CAV1, PAQR3, DUSP22, SFRP1, CDK6, SH3BP5L, QARS, ADORA2A, GNAQ, PKIA, TAF7, FGFR1OP, CRIPAK, TRIB3, SPRY1, PTPN6, EPHA1, CHMP6]
GO:0010719;negative regulation of epithelial to mesenchymal transition;6.0;0.8259837884571596;0.7361122068187242;9.434368238051164;171.1659509920613;6.481236761676141;0.005728770340349481;0.6545710619905948;[PPP2CA, SFRP1, PTEN]
GO:0031658;negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle;13.0;1.0;0.9625549647676366;9.628524252492122;3330.314475181895;7.8311634786251565;0.11146262839589782;0.8630410292508717;[CDKN2D, CDKN2C, CDK6, PTEN]
GO:0009968;negative regulation of signal transduction;6.0;0.43649654099988644;0.5413685830900877;6.680044863788677;140.65047919891595;2.686163805600486;0.0047074449615745265;0.460490854527945;[ERRFI1, PDCD6, EIF4A3, CIB1, RORA, GPATCH3, PARK7, IGF1R, PREX1, RASSF2, RGS1, MYC, WWC3, CPNE1, HOMER3, EPHB4, CDK5RAP3, TLE4, PDGFRB, IGFBP5, ARRDC1, PAQR3, SLC35C1, LEMD3, RUNX2, PIAS2, SFRP1, TWSG1, RFX4, DDIT4, PPIF, MYADM, VDAC2, TRIB3, EPHA1, LRPAP1, KLHL12, APCDD1, STK4, AGER, GLG1, STK3, MTM1, BCL2L12, RNF213, HSPH1, TMEM127, STK38, ABL1, DVL3, NLRP3, RIPK1, CD300LF, PRNP, PRELID1, XBP1, UBE2B, AMBP, WFS1, NONO, CAV1, IFT122, TNFRSF10B, TNFRSF10A, ARHGAP25, NFKBIA, CYLD, IL6, NPLOC4, CNOT7, QARS, CNOT1, BCL3, CALM3, CRIPAK, HYOU1, CALM1, CALM2, EZH2, ITGB1, ONECUT2, YWHAB, SH3KBP1, CHD8, TRADD, PTEN, OTUD7B, PTPN22, BRCA1, PKD2, DUSP14, MED12, FLCN, ING2, LBH, C1QBP, HYAL2, NUP62, PBK, TIMP2, ITGAV, HIF1AN, EMD, DACT1, FGA, DUSP5, PVRIG, FCRL3, FGG, PLAUR, SENP2, TGFBR1, DNM2, DUSP22, CREB3, NCOR1, IRF4, KIT, TMBIM1, RAPGEF1, TAX1BP3, BIRC6, CHMP6, MET, PAFAH1B1, PPP1R15A, HDAC3, RGS19, HIST1H2BJ, HDAC1, MGRN1, GPS1, CLEC12B, GPS2, LILRA2, THBS1, TANK, RELA, ARNTL, PPP2CA, SNX25, CCL5, LMNA, UBQLN1, MFN2, CSK, RFFL, BID, CDKN2D, EYA2, RYK, SYVN1, P2RX7, ITCH, NLRP12, PIK3IP1, TNIP1, SPRY1, PTPN6, TEK, TRIM32, TRIM33]
GO:0032508;DNA duplex unwinding;7.0;0.7980440201809971;0.7499413753476991;9.223059144383958;23.726073882073138;5.734022359845919;7.940903407527885E-4;0.64415753539903;[XRCC6, ANXA1, FBXO18, XRCC5, CHD8, GINS4, CHD1, GTF2H4, SETX, WRN, RAD51, ASCC3, MCM6, MCM2]
GO:0010951;negative regulation of endopeptidase activity;10.0;0.7671156992804218;0.7987988615011312;9.446202695698167;500.3238742612354;4.2676852910524925;0.016745389809270216;0.6334906361130068;[SERPINA3, CSTB, CSTA, ITIH2, SERPINA10, NLRC4, PARK7, UBE2Z, THBS1, AQP1, C3, BCL2L12, NLRP7, TIMP2, TIMP1, RFFL, A2M, CDKN2D, SERPINB1, CSNK2A1, AMBP, SERPINF1, PLAUR, TNFRSF10B, TNFRSF10A, SERPINB6, VIL1, ADORA2A, COL7A1, BIRC6, GAPDH, PICALM]
GO:0032981;mitochondrial respiratory chain complex I assembly;7.0;1.0;0.8509193652572005;9.628524252492122;91.11357555959822;5.618190544320798;0.003049489377085438;0.638233890966345;[NDUFA7, NDUFB7, NDUFS8, NDUFA11, NDUFB10, NDUFS7, NDUFS6, NUBPL, NDUFA10, BCS1L, TAZ, FOXRED1]
GO:0032743;positive regulation of interleukin-2 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;6.409777797693995;0.002183412136085803;0.6509166472493662;[CD4, ANXA1, IRF4, CD80, GLMN, ABL1, CARD11, CCR2, RUNX1]
GO:0060179;male mating behavior;5.0;0.7586651285174919;0.6695735761196662;8.712233520617966;21.23537850411422;8.16763571524637;7.107290079328145E-4;0.7079342821725234;[PTEN]
GO:1903232;melanosome assembly;7.0;1.0;0.8509193652572005;9.628524252492122;62.72328125453724;8.16763571524637;0.0020992917763011008;0.7686126355688037;[RAB38]
GO:0006470;protein dephosphorylation;7.0;0.7586651285174919;0.7302519295159464;9.223059144383958;177.1697810635027;4.458953633836253;0.005929713129744359;0.5789504614541361;[PPP1R15A, PTEN, PTPN22, PPP2R2A, PTPRK, MTMR6, PPM1G, DUSP14, MTM1, PPP1CB, PPP2CA, PPP1CC, PPP6C, PDPR, PPP4C, SBF1, DUSP5, PPP1R12A, EYA2, SSU72, DUSP28, PPP2R5D, SSH3, CDC25A, SSH1, PTP4A1, DUSP22, DUSP23, MINPP1, UBLCP1, PTPRA, CTDSP2, PTPN6]
GO:0007565;female pregnancy;3.0;1.0;0.6981203125901445;9.628524252492122;32.8060485501291;5.299736813202263;0.0010979889214459554;0.4691490996802742;[CLIC5, OXTR, ABCC2, AMBP, IGFBP5, SPHK2, ITGA2, CAD, LNPEP, COMT, ADIPOR2, CRHR1, BYSL, NPPA, PNOC, RARA, KRAS]
GO:0061028;establishment of endothelial barrier;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;35.449043474319204;6.641579411751319;0.0011864475830175945;0.6627709925721352;[RAP1B, RAPGEF1, MYADM, MSN, TJP2]
GO:0032736;positive regulation of interleukin-13 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;7.069023426578259;0.002183412136085803;0.6846304993685643;[IRF4, RARA, NLRP3]
GO:0031641;regulation of myelination;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.055147161688105;6.250713103064308;0.001407547928326502;0.6427820713687392;[EIF2AK3, KIF14, PTEN, RARA, SIRT2]
GO:0031642;negative regulation of myelination;7.0;1.0;0.8509193652572005;9.628524252492122;207.08553610705889;7.9853141584524145;0.006930966528620597;0.7592887026755414;[EIF2AK3, PTEN]
GO:1905143;eukaryotic translation initiation factor 2 complex assembly;5.0;1.0;0.7902410118609202;9.628524252492122;40.42272244673708;9.777073627680469;0.0013529121422039536;0.7902410118609202;[CDC123]
GO:0090336;positive regulation of brown fat cell differentiation;7.0;1.0;0.8509193652572005;9.628524252492122;143.10318807846457;7.57984905034425;0.004789534920478337;0.738553198190834;[METRNL]
GO:0008584;male gonad development;5.0;1.0;0.7902410118609202;9.628524252492122;50.96471695749156;5.2552850506314295;0.001705743211299806;0.5589965337459591;[PDGFRB, RRM1, SFRP1, CSDE1, RNF38, H3F3A, KIT, SOX8, MEA1, TGFBR1]
GO:0030031;cell projection assembly;4.0;0.6729672293956388;0.5864836146978194;8.124446855715847;35.515967283127445;3.9749552523034066;0.0011886874626708887;0.45327939645711923;[SPAG16, CYFIP2, NCKAP1, GALNT11, ONECUT2, FNBP1L, BAG4, TMEM107, ABL1, NEK1, NCKAP1L, SNAP29, NEFH, BBS2, ACTR2, SEPT11, DBNL, GSN, IFT122, EMP3, WDR34, DYNLL2, SEPT2, VAV2, P2RX7, CCDC88A, PARVG, TTLL3, TMEM138, RFX4, CENPJ, KIT, CCDC65, RHOU, FXYD5, CLUAP1]
GO:0007257;activation of JUN kinase activity;14.0;1.0;0.9759193652572005;9.628524252492122;8640.54909511404;6.088194173566533;0.2891914022241413;0.7872698984233759;[ERN1, MAP4K2, DBNL, SYK, RIPK1, CCL19, MAPK8IP3, MAP3K5]
GO:0090330;regulation of platelet aggregation;9.0;0.8259837884571596;0.8092325194088689;9.533214072687796;97.23557350837086;6.943860283624253;0.0032543871389904074;0.7513499630073597;[SYK, FGG, CD9]
GO:0007254;JNK cascade;11.0;1.0;0.9324289523296623;9.628524252492122;290.6144555783003;5.926926025970411;0.009726604292176047;0.735532224928036;[PTGER4, MAP4K2, GPS1, GPS2, IRAK4, MAP3K5]
GO:0045762;positive regulation of adenylate cyclase activity;12.0;0.8933024483968273;0.8947715367885583;9.589303539338841;6276.064729494611;7.697632086000634;0.21005423840463325;0.8417775754447168;[TIMP2, TSHR]
GO:0045766;positive regulation of angiogenesis;7.0;0.811012628672052;0.7564256795932265;9.303101852057495;134.49314513679974;4.7081694254602375;0.0045013645317563845;0.5916953686275062;[ITGB1, CD40, BTG1, PDCD6, ITGB2, CIB1, BRCA1, THBS1, MTDH, AQP1, C3, RRAS, TBXA2R, ABL1, CTSH, MAP3K3, XBP1, ANXA1, JUP, SPHK1, RHOB, RUNX1, PDCL3, SP1, TEK, EPHA1]
GO:0007016;cytoskeletal anchoring at plasma membrane;6.0;1.0;0.8231203125901445;9.628524252492122;66.89368938276097;7.474488534686424;0.002238871583229107;0.7053660038532718;[JUP, TLN1]
GO:0046855;inositol phosphate dephosphorylation;8.0;0.9326813400603323;0.8413406700301662;9.590783924509275;336.6569207659842;7.138016298065211;0.011267604166479381;0.7400384854347593;[SYNJ1, PTEN]
GO:0046856;phosphatidylinositol dephosphorylation;8.0;1.0;0.875;9.628524252492122;218.1540246804484;6.686031174322154;0.007301418880178951;0.7169239451870815;[SYNJ1, PTEN, MTMR6, MTM1]
GO:0018394;peptidyl-lysine acetylation;9.0;0.6696747006330769;0.7310779754968275;8.884083777544626;313.638027190515;5.076593261888053;0.010497182514167671;0.6558578406789737;[DR1, CREBBP, CRTC2, ESCO1, BRPF3, YEATS4, POLE4, YEATS2, IRF4, BLOC1S1, POLE3, EP300, TAF5]
GO:0019483;beta-alanine biosynthetic process;8.0;0.8653626801206646;0.8076813400603323;9.523163736834295;476.973390255232;9.083926447120524;0.015963870123660538;0.839552420951524;[DPYD]
GO:0001701;in utero embryonic development;7.0;1.0;0.8509193652572005;9.628524252492122;22.496195207419138;4.63541007117781;7.529274083310655E-4;0.5879744518658467;[ITGB1, ELL, CHD7, RIC8A, FLCN, CCNB1, FUT8, RXRA, SIN3A, SOX8, MGAT1, ATP7A, SOX6, MBNL1, ENDOG, UBE2B, ANGPT1, TGFBR1, MIB1, ALS2, MAFF, MYH9, CCM2, EIF4E2, APBA3, SEC24C]
GO:0032689;negative regulation of interferon-gamma production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.25422870398782;6.343086423195323;0.002184000309729388;0.647506047256038;[PRNP, C1QBP, RARA, PDCD1LG2, HAVCR2]
GO:0031114;regulation of microtubule depolymerization;9.0;0.8259837884571596;0.8092325194088689;9.420884887713877;74.89162891543653;6.444869117505266;0.0025065554217094913;0.7258315315665724;[MAP1S, CIB1, CLASP1]
GO:0070723;response to cholesterol;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;80.91680144162417;6.686031174322154;0.002708212523857764;0.665044257777226;[LRP8, AACS, TGFBR1]
GO:0071805;potassium ion transmembrane transport;9.0;0.8259837884571596;0.8092325194088689;9.456673995565463;120.6235085317852;4.695669262696007;0.004037160276449102;0.636377369645515;[SLC12A2, KCNG1, KCNK6, KCND1, KCNK12, KCNA3, PKD2L1, ATP1B2, PKD2, MTMR6, AQP1, SLC9A6, SLC9A8, KCNN3, KCNK3]
GO:0090344;negative regulation of cell aging;5.0;0.8653626801206646;0.7229223519212526;9.34084218004034;80.6841056931466;6.686031174322154;0.002700424406568797;0.6321649570480018;[BCL2L12, MAP3K3, FZR1, CDK6, RBL1, ABL1, PTEN]
GO:0007264;small GTPase mediated signal transduction;6.0;0.7369933605727446;0.6916169928765168;8.741221057491218;26.42836680105094;4.015022244900292;8.845336528452411E-4;0.5284487369119741;[RAB3B, BCAR3, NCKAP1, CDKN1A, RTKN, DOCK8, RAB3D, ARHGAP1, PARK7, RAB43, DOCK11, RASGEF1A, ARHGDIB, CFL1, HRAS, RAB8B, ARHGEF11, USP8, DBNL, KSR1, RHOC, VAV1, VAV2, RHOB, NISCH, ALS2, CDC42EP4, RAB35, ELMO1, RAPGEF1, TAX1BP3, ARHGEF1, RAB38, RHOU, DOCK2, KPNB1, RAB5C, RGS19, ROCK2, RAB1B, WAS, RASGRP2, PLD1, RASGRP4, RAB21, RAP1B, ABR, RHOT2, RHOT1, RAB20, RRAS, RAB40C, RAB28, RAB6A, RAB4B, SETDB1, RAB27B, MYO9B, RAB11A, COL1A2, ARHGAP30, RAB13, CDK2, RAB18, KRAS, RGL1]
GO:0007268;chemical synaptic transmission;7.0;0.7369933605727446;0.7194160455435727;8.663443356448536;23.173347188538074;3.922001705478042;7.755910757418987E-4;0.5514907148670789;[PTEN, SLC1A4, HTR3B, GLS, SSH1, ALS2, SYPL1, CDK5, ADORA2A, HRH2, PNOC, VDAC3, MBP, AMPH, NPTX1, SNCB, APBA3, SPG11, KCNK3, NTSR1, PAFAH1B1]
GO:0045773;positive regulation of axon extension;11.0;0.8933024483968273;0.8790801765280758;9.582004236857228;1257.908905926367;6.113511981550823;0.04210107903683872;0.7450742393735527;[BMPR2, TNFRSF12A, RUFY3, TWF2, ADNP, RAB11A, PAFAH1B1]
GO:0007265;Ras protein signal transduction;7.0;0.7586651285174919;0.7302519295159464;8.935377071932177;27.526979089716047;4.2636448815154875;9.213032174599934E-4;0.5689623627776663;[RAB3B, NCKAP1, CDKN1A, RTKN, RAB3D, ARHGAP1, PARK7, RAB43, ARHGDIB, CFL1, HRAS, RAB8B, ARHGEF11, USP8, DBNL, KSR1, RHOC, RHOB, NISCH, ALS2, CDC42EP4, RAB35, ELMO1, RAPGEF1, TAX1BP3, ARHGEF1, RAB38, RHOU, KPNB1, RAB5C, ROCK2, RAB1B, WAS, RASGRP2, PLD1, RAB21, RAP1B, RHOT2, RHOT1, RAB20, RRAS, RAB40C, RAB28, RAB6A, RAB4B, SETDB1, RAB27B, MYO9B, RAB11A, COL1A2, RAB13, CDK2, RAB18, KRAS]
GO:0007266;Rho protein signal transduction;8.0;0.9326813400603323;0.8413406700301662;9.523163736834295;29.60642063139588;5.334422371190153;9.9090025448413E-4;0.6478026081386739;[ARHGEF11, RTKN, ROCK2, ARHGAP1, WAS, MYO9B, RHOC, RHOB, RHOT2, RHOT1, COL1A2, CDC42EP4, ARHGDIB, CFL1, TAX1BP3, ARHGEF1, RHOU]
GO:0008354;germ cell migration;5.0;0.9326813400603323;0.7565816818910864;9.510741216835738;40.540081573954176;7.57984905034425;0.0013568400465755524;0.6778748447945537;[ITGB1, KIT, TGFBR1]
GO:0006177;GMP biosynthetic process;11.0;0.9326813400603323;0.8987696223598284;9.61370916670698;9653.00334287648;8.16763571524637;0.323077334747084;0.8501222226412654;[IMPDH1, IMPDH2]
GO:0042267;natural killer cell mediated cytotoxicity;6.0;0.9326813400603323;0.7894609826203107;9.5544162803384;47.356962503066434;6.7325511899570465;0.001584994916478408;0.6674232935401965;[PRDX1, CEBPG, SLAMF7, PTPN6, LYST]
GO:2000808;negative regulation of synaptic vesicle clustering;7.0;1.0;0.8509193652572005;9.628524252492122;59.77051115816579;9.777073627680469;0.002000465218496107;0.8509193652572005;[PTEN]
GO:0032438;melanosome organization;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;22.01435712052086;6.558197802812269;7.368007211887049E-4;0.6585068532133508;[AP1G1, BLOC1S1, RAB38, LYST, AP1M1]
GO:0045780;positive regulation of bone resorption;7.0;1.0;0.8509193652572005;9.628524252492122;82.90338698468558;6.943860283624253;0.002774701754173115;0.7060287030842711;[TFRC, SYK, PLEKHM1]
GO:0010666;positive regulation of cardiac muscle cell apoptotic process;10.0;1.0;0.9152410118609203;9.628524252492122;149.5070754231924;7.474488534686424;0.005003867266781941;0.7974867031240476;[PTEN, MAP3K5]
GO:0031102;neuron projection regeneration;6.0;0.811012628672052;0.7286266269261705;9.32314260294094;62.73066136185122;6.481236761676141;0.002099538781851234;0.6545710619905948;[ULK1]
GO:0001959;regulation of cytokine-mediated signaling pathway;6.0;0.6108066114563391;0.628523618318314;8.112176763124033;55.1119710577094;4.759793790865545;0.0018445480737477274;0.5665363884080561;[HIST1H2BJ, GFI1, TRADD, GPS2, CCL5, CPNE1, RIPK1, RFFL, CD300LF, IFNAR2, ANGPT1, SYK, SPHK1, CAV1, VRK2, RUNX1, CYLD, IL6, CNOT7, MADD, PTPN6, CD24, TRIM32, LSM14A, PAFAH1B1]
GO:0018149;peptide cross-linking;7.0;0.6007507099811141;0.6512947202477576;8.117066748418225;151.15475272427284;5.69953618377475;0.005059013543235805;0.6423939107509793;[CSTA, ANXA1, TGM6, THBS1]
GO:0071803;positive regulation of podosome assembly;8.0;1.0;0.875;9.628524252492122;306.3544197830862;7.379178354882098;0.01025340672906212;0.7523715242355574;[MSN, LCP1, ARHGEF5]
GO:0030259;lipid glycosylation;6.0;1.0;0.8231203125901445;9.628524252492122;50.53614939134546;7.474488534686424;0.0016913994405466648;0.7053660038532718;[SLC35C1, GBGT1]
GO:0071800;podosome assembly;5.0;1.0;0.7902410118609202;9.628524252492122;81.13164658075348;7.697632086000634;0.00271540319731635;0.6838982747154925;[DBNL, NCF1, SH3PXD2A, SH3PXD2B]
GO:0071801;regulation of podosome assembly;7.0;0.8933024483968273;0.7975705894556142;9.427853557029971;64.45443428147517;7.069023426578259;0.002157231910176139;0.7124295520356204;[GSN, MSN, LCP1, ARHGEF5]
GO:0010880;regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum;10.0;0.8436909121759173;0.837086467948879;9.474373572664863;150.2964918811592;6.518977089658987;0.005030288325201402;0.7486218033895181;[CHD7, CALM3, CALM1, CALM2]
GO:0031340;positive regulation of vesicle fusion;7.0;0.8259837884571596;0.7639112594857803;9.392135474427892;149.60751655096118;7.697632086000634;0.005007228940937215;0.7445766281117727;[ANXA1]
GO:0048812;neuron projection morphogenesis;7.0;0.6547035408479693;0.6782711356811852;8.502512989635898;62.99970935475633;4.360973225476049;0.002108543576046295;0.5739397388140403;[ITGB1, NCKAP1, TOP2B, C12orf57, PTEN, WASL, TRAK1, UGT8, NCKAP1L, NPTX1, ATP7A, NEFH, ZNF365, DBNL, RYK, MAP1S, OMG, DNM2, WEE1, LRFN4, SLC9A6, ALS2, CDK5, ADORA2A, NFIB, TAOK2, PAFAH1B1, PICALM]
GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.11083947336738;4.629579150867016;0.008002824611389124;0.6117568930727868;[ANKRD17, CD40, SLC20A1, TRADD, RELA, MTDH, AKAP13, TFG, UBD, NUP62, ABL1, RIPK1, CCL19, ECT2, TMED4, MAP3K3, UBE2I, ZDHHC13, TNFRSF10B, IRAK4, RHOC, ZDHHC17, CD4, VAPA, TNIP2, LTBR, TRIM32, CARD11]
GO:0006145;purine nucleobase catabolic process;8.0;0.7980440201809971;0.7740220100904985;9.464221201200845;915.7889644076664;8.390779266560578;0.030650632482165402;0.8041048419030481;[DPYD]
GO:0043122;regulation of I-kappaB kinase/NF-kappaB signaling;7.0;0.7866048967936545;0.7442218136540277;9.260799472366804;45.070113835906206;4.406435599552807;0.001508456149618737;0.5762646867385423;[ANKRD17, CD40, SLC20A1, TRADD, OTUD7B, RORA, TANK, RELA, MTDH, AKAP13, TFG, UBD, NUP62, ABL1, CPNE1, RIPK1, CCL19, ECT2, TMED4, MAP3K3, UBE2I, ANGPT1, ZDHHC13, TNFRSF10B, IRAK4, RHOC, ZDHHC17, CD4, NLRP12, VAPA, TNIP1, TNIP2, LTBR, TRIM32, CARD11]
GO:0097190;apoptotic signaling pathway;5.0;0.6954798709641801;0.6379809473430103;8.529911963824013;23.17027026302992;4.145861845859104;7.75488093814194E-4;0.5022605794604473;[CDKN1A, CD40, PDCD6, TRADD, CIB1, BRCA1, BBC3, POLB, CASP3, DPF2, ARL6IP5, CASP2, EP300, IL12A, ITGAV, HRAS, APPL1, PDK1, MAP3K5, TNFRSF12A, RIPK3, PARP2, ERN1, DDIT4, TRIB3, PPP1R15A, DIABLO, KRCC1, TFPT, SGPL1, ZMAT1, BAG3, PERP, MKNK2, TP53BP2, ABL1, RIPK1, ZNF622, BID, DEDD, XBP1, SIVA1, EYA2, CD70, CAV1, G0S2, TNFRSF10B, TNFRSF10A, P2RX7, P2RX4, BCL3, CD24]
GO:0045787;positive regulation of cell cycle;5.0;0.5265193887476639;0.5535007062347522;7.230628979693751;42.184038669436575;3.8238302933926853;0.0014118618110960173;0.4857918708913159;[FEN1, BTG2, CDKN1A, CCNK, CCNH, CCNF, KIF14, BRCA1, PKD2, CKS1B, NIPBL, SIN3A, FNTB, NUP62, CASP2, EP300, GTSE1, PDGFRB, ANXA1, H2AFY, SPHK1, NSMCE2, FLT3LG, RAD23A, KIF23, SIRT2, CDC25A, CIT, RAD51C, TFDP1, ESPL1, TFDP2, CCNE2, CCNE1, RARA, PKP4, ANAPC5, MAPRE3, PAFAH1B1, ANKRD17, BECN1, PCNA, ROCK2, FOXG1, VPS4B, MEPCE, ANAPC11, CCNB1, SPAST, KIF3B, RAD21, TPR, ABL1, ECT2, FAM83D, E2F7, E2F8, ZBTB17, UBE2B, RCC2, CNOT10, CDC7, NDC80, RAB11A, CDK9, CNOT4, NSFL1C, CNOT6, CNOT7, FAP, CNOT1, CNOT3, CDK2, CNOT8, MNAT1, TRIM32, CCNJL, MAD2L1]
GO:0046632;alpha-beta T cell differentiation;7.0;0.7140352122741334;0.7079369713942671;9.04870575723918;90.58502354652471;6.166155715036245;0.0030317992168737967;0.6662568552797195;[PTGER4, ANXA1, BCL3, ABL1, RORA, ATP7A, RC3H2]
GO:0006144;purine nucleobase metabolic process;7.0;0.6954798709641801;0.6986593007392905;9.165900730544008;248.65741003558907;6.599019797332524;0.008322339736750976;0.6883935445785896;[MTHFD1L, MTHFD1, PPAT, DPYD, ACPP]
GO:0043124;negative regulation of I-kappaB kinase/NF-kappaB signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.487551390376;6.063501560976162;0.008015432820232688;0.6850877518099798;[NLRP12, TNIP1, ABL1, OTUD7B, RORA, RIPK1, TANK]
GO:0046638;positive regulation of alpha-beta T cell differentiation;10.0;0.7671156992804218;0.7987988615011312;9.488762310116963;1285.3660192826185;5.970411137910149;0.04302004391107474;0.7205681151061569;[ITPKB, IL4R, ANXA1, SYK, IL23A, CD80, RARA, NLRP3, NCKAP1L, CCL19, IL12RB1, RUNX1]
GO:0048813;dendrite morphogenesis;8.0;0.8259837884571596;0.7879918942285797;9.485423408851448;64.60914726719044;6.063501560976162;0.0021624100145753813;0.6850877518099798;[ITGB1, CDK5, TAOK2, TRAK1, ZNF365, PICALM]
GO:0097187;dentinogenesis;6.0;1.0;0.8231203125901445;9.628524252492122;26.73958370240551;8.390779266560578;8.949498024565515E-4;0.7522251544931926;[FAM20C]
GO:0007229;integrin-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;5.311165509025885;8.87013979980389E-4;0.5947335637161829;[ITGB1, FCER1G, SYK, ITGB4, ITGB3, ITGA2, RCC2, ITGB2, NEDD9, ITGAE, VAV1, FUT8, ABL1, MYH9, CCM2, ITGAV, TLN1]
GO:0043371;negative regulation of CD4-positive, alpha-beta T cell differentiation;11.0;0.7980440201809971;0.8314509624201607;9.541512875502493;1833.4212889427804;6.781341354126479;0.06136296056888007;0.7792270645443136;[IL4R, ANXA1, RC3H2, RUNX1]
GO:0046883;regulation of hormone secretion;7.0;0.5326392268888578;0.6172389787016295;7.769625480426438;67.7447061739125;4.2087291239193725;0.0022673543493635607;0.5661539683803571;[FGA, ANXA1, FGG, CHD7, ITPR2, ARL2, TM7SF3, CRHR1, AACS, ARNTL, BAIAP3, PER2, VAMP8, SFRP1, GAL, ARL2BP, ADORA2A, CCL5, NPPA, RAB8B]
GO:0046641;positive regulation of alpha-beta T cell proliferation;10.0;0.8653626801206646;0.8479223519212526;9.54628615425515;937.8544877713971;6.8867018697843045;0.03138914569146771;0.7674272657460779;[SYK, IL23A, EBI3, CCR2]
GO:0019221;cytokine-mediated signaling pathway;6.0;0.6039883530135606;0.6251144890969248;7.604142487995313;26.50247477320489;3.309374901576116;8.87013979980389E-4;0.49236189895841853;[ITGB1, CXCL6, CIITA, CDKN1A, CD40, CD80, TRADD, ITGB2, IL5RA, CIB1, RORA, IL27, RPS6KA4, RPS6KA5, MYC, CASP3, CFL1, IL12A, TIMP1, CCR2, HLA-DPA1, IFNAR2, IL4R, ANXA1, TNFRSF12A, SYK, FLT3LG, HLA-C, TALDO1, HLA-A, IRAK4, HLA-F, YWHAZ, VAV1, KARS, IL23A, IRF4, KIT, RAPGEF1, PSME2, RHOU, LCP1, HLA-DQB1, EBI3, IL2RG, LRP8, ADIPOR2, RELA, IL22RA2, HSP90B1, RAP1B, BAG4, CCL5, IL21R, NCAM1, RIPK1, CCL19, IL12RB1, CD300LF, HLA-DQA1, CCR10, SH2B2, BBS2, MAP3K3, CCL20, CD70, MX2, TNFRSF10B, MSN, TNFRSF10A, NFKB1, NFKBIA, CD4, IL6, KLF6, COL1A2, TNIP2, HLA-DPB1, SDC1, KRAS, PTPN6, LTBR, PLP2, HLA-DRB3, LIMS1]
GO:0045792;negative regulation of cell size;6.0;1.0;0.8231203125901445;9.628524252492122;29.63014819255531;7.474488534686424;9.916943946027175E-4;0.7053660038532718;[PTEN]
GO:0016197;endosomal transport;5.0;0.7090535922965819;0.6447678080092112;8.817594036275793;47.18803257139101;4.463867648638682;0.0015793409836922997;0.5185234110033771;[TMEM87A, VPS29, VPS4B, DENND1A, GOSR1, CLEC16A, ARHGAP1, WAS, VPS26B, LYST, BLOC1S1, VPS52, CLTCL1, STX5, VPS54, ANKFY1, RAB6A, VPS16, PLEKHJ1, GRIPAP1, ZFYVE21, VPS37A, VPS37B, RAB11A, BAIAP3, EHD4, ALS2, SNX17, RAB13, RAB35, CHMP4B, TBC1D23, CHMP6, PICALM]
GO:0031333;negative regulation of protein complex assembly;6.0;0.620063164412167;0.633151894796228;8.03928904737554;78.76701431095417;4.925043363760852;0.0026362610832770463;0.5749872592508131;[PTGER4, GSN, KIF14, TWF2, TFIP11, PARK7, SPTB, EML2, SIRT2, VIL1, TRIM9, CAPZB, MYADM, EP300, VDAC2, ULK1, MAPRE1, FKBP4, DACT1]
GO:2000810;regulation of bicellular tight junction assembly;6.0;0.8933024483968273;0.7697715367885581;9.377209824211215;28.92769022108224;6.781341354126479;9.681837584686441E-4;0.6699184248047958;[ROCK2, RUNX1]
GO:0022617;extracellular matrix disassembly;5.0;0.8653626801206646;0.7229223519212526;9.377209824211215;37.09213040667776;5.69953618377475;0.0012414402239614005;0.581715557354699;[CTSK, SH3PXD2B, TIMP2, LCP1, TIMP1, A2M]
GO:0043378;positive regulation of CD8-positive, alpha-beta T cell differentiation;11.0;1.0;0.9324289523296623;9.628524252492122;1779.8210772840882;8.390779266560578;0.05956900972172232;0.8615337942327104;[NCKAP1L, RUNX1]
GO:0006397;mRNA processing;8.0;0.7140352122741334;0.7320176061370667;9.165900730544008;234.3529203123214;3.6745150330669007;0.00784358133891816;0.5629148696734654;[AHCYL1, CCNH, EIF4A3, DDX42, DDX41, CASC3, USP39, EFTUD2, UBL5, PTBP1, ALKBH5, RAVER1, PCF11, C1QBP, ARL6IP4, DHX16, ZNF326, RBM5, DDX17, AQR, MBNL1, RBM15, BUD31, SSU72, PAPD4, TFIP11, THOC2, SRRM1, THOC6, ERN1, PRPF4, PSPC1, PRPF3, XRN2, FASTKD5, SNRPG, CD2BP2, SLU7, SF1, TRUB2, SF3B5, SF3B2, POLDIP3, WBP4, DDX23, SUPT6H, RNF113A, PABPN1, U2AF2, POLR2B, POLR2E, SAP18, SNRPB2, POLR2G, SMNDC1, DCPS, SF3B1, SPEN, CPSF6, PRPF38A, GPKOW, WTAP, CPSF3, NONO, CPSF2, CWC15, LSM5, GTF2H4, PAN3, SON, ACIN1, MNAT1, GRSF1]
GO:0007249;I-kappaB kinase/NF-kappaB signaling;6.0;1.0;0.8231203125901445;9.628524252492122;26.42836680105094;5.602686357784832;8.845336528452411E-4;0.6096419534788213;[RIPK3, ROCK2, TRADD, TANK, NFKB1, RELA, NFKBIA, IRAK1BP1, NKIRAS1, TNIP2, TIFA, BCL3, SNIP1, RIPK1, TLR7, CARD11]
GO:0007006;mitochondrial membrane organization;5.0;0.6763753087927167;0.6284286662572787;8.578702127993445;39.09948622157772;4.981283082083729;0.0013086246165831567;0.5449840603320351;[EYA2, YWHAB, AGK, ATPIF1, ATP5J, ATP5I, ATP5O, ATP5F1, ALKBH7, TAZ, YWHAZ, ATP5L, BBC3, APOO, RHOT2, RHOT1, TFDP1, TFDP2, TP53BP2, PPIF, MFN2, BID]
GO:0046651;lymphocyte proliferation;5.0;0.6873818243518346;0.6339319240368375;8.734706376470026;28.263571572696247;5.500407508664414;9.459563049751445E-4;0.571532107649126;[HELLS, CD40, CD151, DOCK8, EBI3, MSN, RC3H2, PIK3CG, P2RX7, IL23A, ELF4, IMPDH1, IMPDH2, ABL1, DOCK2, CARD11]
GO:0001933;negative regulation of protein phosphorylation;9.0;0.6056485694559711;0.6990649099082746;8.75603614327636;664.693789818838;3.7392027077583316;0.02224670295966317;0.5874636255457587;[CDKN1C, ERRFI1, CDKN1A, GMFB, PTEN, CIB1, PTPN22, PARK7, DUSP14, IGF1R, FLCN, PREX1, RASSF2, NNT, MYC, CASP3, HYAL2, NUP62, PBK, CDK5RAP3, DACT1, DUSP5, H2AFY, PAQR3, SIRT2, DUSP22, SFRP1, NCOR1, ADORA2A, CTDSP2, DDIT4, RAPGEF1, MYADM, TRIB3, EPHA1, CHMP6, PAFAH1B1, C9orf72, HDAC3, GPS1, GPS2, PPP2CA, CCNB1, HSPH1, SNX25, STK38, ABL1, CSK, CDKN2D, PRNP, CDKN2C, UBE2B, AMBP, ANGPT1, SEMA4D, CAV1, P2RX7, ITCH, NLRP12, CDK6, SH3BP5L, QARS, TNIP1, GNAQ, PKIA, TAF7, FGFR1OP, CALM3, CRIPAK, SPRY1, PTPN6, CALM1, CALM2]
GO:0016185;synaptic vesicle budding from presynaptic endocytic zone membrane;7.0;1.0;0.8509193652572005;9.628524252492122;41.05829977546847;8.67846133901236;0.0013741843434141336;0.7947362817240173;[DNM2]
GO:0019695;choline metabolic process;5.0;0.811012628672052;0.6957473261969462;9.253830803050711;54.90914702602792;7.57984905034425;0.001837759735937126;0.6778748447945537;[CHKA, ALDH7A1]
GO:0018125;peptidyl-cysteine methylation;9.0;0.9326813400603323;0.8625812952104552;9.582004236857228;367.81618772121425;8.67846133901236;0.01231047678995128;0.8400575416471059;[RAB3B, RAB3D, RAB6A]
GO:0016188;synaptic vesicle maturation;5.0;1.0;0.7902410118609202;9.628524252492122;29.4535246568776;7.474488534686424;9.857829638144466E-4;0.6724867031240476;[PICALM]
GO:0001937;negative regulation of endothelial cell proliferation;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;87.36028873802138;6.193554689224359;0.002923870244906099;0.6676580400938822;[CAV1, ATPIF1, THBS1, TGFBR1]
GO:0050900;leukocyte migration;5.0;0.6023560406934092;0.5914190322076249;8.01908634005802;26.939797568556347;3.896540641279769;9.016507803758389E-4;0.4895102814636384;[ITGB1, CXCL6, GYPA, WDR1, DOCK8, ITGB3, ITGB2, SIRPG, CD99L2, LYST, CORO1A, GLG1, PIK3CG, PREX1, CCL5, NCKAP1L, ITGAV, CCL19, CCR2, HSD3B7, FCER1G, ANXA1, ANGPT1, SYK, CCL20, CAV1, TNFRSF10B, MSN, TNFRSF10A, ATP1B2, IRAK4, VAV1, NLRP12, IL6, COL1A2, KIT, SDC1, MYH9, PTPN6, TEK, CD244, ARHGEF5]
GO:0035924;cellular response to vascular endothelial growth factor stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;62.59148538135601;6.599019797332524;0.00209488068703431;0.6605944919115335;[ERN1, ANXA1, MT1G]
GO:0001938;positive regulation of endothelial cell proliferation;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;87.3065775231622;5.277263957350204;0.0029220725788817177;0.6207988894539612;[PDCL3, BMPR2, SP1, ITGB3, PDCD6, ARNT, TEK, TGFBR1]
GO:0070972;protein localization to endoplasmic reticulum;6.0;0.7866048967936545;0.7164227609869718;9.143016436710422;32.77360880529348;5.014899692882714;0.001096903192380182;0.5795825161008517;[PPP1R15A, RPS9, RPL3, PMM1, RPS7, PMM2, SRP54, RPL23A, UBAC2, RPS15, SEC61A2, SPCS2, VAPA, CHMP4B, RAB3GAP2, RPL29, RAB3GAP1, RPL19]
GO:0007050;cell cycle arrest;6.0;0.811012628672052;0.7286266269261705;9.292052015870908;55.61614271062087;4.7664383335842135;0.0018614222452456451;0.5668761906316916;[CDKN1C, PPP1R15A, CDKN2D, PRNP, CDKN1A, CDC123, CDKN2C, PKD2, THBS1, PRKAB1, TGFBR1, PPM1G, ERN1, CDK6, FAP, RHEB, MYC, TP53INP1, ABL1, IL12A, PRR11, HRAS, EIF4G2, MCPH1]
GO:0043306;positive regulation of mast cell degranulation;11.0;0.8933024483968273;0.8790801765280758;9.584072489921288;1034.300036297698;7.212124270218933;0.03461709140528456;0.8012573229067359;[VAMP8, IL4R, FCER1G, SYK, NPPA]
GO:0040036;regulation of fibroblast growth factor receptor signaling pathway;6.0;0.7866048967936545;0.7164227609869718;9.260799472366804;67.94038154209638;6.375876246018314;0.002273903427840277;0.6491829203200885;[FAM20C, SPRY1, THBS1, RUNX2]
GO:0030073;insulin secretion;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;236.67564318465372;6.166155715036245;0.007921320783140251;0.711578115202808;[GAL, SNX19, ANXA1, PARK7]
GO:0007052;mitotic spindle organization;7.0;0.8259837884571596;0.7639112594857803;9.280217558223907;96.21539173928952;5.486614186532078;0.0032202425732832385;0.6315050699101035;[DCTN2, TUBGCP2, TUBG1, NDC80, RAB11A, CENPE, CCNB1, SPAST, KIF3B, KIF4A, TBCE, NUF2, ZNF207, KPNB1, CLASP1, SPC25]
GO:0043542;endothelial cell migration;7.0;0.7980440201809971;0.7499413753476991;9.143016436710422;24.971868181253015;5.71663061713405;8.357859548042604E-4;0.6432681208679463;[ITGB1, SCARB1, STARD13, PAXIP1, FAP, ITGB2, RAB13, ABL1, PTEN, MYH9, EPHB4, TGFBR1]
GO:0043547;positive regulation of GTPase activity;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;49.33745512692421;3.758480413184235;0.001651280222271285;0.5153291757075998;[ITGB1, ERRFI1, CD40, DOCK8, DENND1A, ARHGAP1, TBC1D3C, DOCK11, PREX1, RGS1, ARHGDIB, EVI5L, TBC1D22A, HRAS, ARHGEF11, SEC13, TBC1D8, TBC1D2B, GMIP, VAV1, ARFGAP1, BCR, DEPDC1B, SFRP1, ALS2, TBC1D20, CDC42EP4, DEPDC1, RAPGEF1, PKP4, TAX1BP3, ARHGEF1, RIN3, DOCK2, EPHA1, ARHGEF5, RABGAP1, RGS19, RASGRP2, RIC8A, ABR, ARHGAP21, CCL5, DVL3, NCKAP1L, CCL19, ECT2, A2M, TBC1D15, S100A10, STARD13, SEMA4D, CCL20, RCC2, MYO9B, ARHGAP26, ARHGAP25, ARHGAP30, GNAQ, RUNDC1, RAB3GAP2, SMAP1, RAB3GAP1, EZH2, LIMS1, PICALM]
GO:0020027;hemoglobin metabolic process;5.0;0.8933024483968273;0.736892236059334;9.461470167828956;80.86766357206795;7.57984905034425;0.0027065679235849286;0.6778748447945537;[CAT]
GO:0032487;regulation of Rap protein signal transduction;9.0;1.0;0.896240625180289;9.628524252492122;48.758993290020136;8.67846133901236;0.0016319196251719597;0.8400575416471059;[KIF14, TIMP2]
GO:0032488;Cdc42 protein signal transduction;9.0;1.0;0.896240625180289;9.628524252492122;29.60642063139588;7.697632086000634;9.9090025448413E-4;0.7898978880348613;[WAS, RHOU]
GO:0031396;regulation of protein ubiquitination;9.0;0.6417349323569144;0.7171080913587462;8.861269099778454;78.0319103741638;4.551326953967268;0.002611657816063264;0.6289956972645234;[WDR48, PAXIP1, PDCD6, PTEN, GPS2, PTPN22, UBE3A, BRCA1, PARK7, UBE2L3, FZR1, U2AF2, UBR5, UBQLN1, ABL1, FBXO5, SKP2, CDK5RAP3, ATG5, FANCI, RNF20, DTX3L, RPS7, ANGPT1, WFS1, FEM1B, SPHK1, CAV1, GLMN, PRMT3, COMMD1, SENP2, MASTL, RNF40, TGFBR1, CDK9, PER2, GNL3L, CDK5, TRIB3, MAD2L1]
GO:0032007;negative regulation of TOR signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.487551390376;5.926926025970411;0.008015432820232688;0.6781032725983739;[FLCN, PREX1, TMEM127, PDCD6, DDIT4, ARNTL, MTM1]
GO:0032480;negative regulation of type I interferon production;6.0;0.7980440201809971;0.722142322680643;9.186691500213083;65.25422870398782;6.015873511986907;0.002184000309729388;0.6307723637598831;[YY1, RNF135, CYLD, ITCH, NPLOC4, GPATCH3, HAVCR2]
GO:0090303;positive regulation of wound healing;7.0;0.7043150770688792;0.7030769037916401;8.753055515138222;62.345319237194666;5.905872616772578;0.002086641727724376;0.6529459655301135;[XBP1, ANXA1, TBXA2R, THBS1, HRAS, HBEGF]
GO:0032483;regulation of Rab protein signal transduction;9.0;1.0;0.896240625180289;9.628524252492122;48.758993290020136;8.390779266560578;0.0016319196251719597;0.8253454670833372;[DENND1A, MADD]
GO:0031394;positive regulation of prostaglandin biosynthetic process;10.0;0.9326813400603323;0.8815816818910864;9.59462270081644;954.1434290848206;8.390779266560578;0.03193432189813256;0.8443458537639685;[ANXA1]
GO:0033572;transferrin transport;10.0;1.0;0.9152410118609203;9.628524252492122;96.80640656383476;6.193554689224359;0.0032400233075819585;0.731979686697602;[STEAP3, TFRC, ATP6V0A2, ARHGAP1, ATP6V1F, DNM2]
GO:0032481;positive regulation of type I interferon production;6.0;0.811012628672052;0.7286266269261705;9.260799472366804;65.23665507211369;5.618190544320798;0.002183412136085803;0.610434838299289;[CREBBP, XRCC6, SYK, XRCC5, ZBTB20, PTPN22, DDX41, TMEM173, NFKB1, RELA, RNF135, POLR3B, POLR3C, EP300, TLR7, LRRFIP1]
GO:0032482;Rab protein signal transduction;8.0;1.0;0.875;9.628524252492122;29.60642063139588;5.500407508664414;9.9090025448413E-4;0.6562910957882058;[RAB3B, RAB5C, RAB4B, RAB3D, RAB1B, RAB27B, RAB11A, RAB21, RAB43, RAB20, RAB40C, RAB13, RAB35, RAB18, RAB38, RAB28, RAB6A, RAB8B]
GO:0042220;response to cocaine;6.0;0.9326813400603323;0.7894609826203107;9.5544162803384;106.24722930474235;6.343086423195323;0.0035559991485312878;0.647506047256038;[EFTUD2, OXTR, DNM2]
GO:0009247;glycolipid biosynthetic process;7.0;0.6664901433067099;0.6841644369105555;8.805323943683979;239.4700653751826;5.69953618377475;0.008014847579040557;0.6423939107509793;[UGT8, DPM3, PIGU, PIGA, GBGT1]
GO:0043312;neutrophil degranulation;9.0;1.0;0.896240625180289;9.628524252492122;132.80263134205524;3.603287523778533;0.004444784556409926;0.5805129167163294;[SERPINA3, PYGB, GPI, SIGLEC9, FRMPD3, RAB3D, ITGB2, HK3, PSMD7, ACTR1B, PSMD2, LAMP2, CPNE1, TIMP2, CTSH, ITGAV, CPNE3, CAPN1, GUSB, SNAP29, CAP1, ACTR2, SERPINB1, FCER1G, DBNL, PLAUR, COMMD3, RNASE3, TMEM173, SCAMP1, UNC13D, SERPINB6, VAMP8, ACLY, CAT, TMBIM1, ALDOC, DOCK2, ALDOA, ACPP, SLC27A2, KPNB1, CSTB, PDXK, RAB5C, CLEC12A, UBR4, IQGAP2, PLD1, C3, RAP1B, COMMD9, CYB5R3, ALDH3B1, PSMB1, NCKAP1L, RAB6A, AP1M1, CTSA, XRCC6, TMEM30A, RAB4B, GSN, JUP, XRCC5, HSPA6, SURF4, LILRB3, NFKB1, FABP5, VAPA, IMPDH1, IMPDH2, RAB18, PTX3, MNDA, DEGS1, MAN2B1, PTPN6]
GO:0043313;regulation of neutrophil degranulation;10.0;0.8933024483968273;0.861892236059334;9.537552474286395;150.84516981286367;7.8311634786251565;0.005048652081797471;0.8157270763441555;[BCR, ABR, SYK, ITGB2]
GO:0046822;regulation of nucleocytoplasmic transport;6.0;0.6547035408479693;0.6504720830141292;8.529911963824013;30.746838917960506;5.040875179285974;0.0010290690282256237;0.5809109036834981;[CDKN1A, HDAC3, NOLC1, PARK7, SUPT6H, PPP1CC, BAG3, HYAL2, TPR, NUP62, XPO5, UBR5, ECT2, GTSE1, EMD, CPSF6, PPP1R12A, ANGPT1, JUP, MX2, NUP153, THOC2, TMEM173, CDK5, PKIA, CAMK1]
GO:0097178;ruffle assembly;6.0;1.0;0.8231203125901445;9.628524252492122;77.5241744012752;7.379178354882098;0.0025946643499833917;0.7004918368257019;[BAG4, DBNL]
GO:0001755;neural crest cell migration;6.0;0.7980440201809971;0.722142322680643;9.089527751759436;22.57397290845719;5.825829909099042;7.555305579894227E-4;0.6210535250702663;[TBX1, SEMA6B, SEMA4D, SEMA4B, CFL1, SOX8]
GO:0035508;positive regulation of myosin-light-chain-phosphatase activity;11.0;1.0;0.9324289523296623;9.628524252492122;1250.9738681086212;9.777073627680469;0.0418689695622076;0.9324289523296623;[PPP1R12A]
GO:0051174;regulation of phosphorus metabolic process;5.0;0.40182682751602716;0.49115442561893385;6.054307706698325;26.78229071161683;2.304004539648272;8.963791676210415E-4;0.4080679111657012;[ERRFI1, CCNK, GMFB, CCNH, CCNF, PPP2R2A, RPS6KA4, PREX1, RPS6KA5, RASSF2, MYC, ARL6IP5, IL12A, EPHB4, CDK5RAP3, PDK1, PAQR3, FLT3LG, MAPK8IP3, COX7A2L, SFRP1, TWSG1, KARS, IL23A, DDIT4, JTB, CD2BP2, MTCP1, TRIB3, EPHA1, CDCA2, CRHR1, IL22RA2, C3, NUAK1, HSPH1, RRAS, PRDX1, NCKAP1L, NTSR1, XRCC6, XRCC5, EIF2AK3, PILRB, CCDC88A, EHD4, ARL2BP, QARS, PKIA, CALM3, CRIPAK, CALM1, CD24, CALM2, CCNJL, EZH2, CDKN1C, CDKN1A, CD40, ELL, PPP1R11, KIF14, SMG5, AKAP13, NNT, HYAL2, PBK, TIMP2, HRAS, CCR2, HAVCR2, CAP1, DUSP5, MAP4K2, DBNL, RIPK3, SYK, SPHK1, FCRL3, ATPIF1, GFRA2, SIRT2, VAV2, ITPKB, NCOR1, KIT, RAPGEF1, FAM20C, MAPRE3, TLR7, ARHGEF5, PAFAH1B1, HBEGF, GPS1, GPS2, PPP2CA, PDPR, PPP1R7, SNX25, CCL19, CDKN2D, MAP3K3, CDKN2C, MAP3K1, CCL20, RYK, GPR55, CENPE, PDCL3, ITCH, NLRP12, TAOK2, CAMK1, SCARB1, NCF1, CD80, CIB1, PARK7, IGF1R, PPME1, NEK1, MAP3K5, PDGFRB, FBXO18, SWAP70, VRK2, CDC25A, ERN1, CCNE2, TBL1XR1, CCNE1, MADD, PPIF, MYADM, ADNP, PKMYT1, STK4, AGER, STK3, HSP90B1, RAP1B, CCNB1, BAG4, STK38, ABL1, DVL3, RIPK1, ECT2, FAM83D, MARK2, PRNP, UBE2B, AMBP, CAV1, GLMN, TNFRSF10B, TNFRSF10A, CDK9, NSFL1C, IL6, COPS5, CDK6, CNOT7, SH3BP5L, CDK5, GNAQ, RCAN3, FGFR1OP, MNAT1, BCAR3, BMPR2, YWHAB, ITGB3, ITGB2, PTEN, PTPN22, LDB2, PKD2, TAZ, PIK3CG, DUSP14, CKS1B, FLCN, PTBP1, CASP3, NUP62, PHACTR2, ITGAV, ATP7A, DACT1, FGA, PPP1R12A, KSR1, H2AFY, ITGA2, FGG, PLAUR, ZFP91, ARNT, PPP2R5D, BPGM, OXSR1, SENP2, MASTL, TGFBR1, DUSP22, RBL1, ALS2, ADORA2A, CTDSP2, LCP2, CHMP6, MET, MCPH1, C9orf72, PPP1R15A, VAC14, STOML2, HDAC3, ROCK2, ITLN1, LRP8, THBS1, KCTD20, CCL5, CSK, ZNF622, TBX1, PPP1R14B, PDE6H, ANGPT1, SEMA4D, TSHR, MYO1D, P2RX7, CD4, PIK3IP1, TNIP1, TAF7, CDK2AP1, KRAS, SPRY1, PTPN6, TEK, LTBR, CD244]
GO:0001519;peptide amidation;7.0;1.0;0.8509193652572005;9.628524252492122;60.01596331221528;9.083926447120524;0.0020086802811995464;0.8154717862087246;[PAM]
GO:0010469;regulation of signaling receptor activity;6.0;0.5916390046238794;0.6189398149020842;7.95454781892045;48.619731222684926;3.470798340732454;0.0016272586491059737;0.5006171011438312;[ITGB1, ERRFI1, CXCL6, GPI, COPA, GMFB, NCF1, EBI3, CLEC12B, PTEN, IL27, PARK7, METRNL, AGER, CXCL14, CCL5, NPPA, IL12A, FAM3C, CCL19, CAPN1, TIMP1, CMTM7, UBE2I, CCL20, CD70, BUD31, FLT3LG, NETO2, KLHL24, IL6, GAL, CDK5, IL23A, PNOC, SCGB3A1, CHMP6, KCNK3, HBEGF]
GO:2000601;positive regulation of Arp2/3 complex-mediated actin nucleation;13.0;1.0;0.9625549647676366;9.628524252492122;774.2616619260014;7.8311634786251565;0.025913841034406984;0.8630410292508717;[NCKAP1, WAS, WASL]
GO:0008360;regulation of cell shape;6.0;0.6763753087927167;0.6613079669865028;8.690254613899192;41.77565885716001;4.6590798152637145;0.0013981937062970905;0.5613858710120996;[WDR1, EPB41, SH3KBP1, WIPF2, LST1, ITGB2, WAS, WASL, CORO1A, TBCCD1, ANXA1, SEMA4D, MSN, CDC7, VRK1, VRK2, RHOC, RHOB, VIL1, MKLN1, CFDP1, FES, CDC42EP4, TAOK2, KIT, MYH9, RHOU, ALDOA, CSNK1G2, CSNK1G1]
GO:0007270;neuron-neuron synaptic transmission;8.0;1.0;0.875;9.628524252492122;25.73829654599903;7.8311634786251565;8.61437622431563E-4;0.7754860644832351;[VDAC3, PTEN]
GO:0007032;endosome organization;5.0;0.8436909121759173;0.712086467948879;9.223059144383958;20.915744831851537;5.528578385631111;7.000311565738116E-4;0.5729727676072827;[VPS18, ARFGEF2, USP8, PDCD6IP, VTA1, VPS4B, VPS33B, VPS37A, VPS37B, RAB11A, ALS2, TMEM127, VPS11, CHMP4B, PIK3C3, CHMP6, PLEKHJ1]
GO:0006183;GTP biosynthetic process;11.0;1.0;0.9324289523296623;9.628524252492122;9648.749331526727;7.379178354882098;0.32293495681556944;0.8098004765652196;[IMPDH1, IMPDH2, NME1]
GO:0008361;regulation of cell size;5.0;0.7763722522362496;0.6784271379790451;8.999915593069748;28.02071028012121;5.54296712308321;9.378279560736312E-4;0.5737086083097278;[SLC12A2, P2RX7, MTPN, PTEN, MSN, ATP7A, CLCN3, VAV1, AQP1, VAV2]
GO:0046836;glycolipid transport;6.0;0.8933024483968273;0.7697715367885581;9.377209824211215;35.80744873089876;7.9853141584524145;0.0011984430844115227;0.7314896500084853;[GLTP]
GO:0032228;regulation of synaptic transmission, GABAergic;7.0;0.8933024483968273;0.7975705894556142;9.405380701177911;30.61939422688933;6.311337724880743;0.001024803569108247;0.6736814700148209;[USP46, NISCH, OXTR, ADORA2A, PTEN, KRAS, BAIAP3]
GO:0030049;muscle filament sliding;6.0;1.0;0.8231203125901445;9.628524252492122;20.959081145343944;6.139487467954083;7.014815839862524E-4;0.6370939872166814;[MYL4, MYL6, MYL6B]
GO:0007281;germ cell development;4.0;0.8653626801206646;0.6826813400603323;9.34084218004034;71.68419734523428;4.759793790865545;0.0023992055735558276;0.4934160758179115;[TIAL1, ING2, SPAG6, STRBP, H3F3A, KIT, RARA, CIB1, AFF4, IQCG, PAFAH1B1]
GO:0007043;cell-cell junction assembly;5.0;0.7508913569872202;0.6656866903545304;8.817594036275793;53.94372379865016;5.16195311083921;0.0018054478893412883;0.554223534004606;[PDCD6IP, WDR1, JUP, ARL2, RHOC, MTDH, UGT8, FLCN, RAB13, CD9, PKP4, ECT2, TLN1]
GO:0007044;cell-substrate junction assembly;5.0;0.8653626801206646;0.7229223519212526;9.377209824211215;36.1037539480283;6.088194173566533;0.0012083601533714658;0.6015915450270957;[CD151, ITGB4, ITGA2, RCC2, TAOK2, TESK2, PTPRK, TLN1]
GO:0030042;actin filament depolymerization;7.0;0.9326813400603323;0.8172600352873667;9.548481544818586;62.215548486061174;7.474488534686424;0.002082298417470032;0.7331650565203278;[VIL1, WDR1, CFL1, TWF2]
GO:0030041;actin filament polymerization;7.0;0.9326813400603323;0.8172600352873667;9.548481544818586;66.55674193746657;6.409777797693995;0.0022275942554681166;0.6787156999164222;[VIL1, PREX1, GSN, ARPC2, WAS]
GO:0042246;tissue regeneration;4.0;0.7586651285174919;0.629332564258746;8.935377071932177;42.88961059103013;6.039404009397101;0.0014354766683382502;0.5588554019015759;[MTPN, CCNB1, GSN]
GO:1990000;amyloid fibril formation;5.0;1.0;0.7902410118609202;9.628524252492122;65.1103285866179;7.697632086000634;0.0021791841023027143;0.6838982747154925;[GSN, RIPK3, RIPK1]
GO:0045761;regulation of adenylate cyclase activity;11.0;0.7763722522362496;0.820615078447787;9.452633586028458;755.0027468515221;6.088194173566533;0.02526926247876245;0.7437794854958376;[CAP1, TIMP2, CRHR1, TSHR, CCR2]
GO:0035965;cardiolipin acyl-chain remodeling;9.0;1.0;0.896240625180289;9.628524252492122;149.28317654303592;8.390779266560578;0.004996373572759013;0.8253454670833372;[TAZ]
GO:0035723;interleukin-15-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;7.212124270218933;0.00101047745553359;0.7197477358342742;[CD4, IL2RG]
GO:0030036;actin cytoskeleton organization;5.0;0.6347111282356054;0.607596575978723;8.048073876931273;29.6146440060229;3.9779809732199434;9.911754834323397E-4;0.49367514382642164;[ITGB1, NCKAP1, RTKN, WDR1, EPB41, ROCK2, WIPF2, ARPC1A, WAS, TESK2, WASL, CORO1A, AQP1, ABR, CAPZB, CFL1, ABL1, NCKAP1L, PDGFRB, ARHGEF11, PDCD6IP, ANXA1, KIF23, RHOC, ARHGAP26, CORO2A, RHOB, SSH1, BCR, VIL1, NISCH, MKLN1, DIAPH3, PARVG, CDK5, RAB13, TAOK2, KIT, SPECC1L, ELMO1, MYH9, KRAS, RHOU, DOCK2, TLN1, TRIM32, ARHGEF5, PAFAH1B1]
GO:0032456;endocytic recycling;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;48.979792040619635;6.409777797693995;0.0016393095606485504;0.6509166472493662;[EHD4, DENND1A, RAB13, VPS52, RAB35]
GO:0035722;interleukin-12-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.948432231191374;0.00101047745553359;0.6551224661907153;[RAP1B, CFL1, PSME2, TALDO1, MSN, IL12A, LCP1, IL12RB1]
GO:0010020;chloroplast fission;6.0;1.0;0.8231203125901445;9.628524252492122;42.36455142891426;8.67846133901236;0.0014179034107047993;0.7669372290569613;[DNM2]
GO:0007098;centrosome cycle;4.0;1.0;0.75;9.628524252492122;37.692070457630365;6.088194173566533;0.0012615196775557923;0.5613505331661754;[PPP1R12A, FES, NUP62, ARL2, BRCA1, CKAP5]
GO:0000212;meiotic spindle organization;7.0;0.7671156992804218;0.7344772148974115;9.168991923113682;69.6769368299192;7.292166977892469;0.002332024370525413;0.7238411236270654;[ESPL1, MYH9, FBXO5, TUBG1]
GO:0019087;transformation of host cell by virus;7.0;0.9326813400603323;0.8172600352873667;9.533214072687796;43.73295546735172;8.67846133901236;0.0014637026623876212;0.7947362817240173;[HYAL2]
GO:0048642;negative regulation of skeletal muscle tissue development;8.0;0.7866048967936545;0.7683024483968273;9.310070521373587;215.71554513694034;7.212124270218933;0.007219805164346847;0.7438283705770736;[TSC22D3]
GO:0015949;nucleobase-containing small molecule interconversion;6.0;0.7671156992804218;0.7066781622303554;9.271849308553389;109.52544358977337;6.409777797693995;0.003665718030449963;0.6509166472493662;[DUT, TXNRD1, AK2, GLRX, NME1]
GO:0033137;negative regulation of peptidyl-serine phosphorylation;10.0;0.8933024483968273;0.861892236059334;9.56398573135455;780.3281191277907;6.518977089658987;0.026116879897493853;0.7486218033895181;[RASSF2, CAV1, DDIT4, PAQR3]
GO:0010259;multicellular organism aging;4.0;0.9326813400603323;0.7163406700301662;9.474373572664863;29.177677042081047;6.943860283624253;9.765505923939418E-4;0.6051093378270707;[WRN, NDUFS6, HYAL2]
GO:0071897;DNA biosynthetic process;7.0;0.7090535922965819;0.7054461614054914;9.249034630787218;573.3007402310989;5.058574756385375;0.01918785983836615;0.609615113546532;[RFC5, CDKN2D, POLQ, RFC3, RFC4, PCNA, RFC1, WRNIP1, SMG5, POLE4, POLB, CENPF, WRN, POLA2, NPLOC4, POLE2, POLE3, TK2]
GO:0050715;positive regulation of cytokine secretion;9.0;0.6913464685778243;0.7419138594692012;9.0689084645567;549.4808578036607;5.03214149931722;0.0183906298100222;0.6535845754738829;[PTGER4, XBP1, IL4R, CADM1, SYK, GLMN, PTPN22, P2RX7, NLRP12, KARS, NLRP7, HYAL2, NLRP2, ABL1, NLRP3, MBP, CCL19, GAPDH, CD244, HAVCR2]
GO:0071895;odontoblast differentiation;7.0;1.0;0.8509193652572005;9.628524252492122;26.97430872096675;8.67846133901236;9.028058375889943E-4;0.7947362817240173;[FAM20C]
GO:0015701;bicarbonate transport;7.0;1.0;0.8509193652572005;9.628524252492122;31.887457555831563;6.015873511986907;0.0010672445075450394;0.6585714164269392;[CYB5R1, AQP1]
GO:0035556;intracellular signal transduction;5.0;0.5140152493238541;0.5472486365228473;6.9204740513899115;23.17027026302992;2.4005655013542495;7.75488093814194E-4;0.41300604323788886;[NCKAP1, OXTR, TESK2, CALML4, RPS6KA4, PREX1, RPS6KA5, RPS6KA2, MYC, ARL6IP5, GTSE1, PDK1, PAQR3, BCR, NISCH, DEPDC1B, KARS, DDIT4, TRIB3, PAXIP1, CRHR1, ABR, NUAK1, RHOT2, RHOT1, PPP4C, RRAS, TP53BP2, STK38L, CCR10, SULT1A3, XBP1, SETDB1, EIF2AK3, RAB27B, SETX, CCDC88A, CYLD, COL1A2, CALM3, CALM1, RGL1, CD24, CALM2, BTG2, CDKN1A, CD40, ARHGAP1, BRCA1, BBC3, AKAP13, AKAP11, NKIRAS1, C1QBP, CTSH, HRAS, TEAD2, RAB8B, CCR2, DUSP5, MAP4K2, DBNL, RIPK3, SPHK1, TMEM173, RHOC, GMIP, GFRA2, SIRT2, VAV1, CIT, VAV2, RHOB, ITPKB, GAL, CDC42EP4, KIT, DEPDC1, RAPGEF1, TAX1BP3, ARHGEF1, TLR7, RHOU, ARHGEF5, EXOC1, HBEGF, PTGER4, PCNA, GPS1, ADCY4, WAS, GPS2, TANK, RELA, PPP2CA, PERP, BID, MAP3K3, MAP3K1, GSN, CCL20, MYO9B, RAB11A, ITCH, CAMK4, TAOK2, CAMK1, TJP2, RAB3B, DGKD, RTKN, DGKA, CD80, RAB3D, SIRPG, IL5RA, DEFB1, PARK7, IGF1R, RAB43, DOCK11, ARHGDIB, CFL1, EP300, SNIP1, NEK1, MAP3K5, IFNAR2, PDGFRB, USP8, IGFBP5, ERN1, RAB35, ELMO1, RAB38, KPNB1, CARD11, RAB5C, DIABLO, CLEC16A, ITPR2, RASGRP2, STK4, PLD1, KRCC1, RASGRP4, STK3, RAP1B, CCNB1, ZMAT1, TBXA2R, STK38, ABL1, DVL3, MBP, RIPK1, ECT2, RAB6A, MARK2, PRNP, RAB4B, IFT122, TNFRSF10B, CNOT10, CORO2A, NFKB1, NFKBIA, CNOT4, CNOT6, IRAK1BP1, CNOT7, ARHGAP30, SH3BP5L, PTPRA, CNOT1, GNAQ, RCAN3, BCL3, CNOT3, CDK2, PLEKHM1, NMUR1, CNOT8, LSM14A, BCAR3, MCTP1, PRKCSH, MAST3, YWHAB, DOCK8, TRADD, PTEN, ATP2A2, PKD2, PIK3CG, POLB, FLCN, RASGEF1A, CASP3, CASP2, ITGAV, ARHGEF11, KSR1, OXSR1, IRAK4, MASTL, SPTB, TGFBR1, PJA2, TFDP1, ALS2, TFDP2, ADORA2A, PIK3C3, LCP2, LCP1, DOCK2, MET, PPP1R15A, RGS19, ROCK2, TUFT1, RAB1B, IL2RG, RAB21, FZR1, GNG2, RAB20, PABPN1, RAB40C, CCL5, TIFA, MKNK2, NCAM1, ZNF622, RAB28, SH2B3, E2F7, SH2B2, E2F8, ARFGEF2, ANGPT1, TSHR, MAPK13, SNRK, P2RX4, TNIP2, ASB8, RAB13, RAB18, CCM2, KRAS, PTPN6, TEK, ASB3]
GO:0032049;cardiolipin biosynthetic process;9.0;1.0;0.896240625180289;9.628524252492122;810.2807285887932;7.8311634786251565;0.027119366780555196;0.7967266896635242;[TAZ, CRLS1]
GO:0032286;central nervous system myelin maintenance;6.0;1.0;0.8231203125901445;9.628524252492122;21.34652774794371;8.390779266560578;7.144490730959624E-4;0.7522251544931926;[PTEN]
GO:0050728;negative regulation of inflammatory response;7.0;0.6729672293956388;0.6874029799550199;8.712233520617966;126.17514047852296;5.085725745451326;0.004222968401562039;0.6110036163900148;[PTGER4, CUEDC2, SERPINF1, GPS2, RORA, METRNL, AGER, NFKB1, IL22RA2, BCR, ABR, NLRP12, ADORA2A, NLRP7, PBK, NLRP3, TEK]
GO:0034220;ion transmembrane transport;5.0;0.44800904580126355;0.514245534761552;6.183841758890227;26.332710660334534;2.96803432163749;8.813321279004005E-4;0.4420264250971726;[KCNG1, KCNK6, SLC23A2, CLIC5, SLC25A3, STEAP3, COX4I1, SLC35B1, ARHGAP1, ATP2A2, PKD2L1, COX6A1, PKD2, BEST3, GPR89B, AQP1, CPT2, NNT, ARL6IP5, PMPCB, ITGAV, CLCC1, ATP7A, SLC30A7, SLC36A1, KCND1, SLC35C2, KCNK12, TSC22D3, CACNA2D3, ZDHHC13, ATP1B2, HTR3B, ATP5F1, TRPC4AP, SLC39A14, ZDHHC17, SLC5A6, COX7A2L, SLC9A6, NDUFS7, SLC25A19, SLC9A8, VDAC3, VDAC2, SLC25A10, XPR1, STOML2, SLC35D1, SLC20A1, COX15, KCNA3, ITPR2, ATP5J, ATP5I, SLC1A4, COX5B, ATP5O, CLCN3, ACACA, MTMR6, ATP5L, RHD, ANKH, ATP6V0A2, SLC38A6, CYC1, SLC25A20, CCL19, KCNN3, APOL1, SLC36A4, NTSR1, ATP6V1F, TIMM8B, SLC35A2, SLC12A2, SLC37A1, ATP13A1, SLC31A1, P2RX7, P2RX4, SFXN3, SFXN4, FXYD5, ATP13A3, PLP2, CALM1, KCNK3, PICALM]
GO:0050729;positive regulation of inflammatory response;7.0;0.657518819034173;0.679678774774287;8.587070377663961;125.85203775116636;4.973052582947213;0.0042121544440509905;0.6052415056197167;[PTGER4, SUCNR1, FCER1G, ITGA2, PARK7, PIK3CG, MAPK13, NFKBIA, C3, VAMP8, NLRP12, IL6, KARS, TNIP1, IL23A, HYAL2, NPPA, TLR7, GPSM3, CCR2]
GO:1902963;negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process;12.0;1.0;0.9481203125901445;9.628524252492122;1477.8294340208338;9.083926447120524;0.049461621196535015;0.9126727335416687;[PICALM]
GO:1902961;positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process;11.0;1.0;0.9324289523296623;9.628524252492122;1348.57412674769;7.9853141584524145;0.04513556238432715;0.8407982897480031;[ROCK2, PICALM]
GO:0000226;microtubule cytoskeleton organization;5.0;0.579397892394798;0.5799399580583193;7.662411396119289;30.307791186580253;3.8212362582156385;0.0010143744957736317;0.4856592118117268;[SPAG16, CIB1, CALML4, TUBA1C, TUBA1B, TUBB6, KIF19, NUF2, ZNF207, FBXO5, NEFH, MAP1S, TUBG1, CKAP5, IQCG, EML3, NCOR1, ESPL1, KATNAL1, MAP7D1, MYH9, KIF2C, MAPRE3, KIF20A, VAMP4, MAPRE1, GAPDH, KPNB1, PAFAH1B1, MCPH1, HDAC3, DCTN2, TUBGCP2, VPS4B, TUBD1, CCNB1, SPAST, KIF3B, LMNA, CLASP1, MARK2, BBS2, UBE2B, CEP350, NDC80, RAB11A, CCDC88B, NSFL1C, CENPE, CCDC88A, NIN, WEE1, SON, CDK5, TTLL3, FES, KIF4A, CENPJ, TBCE, FGFR1OP, SPRY1, CALM1, SPC25]
GO:1902966;positive regulation of protein localization to early endosome;8.0;1.0;0.875;9.628524252492122;104.26631903438536;7.9853141584524145;0.00348969986448594;0.7833693374183408;[DTX3L, ROCK2, MSN]
GO:0060997;dendritic spine morphogenesis;8.0;1.0;0.875;9.628524252492122;122.19110678714402;6.8867018697843045;0.004089626379309125;0.7271862538851576;[PTEN, WASL, ZNF365]
GO:0061844;antimicrobial humoral immune response mediated by antimicrobial peptide;6.0;1.0;0.8231203125901445;9.628524252492122;44.28377145688295;5.682729065458369;0.0014821379778550245;0.6137353412716126;[CXCL6, HIST1H2BJ, DEFB1, RNASE3, GAPDH, HIST1H2BC]
GO:0001558;regulation of cell growth;5.0;0.5833093054345528;0.5818956645781967;7.6590836060266145;26.25041167864861;3.793137346993279;8.785776550476476E-4;0.4842222321850823;[CDKN1A, BMPR2, BTG1, KIF14, CIB1, TMEM97, FLCN, KIAA1109, HYAL2, NPPA, SEMA6B, ARHGEF11, G6PD, CSNK2A1, IGFBP5, TNFRSF12A, PARP2, SPHK1, TGFBR1, DNM2, OLFM1, SFRP1, GAL, RUFY3, ADNP, PAFAH1B1, HBEGF, MTPN, EI24, TWF2, DERL2, RASGRP2, ADIPOR2, FBLN5, RAB21, PPP2CA, SERTAD3, SERTAD2, ABL1, RBBP7, CDKN2D, CDKN2C, EGLN2, SEMA4D, SEMA4B, H3F3A, EAF2, RAB11A, ITCH, CDK5, TAOK2, FGFR1OP, SCGB3A1, TRIM32, EIF4G2]
GO:0046474;glycerophospholipid biosynthetic process;7.0;0.6634067003016617;0.6826227154080313;8.822899088505487;510.210298105942;4.383446081328108;0.01707627951814874;0.5750890017074093;[ARF3, AGPAT5, VAC14, PIGU, DGKA, PTEN, PLD1, TAZ, PIK3CG, MTMR6, MTM1, CPNE1, CPNE3, SBF1, PLA2G12A, CHKB, CHKA, PLEKHA2, AGK, STARD7, STARD10, CRLS1, RUFY1, DPM3, SYNJ1, FABP5, GPAM, PIGA, PIK3C3]
GO:0015718;monocarboxylic acid transport;8.0;0.5640623033008358;0.6570311516504179;7.75672207559053;50.19664702939052;4.879233827729558;0.0016800366020243219;0.6245242448576669;[PLA2G12A, ABCC2, ABCD3, ANXA1, ABCB4, STARD10, ACACA, SLC16A14, SLC5A6, RXRA, CPT2, SLC16A6, SLC25A20, SLC27A2, SLC16A5]
GO:2000643;positive regulation of early endosome to late endosome transport;8.0;1.0;0.875;9.628524252492122;187.5816030452836;7.697632086000634;0.006278187441443136;0.7686572628545723;[RAB21, VPS11, MSN]
GO:0050727;regulation of inflammatory response;6.0;0.5272636092234699;0.5867521172018795;7.400047131651798;31.586589572713706;3.8007227183825356;0.00105717472691369;0.517489449159909;[PTGER4, CUEDC2, SUCNR1, CFH, OTUD7B, GPS2, RORA, PARK7, METRNL, AGER, RELA, PIK3CG, C2, IL22RA2, C3, ABR, NLRP7, C1QBP, CCL5, HYAL2, NPPA, PBK, NLRP3, A2M, GPSM3, CCR2, FCER1G, ANXA1, ITGA2, SERPINF1, NFKB1, MAPK13, BCR, NFKBIA, VAMP8, NLRP12, IL6, KARS, ADORA2A, TNIP1, IL23A, TLR7, TEK, TBC1D23, DNASE1L3, MGLL, C1QC, MCPH1]
GO:2000401;regulation of lymphocyte migration;8.0;0.6547035408479693;0.7023517704239847;8.935377071932177;53.02995074112654;5.885253329569843;0.0017748647274483335;0.6759721289664703;[RIPK3, CCL20, DOCK8, CCL5, MSN, CD99L2, WASL, CXCL14, CCR2]
GO:0033128;negative regulation of histone phosphorylation;10.0;0.9326813400603323;0.8815816818910864;9.60383163990175;1476.02840938532;8.67846133901236;0.0494013425228013;0.8590579283277371;[UBE2B, H2AFY]
GO:0071404;cellular response to low-density lipoprotein particle stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;56.74958382123113;7.004484905440688;0.0018993574991869968;0.6813299963962409;[ITGB1, FCER1G, SYK, ITGB2, CD9]
GO:0030091;protein repair;6.0;0.7980440201809971;0.722142322680643;9.223059144383958;83.35257022185557;7.9853141584524145;0.0027897355128825266;0.7314896500084853;[MSRA, PARK7]
GO:0060548;negative regulation of cell death;5.0;0.5408746917014966;0.5606783577116685;7.270369308343265;41.94029430001592;2.875336421023895;0.0014037039064071987;0.4372858501489002;[CIB1, PARK7, UBE2Z, TM7SF3, IGF1R, AQP1, MYC, CFL1, SOX8, EPHB4, IER3, PDGFRB, CSNK2A1, SERPINF1, FLT3LG, THOC6, NUP93, SFRP1, CFDP1, PPIF, VDAC2, CHMP4B, ADNP, EPHA1, PPID, LRPAP1, ABCB4, CORO1A, MTDH, HSP90B1, BCL2L12, BAG4, HSPH1, BAG3, BAG1, ABL1, NCKAP1L, RIPK1, NTSR1, SULT1A3, ATG5, TFAP2A, PRNP, PRELID1, XBP1, UBE2B, CBX4, WFS1, NONO, RHBDD1, CAV1, PYCR1, TNFRSF10B, TNFRSF10A, NFKB1, SETX, VIL1, NFKBIA, IL6, SON, COPS5, CDK5, QARS, BCL3, HYOU1, MNAT1, CPEB4, AVEN, ITGB1, ARF4, BTG2, CDKN1A, DOCK8, TRADD, KIF14, PTEN, BRCA1, AATF, PIK3CG, ING2, NNT, SIN3A, CASP3, NUP62, CASP2, CTSH, ITGAV, TIMP1, HRAS, TEAD2, TSC22D4, FGA, DFFA, FCER1G, ANXA1, SPHK2, PARP2, SPHK1, TSC22D3, FGG, PLAUR, YWHAZ, TGFBR1, DDB1, ITPKB, CREB3, ADORA2A, PTRH2, KIT, CAT, TMBIM1, RARA, BIRC6, MET, BECN1, HDAC3, HDAC1, VPS4B, NLRC4, THBS1, RELA, UNG, CLN3, CCL5, LMNA, CCL19, RFFL, SNCB, BID, DCPS, TBX1, CDKN2D, ANGPT1, SEMA4D, EYA2, RYK, SYVN1, ITCH, GPAM, TNIP2, PSMC1, KRAS, ERCC5, PDCD1, TEK, TRIM32, MAD2L1]
GO:0090394;negative regulation of excitatory postsynaptic potential;8.0;0.8933024483968273;0.8216512241984136;9.551563211355994;398.5774323400213;7.57984905034425;0.013340027964019948;0.7626338329336335;[EIF4A3, PTEN]
GO:0060545;positive regulation of necroptotic process;7.0;1.0;0.8509193652572005;9.628524252492122;151.94543820684703;9.083926447120524;0.005085477074766827;0.8154717862087246;[RIPK3, RIPK1]
GO:0048661;positive regulation of smooth muscle cell proliferation;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;63.45804869205661;5.433268205826786;0.002123883781187112;0.6009779013089371;[PDGFRB, IGFBP5, ITGA2, IRAK4, THBS1, ERN1, IL6, CCL5, MFN2, SKP2, MNAT1, HBEGF, MAP3K5]
GO:0019064;fusion of virus membrane with host plasma membrane;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;56.73089801191601;7.8311634786251565;0.0018987321019653565;0.7514054297404357;[CD4, HYAL2]
GO:0014839;myoblast migration involved in skeletal muscle regeneration;7.0;1.0;0.8509193652572005;9.628524252492122;22.014357120524497;9.083926447120524;7.368007211888268E-4;0.8154717862087246;[BIN3, ANXA1]
GO:0048662;negative regulation of smooth muscle cell proliferation;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;63.58586787906956;5.970411137910149;0.0021281617743466354;0.6284474158353811;[CDKN1A, IGFBP5, PTEN, MFN2, IL12A, COMT, SF1]
GO:0070588;calcium ion transmembrane transport;9.0;0.7140352122741334;0.7532582313173557;9.078477915572849;116.6808485568922;4.562137870071484;0.003905202995253044;0.629548568016852;[STOML2, ATP13A1, CACNA2D3, ITPR2, ATP2A2, PKD2L1, PKD2, TRPC4AP, P2RX7, P2RX4, PMPCB, ITGAV, CCL19, ATP13A3]
GO:0032268;regulation of cellular protein metabolic process;6.0;0.36714539409510516;0.5066930096376971;6.125974376569679;70.75951198159159;1.9442661111556045;0.0023682571865975056;0.4225501719322627;[CYFIP2, ERRFI1, CCNK, GMFB, CCNH, GFI1, CCNF, EIF4A3, PPP2R2A, UBE2L3, AQP1, RPS6KA4, PREX1, RPS6KA5, RASSF2, MYC, ARL6IP5, IL12A, FBXO5, SKP2, EPHB4, CDK5RAP3, CSNK2A1, SERPINF1, SECISBP2, PAQR3, ATG10, FLT3LG, MAPK8IP3, MIF4GD, EID1, SFRP1, TWSG1, KARS, XRN1, IL23A, DDIT4, JTB, PSME2, MTCP1, TRIB3, EPHA1, ZNF274, CDCA2, PAXIP1, NOLC1, GLG1, IL22RA2, C3, FXR1, NUAK1, ZNHIT1, HSPH1, RRAS, PRDX1, VPS11, NCKAP1L, A2M, ATG5, PRELID1, XBP1, XRCC6, XRCC5, EDEM1, EIF2AK3, PILRB, UBAC2, PUM2, CCDC88A, EHD4, ARL2BP, QARS, PKIA, CALM3, CRIPAK, CALM1, CD24, CALM2, CCNJL, EZH2, CPEB4, CDKN1C, SETD5, SERPINA3, BTG2, CDKN1A, CD40, WDR48, PPP1R11, ZFAND2A, SERPINA10, KIF14, BRCA1, BBC3, AKAP13, NIPBL, ING2, NNT, C1QBP, HYAL2, PBK, TIMP2, CTSH, TIMP1, JARID2, HRAS, HAVCR2, UPF1, DUSP5, MAP4K2, SERPINB1, DBNL, RIPK3, SYK, SPHK1, FCRL3, ATPIF1, PRMT3, COMMD1, GFRA2, SIRT2, SERPINB6, GNL3, ITPKB, NCOR1, MTF2, KIT, RAPGEF1, RARA, MAPRE3, TLR7, ARHGEF5, RNF166, PAFAH1B1, HBEGF, CSTB, CSTA, CDC123, DERL3, GPS1, DERL2, GPS2, TANK, RELA, ARNTL, PPP2CA, RXRA, RNF138, PPP1R7, SNX25, PERP, CCL19, BID, CDKN2D, ZNF462, MAP3K3, CDKN2C, MAP3K1, GSN, YTHDF3, CCL20, RYK, GPR55, PER2, CENPE, PDCL3, ITCH, NLRP12, PSMC1, TAOK2, RAB3GAP2, CAMK1, KBTBD8, RAB3GAP1, MAD2L1, NCF1, CD80, PDCD6, CIB1, UBE3A, CASC3, PARK7, UBE2Z, IGF1R, EIF4ENIF1, PPME1, EP300, NEK1, NUDT15, MAP3K5, PDGFRB, RPS9, G6PD, FBXO18, IGFBP5, RPS7, SWAP70, VRK2, CDC25A, RNF40, ERN1, ILF3, BRMS1, CCNE2, CCNE1, MADD, MYADM, ADNP, DIABLO, CLEC16A, PKMYT1, STK4, SUPT6H, AGER, STK3, HSP90B1, MTM1, RAP1B, BCL2L12, ATXN2, CCNB1, BAG4, NLRP7, TPR, STK38, UBR5, NLRP2, ABL1, DVL3, NLRP3, MBP, RIPK1, ECT2, FAM83D, MARK2, FANCI, EIF2B4, PRNP, UBE2I, UBE2B, KLHL25, AMBP, WFS1, RHBDD1, CAV1, GLMN, TNFRSF10B, MSN, CNOT10, TNFRSF10A, EIF2S1, NFKB1, SSH1, CDK9, VIL1, NFKBIA, NSFL1C, CNOT6, IL6, GNL3L, COPS5, CDK6, CNOT7, SH3BP5L, CDK5, CNOT1, GNAQ, CAPRIN1, RCAN3, BCL3, CNOT3, ZFP64, FGFR1OP, ACO1, CNOT8, MNAT1, LSM14A, EIF4G2, PHF19, PICALM, BCAR3, EIF4E3, BMPR2, YWHAB, ITGB3, TRADD, ITGB2, PTEN, PTPN22, PKD2, PIK3CG, DUSP14, CKS1B, RBM3, FLCN, PTBP1, SIN3A, ZNF407, CASP3, NUP62, PHACTR2, ITGAV, DACT1, FGA, EIF5B, PPP1R12A, KSR1, DTX3L, H2AFY, ITGA2, FGG, PLAUR, ZFP91, ARNT, RAD23A, PPP2R5D, OXSR1, SENP2, MASTL, TGFBR1, DUSP22, ALS2, ADORA2A, CTDSP2, MYH9, LCP2, ETF1, BIRC6, EIF4E2, CHMP6, MET, GAPDH, C9orf72, PPP1R15A, MTPN, HDAC3, ITIH2, WBP2, ROCK2, POLDIP3, PNKP, ITLN1, NLRC4, LRP8, THBS1, CLN3, CLEC3B, FZR1, U2AF2, CCL5, MKNK2, UBQLN1, POLR2G, CSK, LRIG2, ZNF622, RFFL, TBX1, RNF20, PPP1R14B, PDE6H, ANGPT1, SEMA4D, FEM1B, HSPE1, P2RX7, CD4, TNIP1, COL7A1, TAF7, CDK2AP1, KRAS, SPRY1, PTPN6, TEK, LTBR, TRIM32, TNRC6A]
GO:2000651;positive regulation of sodium ion transmembrane transporter activity;10.0;0.8259837884571596;0.8282329060895002;9.464221201200845;676.006430662935;7.212124270218933;0.022625326867999323;0.7840693824379941;[GLRX, DNM2]
GO:0050732;negative regulation of peptidyl-tyrosine phosphorylation;10.0;0.7980440201809971;0.8142630219514189;9.446202695698167;781.0212663083519;5.926926025970411;0.02614007890983527;0.7183442844592942;[PPP2CA, ERRFI1, SFRP1, SH3BP5L, SEMA4D, CAV1, HYAL2, FGFR1OP, PTPN6, CHMP6]
GO:0033591;response to L-ascorbic acid;7.0;0.9326813400603323;0.8172600352873667;9.5544162803384;69.44758579076571;7.9853141584524145;0.0023243481976474804;0.7592887026755414;[ITGA2, CAT]
GO:0035771;interleukin-4-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;8.390779266560578;0.00101047745553359;0.7800242071602487;[IL4R, IL2RG]
GO:0035772;interleukin-13-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;9.777073627680469;0.00101047745553359;0.8509193652572005;[CD300LF]
GO:0046006;regulation of activated T cell proliferation;9.0;0.8933024483968273;0.8428918493787028;9.4949928598676;82.73268373679576;6.166155715036245;0.002768988470089192;0.711578115202808;[PRNP, GPAM, RIPK3, IL23A, CASP3, PDCD1LG2, IL12RB1, CD24, AGER]
GO:1903830;magnesium ion transmembrane transport;9.0;0.8933024483968273;0.8428918493787028;9.56398573135455;114.73493840783627;6.943860283624253;0.0038400751337695784;0.7513499630073597;[ZDHHC13, ZDHHC17]
GO:0001780;neutrophil homeostasis;6.0;1.0;0.8231203125901445;9.628524252492122;41.67181410794555;8.16763571524637;0.0013947181159950893;0.7408135829017477;[ANXA1, MTHFD1]
GO:0061621;canonical glycolysis;15.0;1.0;0.9883613244510648;9.628524252492122;17318.20443184688;6.558197802812269;0.5796247169618144;0.8237478650742711;[HK3, GPI, TPI1, ADPGK, ALDOC, BPGM, ALDOA, GAPDH]
GO:2000427;positive regulation of apoptotic cell clearance;9.0;0.9326813400603323;0.8625812952104552;9.571365838652174;227.08343208129315;7.8311634786251565;0.007600278109940302;0.7967266896635242;[C3, CD300LF, C2]
GO:2000426;negative regulation of apoptotic cell clearance;9.0;0.9326813400603323;0.8625812952104552;9.571365838652174;226.6651823375042;9.083926447120524;0.007586279667416017;0.8607930461318132;[CD300LF]
GO:0019054;modulation by virus of host process;7.0;0.5470854108181258;0.6244620706662634;7.695686185004162;74.19637833408251;6.641579411751319;0.0024832860104364728;0.6905700452391912;[CD4, CCNK, PABPN1, VAPA, KPNA4, KPNB1]
GO:0048675;axon extension;5.0;0.8933024483968273;0.736892236059334;9.427853557029971;51.99108915072818;6.221725566191056;0.0017400949649324319;0.6084203466557585;[ITGB1, SLC9A6, CDK5, ULK1, SPG11, C9orf72]
GO:0002625;regulation of T cell antigen processing and presentation;8.0;0.8933024483968273;0.8216512241984136;9.485423408851448;61.59706040413021;9.083926447120524;0.0020615981779709388;0.839552420951524;[WAS]
GO:0032496;response to lipopolysaccharide;5.0;0.8933024483968273;0.736892236059334;9.446202695698167;64.414971589946;4.086714173356409;0.002155911129404774;0.4992357647380114;[PTGER4, CXCL6, SCARB1, CD40, GFI1, CD80, ABCB4, ATP2A2, PTPN22, COMT, LIAS, RELA, ABR, PABPN1, NLRP7, TBXA2R, CASP3, ABL1, NLRP3, IL12A, HAVCR2, UPF1, XBP1, ABCC2, CCL20, TNFRSF10B, TNFRSF10A, PDCD1LG2, NFKB1, BCR, P2RX7, IL6, TNIP1, TNIP2, RARA, LTBR, NFKBIB]
GO:0016601;Rac protein signal transduction;8.0;1.0;0.875;9.628524252492122;29.60642063139588;6.7325511899570465;9.9090025448413E-4;0.719302980950052;[NISCH, NCKAP1, DBNL, ALS2, ELMO1, RHOU]
GO:0032091;negative regulation of protein binding;5.0;0.6997970393407541;0.6401395315312973;8.48339194818912;32.716075545242866;5.171903441692378;0.0010949776059428606;0.5547323943871747;[LRPAP1, GNL3L, CAV1, TFIP11, CAMK1, ADNP, PARK7, SENP2, MET, EIF2S1, DACT1]
GO:0045329;carnitine biosynthetic process;6.0;1.0;0.8231203125901445;9.628524252492122;241.98945829510677;8.16763571524637;0.008099169392763998;0.7408135829017477;[TMLHE]
GO:0002685;regulation of leukocyte migration;7.0;0.5577261244500507;0.6297824274822259;8.169909229792605;50.8327261637902;4.6122876537569555;0.0017013255982186238;0.586791970363642;[PTGER4, CXCL6, DOCK8, CD99L2, MIA3, WASL, THBS1, CXCL14, ABR, C1QBP, CCL5, NCKAP1L, IL12A, CCL19, GPSM3, CCR2, ANXA1, RIPK3, CCL20, ITGA2, SWAP70, MSN, BCR, CREB3, IL6, KARS, IL23A]
GO:0043392;negative regulation of DNA binding;5.0;0.7586651285174919;0.6695735761196662;8.866384200445225;32.533753988449135;5.788089581116195;0.0010888754675157227;0.5862441822128946;[PER2, NFKBIA, ZNF462, SIN3A, SUMO3, CPNE1, ZFP90]
GO:0042063;gliogenesis;5.0;1.0;0.7902410118609202;9.628524252492122;21.75937296335754;7.9853141584524145;7.282666309192915E-4;0.6986103492792611;[CDK6, ANXA1]
GO:0043154;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;12.0;0.8653626801206646;0.8808016526504769;9.556203590912496;734.4861809891323;5.277263957350204;0.024582591483058774;0.7179998367869053;[CDKN2D, CSNK2A1, PLAUR, TNFRSF10B, TNFRSF10A, NLRC4, PARK7, UBE2Z, THBS1, AQP1, VIL1, BCL2L12, ADORA2A, BIRC6, RFFL]
GO:0035116;embryonic hindlimb morphogenesis;6.0;1.0;0.8231203125901445;9.628524252492122;58.806290969860136;6.444869117505266;0.001968193636535348;0.6527112189764278;[CHD7]
GO:0034260;negative regulation of GTPase activity;6.0;1.0;0.8231203125901445;9.628524252492122;61.14468506277762;5.970411137910149;0.0020464575824072424;0.6284474158353811;[RTKN, RCC2, GPS1, PDE6D, TMED2, ARL2, GPS2, SPRY1, IQGAP2, GMIP, HRAS]
GO:0032088;negative regulation of NF-kappaB transcription factor activity;12.0;0.9326813400603323;0.9144609826203107;9.587702257971866;279.61713652769816;5.420364800990877;0.009358533920496976;0.725318020585559;[GFI1, COMMD1, NFKBIA, CYLD, ITCH, NLRP12, BRMS1, ADORA3, CAT, NLRP2, NLRP3, CDK5RAP3, HAVCR2]
GO:0045577;regulation of B cell differentiation;8.0;0.7369933605727446;0.7434966802863723;9.223059144383958;130.3775146173893;6.518977089658987;0.004363618082098712;0.7083807915285978;[CYLD, SFRP1, XBP1, SYK, FCRL3, NCKAP1L, PTPN6, CARD11]
GO:0002690;positive regulation of leukocyte chemotaxis;9.0;0.7508913569872202;0.7716863036738992;9.33127272902419;423.36221235109986;5.288437257948329;0.014169552246136892;0.6666915524892495;[CXCL6, SWAP70, THBS1, CXCL14, CREB3, IL6, KARS, IL23A, C1QBP, CCL5, NCKAP1L, IL12A, CCL19, GPSM3, CCR2]
GO:0046425;regulation of JAK-STAT cascade;8.0;0.7586651285174919;0.754332564258746;9.158520623246385;46.16872612457469;4.77312732173501;0.0015452257142336023;0.6190979532066485;[PIGU, CD40, CAV1, GFRA2, IL22RA2, PPP2CA, IL6, CNOT7, ARL2BP, IL23A, CCL5, BCL3, KIT, IL12A, SH2B2]
GO:0048843;negative regulation of axon extension involved in axon guidance;12.0;1.0;0.9481203125901445;9.628524252492122;2931.023726508963;6.558197802812269;0.09809872637615838;0.7835068532133509;[SEMA6B, SEMA4D, SEMA4B]
GO:0090383;phagosome acidification;12.0;0.9326813400603323;0.9144609826203107;9.57973408832269;182.53781204849716;8.390779266560578;0.006109376295897887;0.8772251544931927;[RAB20, RAB38]
GO:0045579;positive regulation of B cell differentiation;9.0;0.8436909121759173;0.8180860812682478;9.503361109538115;803.2041625246294;7.212124270218933;0.026882520482883615;0.7650689957573628;[XBP1, SYK, NCKAP1L]
GO:1900745;positive regulation of p38MAPK cascade;12.0;1.0;0.9481203125901445;9.628524252492122;1761.632567075866;6.7325511899570465;0.05896025665364957;0.7924232935401965;[MAP3K3, KARS, NCF1, AGER, MAP3K5]
GO:0000266;mitochondrial fission;5.0;1.0;0.7902410118609202;9.628524252492122;40.48578058269761;6.686031174322154;0.0013550226412659145;0.6321649570480018;[MX2, DNM2]
GO:0043161;proteasome-mediated ubiquitin-dependent protein catabolic process;9.0;0.7586651285174919;0.775573189439035;9.310070521373587;348.3589749790861;4.015022244900292;0.01165926138982685;0.6015690495021188;[CCNF, KIF14, BUB1B, UBE3A, PSMD8, TRIM9, PSMD7, PSMD4, PSMD2, CDC26, SKP2, C18orf25, SEC13, RNF44, FBXO18, RAD23A, KCTD2, KCTD5, SIRT2, DDB1, PSMA1, KCTD10, TBL1XR1, ANAPC5, MAN1B1, DERL3, RNF38, DERL2, PSMB10, PSMA7, ANAPC11, ARNTL, HSP90B1, CCNB1, FZR1, PSMB5, PSMB1, UBQLN1, RFFL, UBE2I, LRRC29, UBE2B, WFS1, EDEM1, SYVN1, FBXL15, ERLIN2, FBXL16, BTBD6, MARCH6, KBTBD4, NSFL1C, ITCH, SPSB1, RNF103, NPLOC4, PSMC1, CDC16, FBXL3, MAD2L1]
GO:0009052;pentose-phosphate shunt, non-oxidative branch;6.0;1.0;0.8231203125901445;9.628524252492122;180.2124920597274;7.9853141584524145;0.006031549928525885;0.7314896500084853;[RPIA, TALDO1]
GO:0009051;pentose-phosphate shunt, oxidative branch;11.0;1.0;0.9324289523296623;9.628524252492122;369.5748319676681;8.67846133901236;0.012369337030203025;0.8762458687964789;[G6PD]
GO:0060982;coronary artery morphogenesis;6.0;1.0;0.8231203125901445;9.628524252492122;32.54494596988572;7.57984905034425;0.0010892500530622757;0.710754145523778;[TBX1, TGFBR1]
GO:0034497;protein localization to phagophore assembly site;5.0;1.0;0.7902410118609202;9.628524252492122;29.829169826127035;7.212124270218933;9.983554695705216E-4;0.659069382437994;[MFN2, PIK3C3]
GO:0045588;positive regulation of gamma-delta T cell differentiation;10.0;1.0;0.9152410118609203;9.628524252492122;1283.265958453736;8.67846133901236;0.04294975676506408;0.8590579283277371;[SYK, NCKAP1L]
GO:0045589;regulation of regulatory T cell differentiation;9.0;0.7866048967936545;0.7895430735771163;9.517298617381897;133.46855707074621;6.518977089658987;0.004467072491254967;0.7296214167088868;[CTLA4, RUNX1]
GO:1901837;negative regulation of transcription of nucleolar large rRNA by RNA polymerase I;12.0;1.0;0.9481203125901445;9.628524252492122;2086.815075618263;8.67846133901236;0.06984382256930605;0.8919372290569614;[H2AFY]
GO:2000452;regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation;12.0;0.8933024483968273;0.8947715367885583;9.510741216835738;113.48645055464661;9.083926447120524;0.00379828936888944;0.9126727335416687;[RIPK3]
GO:0070542;response to fatty acid;5.0;0.6696747006330769;0.6250783621774587;8.578702127993445;43.78950961223322;5.382624473008031;0.0014655954787213788;0.5655086777281872;[YY1, PTGER4, SFRP1, CCNB1, GNG2, XRCC5, CAT, CCL19, ACACA, AACS, NME1]
GO:0070301;cellular response to hydrogen peroxide;6.0;1.0;0.8231203125901445;9.628524252492122;361.02555909653125;5.682729065458369;0.012083200561052132;0.6137353412716126;[BECN1, PCNA, ANXA1, PARK7, RELA, AQP1, RHOB, MAPK13, SETX, IL6, PPIF, ABL1, ECT2, EZH2, MAP3K5]
GO:0035335;peptidyl-tyrosine dephosphorylation;8.0;0.8933024483968273;0.8216512241984136;9.52844079393514;179.24922260518233;5.181953777545879;0.005999310166768488;0.6400053571691908;[DUSP5, EYA2, PTEN, DUSP28, PTPN22, PTPRK, SSH3, CDC25A, MTMR6, DUSP14, MTM1, SSH1, PTP4A1, DUSP22, DUSP23, PTPRA, PTPN6]
GO:0050708;regulation of protein secretion;7.0;0.544374901031353;0.623106815772877;7.862740269667327;96.15283043706451;3.7392027077583316;0.003218148702799284;0.5421423656226702;[PTGER4, GPI, CD40, PPP1R11, ITPR2, ARL2, PTPN22, TM7SF3, AACS, ARNTL, NLRP7, CCL5, HYAL2, NLRP2, ABL1, NLRP3, MBP, ARFIP1, CCL19, HAVCR2, ATG5, FGA, XBP1, IL4R, ANXA1, CADM1, ANGPT1, SYK, RHBDF2, IDH2, FGG, GLMN, BAIAP3, PER2, P2RX7, NLRP12, SFRP1, IL6, KARS, GPAM, ARL2BP, ADORA2A, PIK3C3, PAM, GAPDH, CD244, PPID, EXOC1]
GO:0014891;striated muscle atrophy;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;39.63104934579025;7.57984905034425;0.0013264155559747973;0.710754145523778;[GSN]
GO:0044267;cellular protein metabolic process;5.0;0.3358520568840654;0.45816704030295297;5.574370570853267;80.86766357206795;1.6585685600933726;0.0027065679235849286;0.3750602851554211;[RPL3, GMFB, MAML1, TESK2, PSMD8, PSMD7, PSMD4, PSMD2, MYC, CDK5RAP3, CSNK2A1, ATG10, PRKAB1, RC3H2, BCR, PSME2, RPL29, ANAPC13, CDCA3, RPN1, COPS7B, COPS7A, MTMR6, ANAPC11, C3, RHOT1, RNF213, PPP4C, BLOC1S1, SULT1A3, ATG5, CREBBP, PMM1, ABCA3, EDEM1, H3F3A, PMM2, EIF2AK3, LNPEP, CDC7, ERLIN2, PGA3, RPL3L, PGA5, SETX, CYLD, RNF103, PAM, EZH2, CPEB4, PIGS, ARF4, BTG2, SMG1, PIGU, WDR48, PIGT, SETD3, BTG1, SERPINA10, CLTA, MRPL37, MED12, TRIM9, UBL5, TRIM7, PBK, TIMP1, PCMTD1, DUSP5, ANXA1, RIPK3, SIRT7, JOSD1, SIRT2, CIT, SUMF1, DDB1, ITPKB, PSMA1, PIGA, MED20, RARA, RNF166, HBEGF, GPS1, GPS2, PSMA7, RNF135, GGA3, PSMB5, RNF138, PSMB1, AP2S1, HARS, APOL1, RPL19, EGLN2, GSN, MBD6, SYVN1, GTF2H4, SPSB1, TTLL3, PSMC1, RFWD3, TAOK2, RPL22L1, RAB3B, RAB3D, IL5RA, STK19, YEATS4, PARK7, YY1, PPP1CB, PPP1CC, NPEPPS, FNTB, LAMP2, CFL1, NEK1, PMPCB, C18orf25, MAP3K5, USP8, RPS9, RNF44, FBXO18, IGFBP5, RPS7, VPS33B, SARS, VRK1, VRK2, CDC25A, PIAS2, RNF40, MINPP1, ILF3, ANAPC5, RAB38, FKBP4, CSNK1G2, CSNK1G1, UBR4, PKMYT1, RLF, HSP90B1, MTM1, STK35, MED30, STK38, UBR5, ABL1, MBP, RAB6A, DR1, TOR1A, SDF2L1, AMBP, WFS1, BRPF3, BTBD6, MARCH6, NFKB1, MARCH3, CDK9, CNOT4, COPS5, CDK6, CDK5, UBLCP1, YEATS2, PTPRA, CDK2, FGFR1OP, MNAT1, BMPR2, PTEN, PTPN22, MSLN, PIK3CG, DUSP14, PPP6C, SIN3A, SUMO3, PGM3, TRIM69, ITGAV, HIF1AN, ATP7A, PPP1R12A, KSR1, DTX3L, ZFP91, DUSP28, RAD23A, SPTB, RABGGTA, PTP4A1, DUSP22, DUSP23, ADORA2A, CTDSP2, PIK3C3, ETF1, BIRC6, MET, GAPDH, PPP1R15A, BECN1, HDAC3, ITIH2, HDAC1, ROCK2, MGRN1, RAB1B, RNF38, GLRX, NLRC4, IL2RG, PPM1G, FZR1, RBBP5, CCL5, SAP18, CSK, RBBP7, RFFL, SEC11A, SEC11C, RNF20, NDUFA7, ANGPT1, FEM1B, FBXL15, RPL23A, FBXL16, P2RX7, SNRK, DOLPP1, TSPAN17, RAB13, MGAT4B, ASXL2, CCM2, PTPN6, TRIM32, TRIM33, METAP2, OXTR, CCNK, CCNH, CCNF, ZDHHC5, ZDHHC6, PPP2R2A, UBE2L3, RPS6KA4, RPS15, HERC4, RPS6KA5, RASSF2, HERC1, RPL36AL, RPS6KA2, CDC26, TRIM24, CPNE3, SKP2, SEPHS1, ATXN7L3, EPHB4, PDK1, ST6GAL1, ESCO1, ARRDC1, SLC35C2, COG3, NSMCE2, PAQR3, SLC35C1, MRPS18B, ALG2, MRPS18A, ALG1, GBGT1, KARS, KCTD10, TRIB3, ULK1, EPHA1, CBLL1, PAXIP1, FUT11, MYCBP2, LIAS, TGOLN2, NUAK1, HLTF, STK38L, ZBED1, RPL39L, SETDB1, BCL11A, MSRA, KLHDC8A, CDC16, CALU, FBXL3, CALM1, HBS1L, MRPS16, PPP1R11, FASTKD1, GPAA1, SUV39H1, OTUD7B, MIA3, BRCA1, PTPRK, AKAP13, ZMYM2, CTSH, HRAS, VKORC1, MAP4K2, MRPS24, SYK, PARP2, PRMT3, ZDHHC12, COMMD1, GFRA2, ZDHHC17, GAK, PDIK1L, KIT, FASTKD5, FAM20C, TLR7, MRRF, PTGER4, CSTA, PCNA, MRPS36, DERL3, ZDHHC23, ZDHHC24, DERL2, NEDD8, TRAK1, PPP2CA, PDPR, MGAT3, MGAT1, UBL4A, MAP3K3, MAP3K1, DOHH, RAB11A, MIB1, PER2, ITCH, SPCS2, CAMK4, KBTBD2, CAMK1, KBTBD8, GALNT12, DPAGT1, GALNT11, CRTC2, ARID4A, BUB1B, UBE3A, UBE2Z, GALNT10, IGF1R, PPME1, NPPA, EP300, TGM6, SBF1, PDGFRB, SSU72, TRPC4AP, ERN1, DPM3, BRMS1, TBL1XR1, CCNE1, RPL7L1, PPIF, PPID, HIST1H2BC, DTX2, KLHL12, STK4, RASGRP4, FUT4, STK3, VCPIP1, CCNB1, FUT8, UBD, GRK6, NLRP3, USP51, RIPK1, SUDS3, MARK2, MGEA5, UBE2I, UBE2B, KLHL25, CBX4, RHBDD1, DOLK, KLHL24, CLK4, SSH3, EIF2S1, CLK3, SSH1, CLK1, NFKBIA, IL6, PAN3, TMEM115, MAN2B2, FES, UBE2T, STT3A, MAN2B1, USP36, USP37, USP38, PRKCSH, MAST3, USP32, YWHAB, USP34, USP39, GPHN, SENP6, POLB, RASGEF1A, USP46, FGA, FGG, CAD, PPP2R5D, OXSR1, IRAK4, SENP2, MASTL, TGFBR1, PJA2, IRF4, MAN1B1, USP41, B4GALT7, THOP1, STOML2, HIST1H2BO, HIST1H2BJ, USP12, RRBP1, THBS1, PSMB10, TFPT, PABPN1, RAB40C, MKNK2, NCAM1, MTA2, EYA2, GALNT1, MAPK13, POLE4, WEE1, TNIP1, TNIP2, ASB8, POLE3, KRAS, FAM98A, TAF5, TEK, ASB3, OTUD1]
GO:0060736;prostate gland growth;4.0;0.8653626801206646;0.6826813400603323;9.405380701177911;43.8113314783287;7.474488534686424;0.00146632583694119;0.6322456912631272;[PTEN, UBE3A]
GO:0001578;microtubule bundle formation;6.0;0.8436909121759173;0.7449657686781032;9.310070521373587;33.1981629444775;5.8067817141283475;0.0011111126373447525;0.6200793994936333;[BBS2, SPAG16, SPAST, UBE2B, TTLL3, FES, MAP1S, ZNF207, KIF20A, CLASP1, IQCG]
GO:0042098;T cell proliferation;6.0;0.7248374789738407;0.6855390520770648;9.081980546124052;51.294476028837884;6.343086423195323;0.0017167799506538708;0.647506047256038;[P2RX7, CD151, IL23A, ELF4, DOCK8, EBI3, ABL1, MSN, DOCK2, RC3H2, PIK3CG]
GO:0032058;positive regulation of translational initiation in response to stress;10.0;0.8653626801206646;0.8479223519212526;9.561082971696589;3006.0118615556844;8.390779266560578;0.10060851177123209;0.8443458537639685;[PPP1R15A]
GO:0033146;regulation of intracellular estrogen receptor signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.427853557029971;43.64299748026755;6.088194173566533;0.0014606918495168463;0.6622698984233759;[LBH, GPAM, CNOT1, WBP2, CRIPAK, BRCA1, SKP2, RUNX1]
GO:2000463;positive regulation of excitatory postsynaptic potential;8.0;0.9326813400603323;0.8413406700301662;9.589303539338841;397.97278468673557;6.518977089658987;0.013319790951212034;0.7083807915285978;[PTEN, SSH1]
GO:0035329;hippo signaling;6.0;1.0;0.8231203125901445;9.628524252492122;26.42836680105094;6.375876246018314;8.845336528452411E-4;0.6491829203200885;[YWHAB, CASP3, STK4, TEAD2, PJA2, STK3, TJP2]
GO:0071621;granulocyte chemotaxis;8.0;0.8653626801206646;0.8076813400603323;9.434368238051164;96.32399332974941;5.311165509025885;0.0032238773707808457;0.6466132511260384;[CXCL6, PREX1, FCER1G, ANXA1, SYK, CCL20, CCL5, ITGB2, NCKAP1L, CCL19, VAV1, PIK3CG]
GO:0009060;aerobic respiration;6.0;0.7671156992804218;0.7066781622303554;8.874752450115741;31.550561209678754;5.926926025970411;0.0010559688900263317;0.6262235851885184;[CHCHD5, NDUFS8, NDUFS7, COX15, BLOC1S1, COX4I1, CAT, PMPCB, COX5B, COX6A1]
GO:0070536;protein K63-linked deubiquitination;10.0;0.9326813400603323;0.8815816818910864;9.577230958104572;204.99431233642397;6.375876246018314;0.006860975150996652;0.7413036195908642;[USP8, CYLD, OTUD7B, OTUD1]
GO:2000483;negative regulation of interleukin-8 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;753.9724324201893;7.8311634786251565;0.02523477878196853;0.8157270763441555;[ANXA1, PTPN22]
GO:0034198;cellular response to amino acid starvation;7.0;0.8653626801206646;0.7836007053175329;9.446202695698167;115.90251486529202;5.970411137910149;0.003879152867050031;0.6562464685024372;[BECN1, CDKN1A, SEH1L, EIF2AK3, EIF2S1, MAP3K5]
GO:1900017;positive regulation of cytokine production involved in inflammatory response;8.0;1.0;0.875;9.628524252492122;226.66426644256094;7.004484905440688;0.0075862490132365176;0.7332096838060964;[KARS, GPSM3]
GO:1903526;negative regulation of membrane tubulation;7.0;1.0;0.8509193652572005;9.628524252492122;66.13488992371046;9.083926447120524;0.0022134752482098636;0.8154717862087246;[WASL, DNM2]
GO:0046185;aldehyde catabolic process;4.0;0.7369933605727446;0.6184966802863723;8.781226392104918;82.88261656186464;7.474488534686424;0.002774006586813465;0.6322456912631272;[ALDH3B1]
GO:0000186;activation of MAPKK activity;13.0;0.8259837884571596;0.8755468589962163;9.54300207905396;3706.2450018205795;5.845247994956144;0.12404468480698592;0.7614812190615239;[MAP3K3, MAP3K1, TAOK2, RAPGEF1, TGFBR1, MAP3K5]
GO:0000184;nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;10.0;0.8933024483968273;0.861892236059334;9.57851383191746;717.2549128915896;4.989581884898423;0.0240058764469685;0.6704084614939124;[UPF2, UPF1, RPS9, SMG1, RPL3, RPS7, EIF4A3, RPL23A, PPP2R2A, CASC3, SMG5, PNRC1, PPP2CA, RPS15, DHX34, SKIV2L, ETF1, DCP1A, RPL29, DCP2, RPL19]
GO:0031915;positive regulation of synaptic plasticity;8.0;0.8653626801206646;0.8076813400603323;9.446202695698167;41.65758488823441;7.57984905034425;0.0013942418768168238;0.7626338329336335;[SSH1]
GO:0034184;positive regulation of maintenance of mitotic sister chromatid cohesion;11.0;0.8653626801206646;0.8651102923899945;9.538912093802434;1023.0912809008746;8.16763571524637;0.03424194444937782;0.8501222226412654;[H2AFY, NSMCE2]
GO:1900026;positive regulation of substrate adhesion-dependent cell spreading;8.0;1.0;0.875;9.628524252492122;350.51777089970517;6.280566066213989;0.011731514346499779;0.6961884407023742;[FGA, PREX1, ARPC2, C1QBP, FGG, ABL1, MYADM, CIB1, UNC13D, LIMS1, S100A10, DNM2]
GO:1900029;positive regulation of ruffle assembly;9.0;1.0;0.896240625180289;9.628524252492122;200.30665838708023;7.138016298065211;0.006704083591926775;0.7612791106150483;[PLEKHM1, FAM98A, HRAS]
GO:0006974;cellular response to DNA damage stimulus;4.0;0.5696777571895439;0.534838878594772;7.469040003138749;28.997869804256865;3.161008442547652;9.705326059599744E-4;0.4116541187538124;[DCLRE1A, CCNK, DCLRE1C, CCNH, MUM1, CIB1, PARK7, ALKBH7, YY1, MYC, EP300, NEK1, GTSE1, CDK5RAP3, AQR, TIPIN, FBXO18, NSMCE2, NEIL3, MSH3, DDIT4, TIMELESS, PAXIP1, COPS7B, COPS7A, XPC, RAD51AP1, NUAK1, CCNB1, RAD21, UBR5, ABL1, USP51, FANCI, XRCC6, UBE2B, XRCC5, INTS3, NONO, CNOT10, CDC7, FANCE, SETX, CDK9, CNOT4, CNOT6, COPS5, NPLOC4, CNOT7, CNOT1, UBE2T, BCL3, CNOT3, CDK2, INTS7, CNOT8, MNAT1, USP36, FEN1, BTG2, CDKN1A, SMG1, WDR48, SUV39H1, MCM10, BRCA1, AATF, POLB, NIPBL, CHAF1B, CHAF1A, EXO1, CASP3, CASP2, CTLA4, TOPBP1, RFC5, UPF1, RFC3, RFC4, DTX3L, RFC1, NCOA6, PARP2, RAD23A, TFIP11, MASTL, DDB1, RAD51C, TFDP1, TFDP2, PPP1R15A, PCNA, PNKP, GPS1, TANK, UNG, TFPT, FZR1, WRN, POLR2B, RBBP5, RNF138, POLR2E, RAD54L, POLR2G, BID, E2F7, E2F8, POLQ, EYA2, GINS4, DONSON, APEX2, GTF2H4, SMUG1, HIST3H2A, RAD51, TTC5, POLE2, RFWD3, TAOK2, POLE3, MNDA, ERCC5]
GO:0003222;ventricular trabecula myocardium morphogenesis;7.0;0.8933024483968273;0.7975705894556142;9.427853557029971;28.30750056401912;7.004484905440688;9.474265687811956E-4;0.7091290490632969;[CHD7, TGFBR1]
GO:0071361;cellular response to ethanol;6.0;1.0;0.8231203125901445;9.628524252492122;330.81194821622347;7.138016298065211;0.011071978195372667;0.6881587980249038;[TP53INP1, PTEN, ITPR2]
GO:2000009;negative regulation of protein localization to cell surface;7.0;1.0;0.8509193652572005;9.628524252492122;73.78875676133134;7.212124270218933;0.0024696432832320894;0.7197477358342742;[TAX1BP3, COMMD1, PICALM]
GO:0071363;cellular response to growth factor stimulus;5.0;0.7671156992804218;0.6737988615011312;8.935377071932177;60.394260804020476;4.247644540169047;0.0020213415578046274;0.5074657511808371;[BECN1, ERRFI1, BMPR2, EIF4A3, TWF2, PTEN, CIB1, LRP8, THBS1, RELA, CLEC3B, BAG4, CCL5, HYAL2, RIPK1, CPNE3, ATP7A, SOX6, EMD, BPTF, TBX1, PDGFRB, USP8, ANXA1, CAV1, CAD, RUNX2, SIRT2, TGFBR1, SETX, ERN1, VIL1, SFRP1, EHD4, MARS, RAB35, CAT, RAPGEF1, MT1G, LIMS1]
GO:0050680;negative regulation of epithelial cell proliferation;6.0;0.7307253602413294;0.6884829927108091;8.690254613899192;65.19530579150691;4.989581884898423;0.0021820282128758306;0.5782877622231366;[CDKN1C, CAV1, SERPINF1, ATPIF1, EAF2, PTEN, IFT122, PTPRK, THBS1, WDR13, TGFBR1, SFRP1, CDK6, NFIB]
GO:2000484;positive regulation of interleukin-8 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;753.5029195149353;7.069023426578259;0.02521906460756386;0.7767511986393403;[HYAL2, CD244]
GO:0015677;copper ion import;9.0;0.8933024483968273;0.8428918493787028;9.427853557029971;21.372061049954535;7.697632086000634;7.153036497357847E-4;0.7898978880348613;[STEAP3, SLC31A1, ATP7A]
GO:0035264;multicellular organism growth;3.0;1.0;0.6981203125901445;9.628524252492122;22.582921643529833;5.382624473008031;7.558300640989654E-4;0.47338797845741154;[WDR48, NDUFS6, TBL1XR1, H3F3A, RARA, TMED2, CCM2, RC3H2]
GO:0035023;regulation of Rho protein signal transduction;9.0;0.8436909121759173;0.8180860812682478;9.318369324188282;48.758993290020136;4.879233827729558;0.0016319196251719597;0.645764870037956;[PDGFRB, ITGB1, ARHGEF11, GPR55, MYO9B, VAV1, VAV2, BCR, ABR, FLCN, AKAP13, PREX1, ALS2, ARHGDIB, ABL1, ARHGEF1, ECT2, MET, ARHGEF5]
GO:0060024;rhythmic synaptic transmission;7.0;0.8933024483968273;0.7975705894556142;9.405380701177911;30.61939422688933;8.390779266560578;0.001024803569108247;0.7800242071602487;[PTEN]
GO:0035020;regulation of Rac protein signal transduction;9.0;0.8933024483968273;0.8428918493787028;9.461470167828956;48.758993290020136;7.069023426578259;0.0016319196251719597;0.757750811958709;[ALS2, KRAS, DNM2]
GO:1902216;positive regulation of interleukin-4-mediated signaling pathway;8.0;1.0;0.875;9.628524252492122;305.68887294206377;9.083926447120524;0.01023113147524637;0.839552420951524;[CD300LF]
GO:1903307;positive regulation of regulated secretory pathway;9.0;0.7090535922965819;0.75076742132858;9.027750392063192;236.78497455026974;5.948432231191374;0.007924980005555578;0.7004437261138039;[VAMP8, IL4R, FCER1G, CDK5, SYK, AP1G1, RAB3D, NPPA, ITGB2, UNC13D]
GO:1904879;positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel;10.0;1.0;0.9152410118609203;9.628524252492122;367.37913884648174;9.083926447120524;0.012295849157432434;0.8797934328124444;[G6PD]
GO:0002576;platelet degranulation;8.0;1.0;0.875;9.628524252492122;39.85546922145481;4.956792062075433;0.0013339266872485146;0.6284905765689417;[FGA, SERPINA3, WDR1, BRPF3, ITGB3, FGG, RAB27B, THBS1, CYB5R1, CLEC3B, LAMP2, CDC37L1, CD9, PHACTR2, FAM3C, TIMP1, CALM1, ALDOA, A2M, TLN1]
GO:0071394;cellular response to testosterone stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;389.00028322827603;7.697632086000634;0.01301948940212445;0.7167775754447168;[ROCK2, MSN, ELK1, AACS]
GO:0000165;MAPK cascade;9.0;0.7436939687323844;0.7680876095464813;9.236482164716097;231.45054935470895;4.069963362931594;0.007746441594931149;0.6043787408332628;[PTGER4, OXTR, YWHAB, GPS1, IL5RA, GPS2, IL2RG, RASGRP4, PABPN1, RASGEF1A, CCL5, MYC, CTSH, NCAM1, MBP, RIPK1, ITGAV, HRAS, SULT1A3, MAP3K5, PDGFRB, MAP3K3, DUSP5, MAP4K2, MAP3K1, KSR1, ANGPT1, PAQR3, IRAK4, GFRA2, SPTB, NFKB1, MAPK13, SETX, ITPKB, KARS, PTPRA, TNIP2, TAOK2, KIT, CCM2, KRAS, TEK, CALM1, MET, HBEGF]
GO:0048384;retinoic acid receptor signaling pathway;6.0;0.7866048967936545;0.7164227609869718;8.935377071932177;25.568165535828406;7.004484905440688;8.557434906291208E-4;0.6813299963962409;[TBX1, RXRA, RARA]
GO:0051300;spindle pole body organization;4.0;0.8436909121759173;0.6718454560879586;9.271849308553389;37.692070457630365;7.8311634786251565;0.0012615196775557923;0.6504860644832351;[CALML4, CALM1]
GO:0051781;positive regulation of cell division;5.0;0.6763753087927167;0.6284286662572787;8.438940185618286;42.28939918509474;5.358233019883872;0.0014153881327367882;0.5642612976810992;[SPAST, LBH, KIF3B, NUP62, CAT, KIF14, PKP4, KIF23, ECT2, SIRT2, CIT]
GO:0051548;negative regulation of keratinocyte migration;9.0;1.0;0.896240625180289;9.628524252492122;298.86279226053784;9.083926447120524;0.010002668697909467;0.8607930461318132;[PTEN]
GO:0034162;toll-like receptor 9 signaling pathway;12.0;1.0;0.9481203125901445;9.628524252492122;412.6549923027037;7.004484905440688;0.013811191226989502;0.8063299963962409;[TNIP2, PIK3C3, TLR7, IRAK4, HAVCR2]
GO:0033077;T cell differentiation in thymus;7.0;0.8653626801206646;0.7836007053175329;9.420884887713877;66.99450330244977;6.481236761676141;0.002242245734394454;0.6823701146576509;[RIPK3]
GO:2000272;negative regulation of signaling receptor activity;7.0;0.7248374789738407;0.7133381047441208;8.965230035081857;205.5464783691117;6.343086423195323;0.006879455651193543;0.6753050999230941;[ERRFI1, CLEC12B, PTEN, CHMP6, AGER]
GO:0060010;Sertoli cell fate commitment;5.0;1.0;0.7902410118609202;9.628524252492122;42.25641440478021;9.777073627680469;0.0014142841618240358;0.7902410118609202;[RARA]
GO:0071391;cellular response to estrogen stimulus;4.0;1.0;0.75;9.628524252492122;34.48118488206192;7.069023426578259;0.001154054226950925;0.6115101867784198;[SFRP1, WBP2, TRIM24, RARA]
GO:0070295;renal water absorption;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;39.39707145230216;8.67846133901236;0.0013185845264461838;0.7947362817240173;[HYAL2, AQP3]
GO:0071385;cellular response to glucocorticoid stimulus;8.0;0.8436909121759173;0.7968454560879586;9.454170865347344;407.2980594846617;5.734022359845919;0.01363189950649617;0.6682381701418294;[ERRFI1, USP8, ABCC2, ANXA1, SERPINF1, ABCB4, DDIT4, UBE2L3, AQP1]
GO:0070059;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;7.0;0.9326813400603323;0.8172600352873667;9.55953138100517;84.12593595584649;6.343086423195323;0.002815619368015229;0.6753050999230941;[ERN1, PPP1R15A, XBP1, TNFRSF10B, TRIB3, BBC3, MAP3K5]
GO:0038114;interleukin-21-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;7.697632086000634;0.00101047745553359;0.7445766281117727;[IL21R, IL2RG]
GO:0038113;interleukin-9-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;8.16763571524637;0.00101047745553359;0.7686126355688037;[IL2RG]
GO:0036179;osteoclast maturation;4.0;1.0;0.75;9.628524252492122;39.55885145263534;9.777073627680469;0.0013239991574647877;0.75;[FAM20C]
GO:0038110;interleukin-2-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;7.379178354882098;0.00101047745553359;0.728290889492758;[SYK, IL2RG]
GO:1900210;positive regulation of cardiolipin metabolic process;9.0;1.0;0.896240625180289;9.628524252492122;291.20136029582517;9.083926447120524;0.00974624746489165;0.8607930461318132;[STOML2, TAZ]
GO:0038111;interleukin-7-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;6.832634648514029;0.00101047745553359;0.7003406189322132;[IL2RG]
GO:0080058;protein deglutathionylation;7.0;1.0;0.8509193652572005;9.628524252492122;151.15475272427284;9.777073627680469;0.005059013543235805;0.8509193652572005;[GLRX]
GO:1904815;negative regulation of protein localization to chromosome, telomeric region;7.0;0.9326813400603323;0.8172600352873667;9.533214072687796;74.19422186944365;9.083926447120524;0.002483213835505702;0.8154717862087246;[H2AFY]
GO:0030866;cortical actin cytoskeleton organization;6.0;0.7671156992804218;0.7066781622303554;9.117698628726131;53.946853691669205;6.088194173566533;0.0018055526440439148;0.63447084575632;[NCKAP1, PDCD6IP, RTKN, EPB41, ROCK2, WIPF2, WAS, KIF23, WASL, VIL1, CDK5, RAB13, NCKAP1L, TLN1]
GO:0050873;brown fat cell differentiation;5.0;1.0;0.7902410118609202;9.628524252492122;21.75937296335754;6.444869117505266;7.282666309192915E-4;0.6198319182472036;[ZNF516, METRNL]
GO:0031954;positive regulation of protein autophosphorylation;10.0;0.9326813400603323;0.8815816818910864;9.59573442966913;778.6672313762616;6.481236761676141;0.026061291479152104;0.7466917612613706;[RASSF2, SYK, TAOK2, CALM3, CALM1, CALM2]
GO:0032801;receptor catabolic process;6.0;0.8436909121759173;0.7449657686781032;9.34084218004034;102.12013474586499;6.518977089658987;0.003417869007789623;0.6565011041187423;[BECN1, CDK5, SNX25, AP2S1, CLTA, CAPN1]
GO:0016578;histone deubiquitination;10.0;0.8436909121759173;0.837086467948879;9.510741216835738;392.04546458482747;6.686031174322154;0.013121408881642933;0.7571649570480019;[USP36, USP51, ATXN7L3]
GO:1900223;positive regulation of amyloid-beta clearance;5.0;1.0;0.7902410118609202;9.628524252492122;41.03658450598229;7.9853141584524145;0.001373457552886905;0.6986103492792611;[LRPAP1, PICALM]
GO:0006772;thiamine metabolic process;6.0;0.8653626801206646;0.7558016526504768;9.523163736834295;172.32164456529355;8.390779266560578;0.005767450364188875;0.7522251544931926;[TPK1, ACPP]
GO:1900222;negative regulation of amyloid-beta clearance;5.0;1.0;0.7902410118609202;9.628524252492122;41.13931594619586;8.67846133901236;0.0013768958817385593;0.7340579283277371;[LRPAP1]
GO:0007616;long-term memory;7.0;1.0;0.8509193652572005;9.628524252492122;22.22653164046661;6.221725566191056;7.439020114266185E-4;0.6690987000520388;[PRNP, CAMK4, CTNS, PJA2]
GO:0030855;epithelial cell differentiation;4.0;0.5489353771682173;0.5244676885841086;6.961296045910167;21.066225782797595;4.034070439870987;7.050676185779127E-4;0.45630254989846264;[CSTA, PCNA, BMPR2, HDAC1, STK4, FZR1, RXRA, LBH, CASP3, ABL1, E2F7, E2F8, TBX1, GSTK1, ANXA1, ITGA2, MSN, VIL1, NFIB, RARA, FAM20C, CCM2, TPP1, ALDOC, CD24]
GO:0030854;positive regulation of granulocyte differentiation;9.0;0.8653626801206646;0.8289219652406215;9.510741216835738;841.2946472498035;7.697632086000634;0.028157374727424533;0.7898978880348613;[RUNX1]
GO:0071560;cellular response to transforming growth factor beta stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;97.48528473772916;5.788089581116195;0.003262744749111514;0.6191234829421188;[SFRP1, CLEC3B, CAV1, HYAL2, SOX6, TGFBR1, LIMS1]
GO:0072657;protein localization to membrane;5.0;0.5756379274792419;0.5780599756005412;7.585450354983161;29.829169826127035;3.7017275965917853;9.983554695705216E-4;0.4795475332985618;[RAB3B, TRAM1, SYS1, RPL3, NCF1, RAB3D, ITGB2, SRP54, ZDHHC6, ABCA12, TRAM2, GPHN, RPS15, SEC61A2, SH3PXD2B, TMED2, ARL5A, RAB8B, GRIPAP1, RPS9, FCER1G, RPS7, SSR2, ZDHHC12, GAK, RER1, MYADM, CHMP4B, RAB38, RPL29, VAMP5, ROCK2, ZDHHC23, ZDHHC24, AGER, TM9SF4, BAG4, RAB40C, SSR1, BID, RPL19, S100A10, PEX16, BBS2, UBL4A, PEX19, JUP, AGK, CAV1, RAB3IP, IFT122, RPL23A, RAB11A, TM9SF1, CDK5, SLMAP, RAB13, TAOK2, RAB3GAP2, CD24, RAB3GAP1]
GO:0070236;negative regulation of activation-induced cell death of T cells;11.0;1.0;0.9324289523296623;9.628524252492122;227.77452970025269;8.390779266560578;0.0076234085252994;0.8615337942327104;[TSC22D4, GPAM, TSC22D3]
GO:2000045;regulation of G1/S transition of mitotic cell cycle;8.0;0.7436939687323844;0.7468469843661922;9.040737587590003;58.63952701093024;4.821246570079209;0.0019626121969077833;0.6215587738047448;[ANKRD17, BTG2, CDKN1A, PCNA, MEPCE, KIF14, PTEN, PKD2, CCNB1, CASP2, EP300, BID, GTSE1, E2F7, E2F8, DACT1, CDKN2D, CDKN2C, ANXA1, CNOT10, SENP2, CNOT4, CNOT6, TFDP1, CDK6, RBL1, CNOT7, TFDP2, CNOT1, CTDSP2, RFWD3, CNOT3, CDK2, PSME2, PTPN6, CNOT8, EZH2]
GO:0070235;regulation of activation-induced cell death of T cells;10.0;0.8933024483968273;0.861892236059334;9.474373572664863;44.25783294267202;8.16763571524637;0.0014812698391275317;0.8329342821725234;[TSC22D4, GPAM, RIPK3, TSC22D3]
GO:0046390;ribose phosphate biosynthetic process;6.0;0.5902001590945054;0.6182203921373972;8.124446855715847;175.6734732388005;4.629579150867016;0.00587963305344119;0.5598772056629313;[PRPS2, GPI, STOML2, ADPGK, ADK, AK2, ADCY4, ATP5J, ATP5I, COX5B, ATP5O, ATP5L, AQP1, PRPSAP1, HK3, PPAT, NPPA, ATP6V0A2, CYC1, G6PD, TPI1, ACOT7, DCAKD, CAD, BPGM, ATP5F1, COASY, NME1, UCK2, ADORA2A, IMPDH1, IMPDH2, ALDOC, ALDOA, GAPDH]
GO:0030850;prostate gland development;5.0;1.0;0.7902410118609202;9.628524252492122;53.04415849917153;7.379178354882098;0.0017753402483239472;0.6676125360964777;[ANXA1, RARA, FKBP4]
GO:0072659;protein localization to plasma membrane;6.0;0.7866048967936545;0.7164227609869718;9.260799472366804;65.42666064804821;4.677207199856271;0.002189771451718415;0.5623129063031725;[BBS2, RAB3B, GRIPAP1, SYS1, FCER1G, JUP, ROCK2, RAB3D, ZDHHC23, ABCA12, RAB11A, GAK, BAG4, RAB40C, SLMAP, RAB13, MYADM, TMED2, VAMP5, RAB8B, S100A10]
GO:0030853;negative regulation of granulocyte differentiation;9.0;0.8653626801206646;0.8289219652406215;9.510741216835738;843.0444562117294;7.697632086000634;0.028215939258654368;0.7898978880348613;[RARA, C1QC]
GO:0016567;protein ubiquitination;9.0;0.6913464685778243;0.7419138594692012;8.996001693748612;153.79381005389072;3.300101264790787;0.005147340417060716;0.5650079573320931;[PPP1R11, CCNF, UBE3A, BRCA1, UBE2Z, UBE2L3, MED12, TRIM9, NPEPPS, HERC4, TRIM7, HERC1, CDC26, TRIM24, TRIM69, SKP2, C18orf25, ATXN7L3, RNF44, FBXO18, DTX3L, ARRDC1, ZFP91, TRPC4AP, RC3H2, RNF40, PJA2, DDB1, KCTD10, MED20, ANAPC5, BIRC6, THOP1, CBLL1, RNF166, HIST1H2BC, ANAPC13, HIST1H2BO, PCNA, HIST1H2BJ, CDCA3, MGRN1, RNF38, MYCBP2, UBR4, NEDD8, DTX2, KLHL12, NLRC4, ANAPC11, RNF135, VCPIP1, FZR1, RNF213, RAB40C, MED30, RNF138, UBD, HLTF, UBR5, RFFL, RNF20, UBE2I, UBE2B, KLHL25, FEM1B, SYVN1, FBXL15, LNPEP, FBXL16, KLHL24, MARCH6, MARCH3, MIB1, CNOT4, ITCH, SPSB1, RNF103, KLHDC8A, UBE2T, RFWD3, ASB8, TSPAN17, KBTBD2, CDC16, FBXL3, TRIM32, ASB3, KBTBD8, TRIM33]
GO:2000060;positive regulation of ubiquitin-dependent protein catabolic process;10.0;0.811012628672052;0.8207473261969463;9.483342242647623;1661.590298646008;5.192106149009898;0.055611931961498426;0.6807655617789147;[RNF138, ZFAND2A, CAV1, UBQLN1, PTEN, RAD23A, TRIB3, SIRT2, RNF166]
GO:0006740;NADPH regeneration;11.0;0.9326813400603323;0.8987696223598284;9.593432932680852;305.5875104430728;8.67846133901236;0.010227738963625468;0.8762458687964789;[G6PD, NNT]
GO:1903984;positive regulation of TRAIL-activated apoptotic signaling pathway;11.0;1.0;0.9324289523296623;9.628524252492122;491.41789768672834;8.67846133901236;0.016447314788180012;0.8762458687964789;[PTEN]
GO:0006744;ubiquinone biosynthetic process;7.0;0.8259837884571596;0.7639112594857803;9.405380701177911;357.5406619598991;7.004484905440688;0.011966564190092859;0.7091290490632969;[COQ3, COQ2, FDXR, COQ9, COQ10B]
GO:0006986;response to unfolded protein;5.0;0.8653626801206646;0.7229223519212526;9.34084218004034;23.958124258549983;5.75172193694532;8.018568580216882E-4;0.5843843391987277;[HERPUD2, HSPH1, DNAJB5, RHBDD1, HSPA6, MFN2, HSPB3, HSPE1, TM7SF3, THBS1]
GO:0090071;negative regulation of ribosome biogenesis;5.0;0.8436909121759173;0.712086467948879;9.310070521373587;40.92302765080109;8.390779266560578;0.0013696569071385246;0.7193458537639684;[PTEN]
GO:0003226;right ventricular compact myocardium morphogenesis;8.0;1.0;0.875;9.628524252492122;34.7436509323828;9.777073627680469;0.0011628387294510554;0.875;[CHD7]
GO:0047497;mitochondrion transport along microtubule;8.0;0.811012628672052;0.780506314336026;9.446202695698167;156.37963208010012;6.832634648514029;0.005233885553189209;0.7244212536750128;[RHOT2, SPAST, RHOT1, MAP1S, TRAK1]
GO:0071356;cellular response to tumor necrosis factor;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;4.973052582947213;0.0027327542132076126;0.5774424529526606;[ABCC2, CCL20, CIB1, RORA, BRCA1, THBS1, TANK, NFKB1, RELA, SFRP1, BAG4, CCL5, HYAL2, RIPK1, CCL19, MAP3K5]
GO:0016310;phosphorylation;5.0;0.5310727365277519;0.5557773801247963;6.876988939450173;24.405590426795786;2.7321685105510984;8.168331479794688E-4;0.42996423654933263;[OXTR, CCNK, DGKD, GMFB, MAML1, CCNH, DGKA, CD80, IL5RA, BUB1B, TESK2, STK19, IGF1R, RPS6KA4, RPS6KA5, RASSF2, RPS6KA2, MYC, CFL1, TRIM24, NEK1, CPNE3, SEPHS1, EPHB4, PDK1, MAP3K5, PDGFRB, CSNK2A1, PAQR3, ZFYVE21, VRK1, VRK2, PRKAB1, ERN1, BCR, ILF3, KARS, CCNE1, TRIB3, ULK1, EPHA1, CSNK1G2, CSNK1G1, AK2, ATP5J, AK3, ATP5I, ATP5O, PKMYT1, STK4, RASGRP4, ATP5L, STK3, NUAK1, CCNB1, STK35, STK38, GRK6, ABL1, STK38L, MBP, RIPK1, CYC1, MARK2, SULT1A3, CHKB, CHKA, EIF2AK3, DOLK, CDC7, ERLIN2, CLK4, EIF2S1, CLK3, NFKB1, SETX, CLK1, CDK9, GNPTG, UCK2, PAN3, CDK6, CDK5, PTPRA, FES, CDK2, FGFR1OP, CALM1, MNAT1, GPI, CIITA, SMG1, BMPR2, FASTKD1, MAST3, ADPGK, YWHAB, PIK3CG, HK3, AKAP13, ZMYM2, RASGEF1A, PBK, CTSH, ITGAV, TK2, HRAS, DUSP5, MAP4K2, TPI1, KSR1, RIPK3, SYK, SPHK2, SPHK1, DCAKD, CAD, BPGM, OXSR1, IRAK4, ATP5F1, MASTL, GFRA2, SPTB, COASY, VAV1, TGFBR1, NME1, CIT, GAK, ITPKB, PDIK1L, IMPAD1, KIT, FASTKD5, RARA, FAM20C, PIK3C3, ALDOC, TLR7, BIRC6, ALDOA, MET, GAPDH, HBEGF, PRPS2, PTGER4, PDXK, STOML2, ROCK2, PNKP, GPS1, GPS2, COX5B, IL2RG, PABPN1, CCL5, MKNK2, NCAM1, CSK, MAP3K3, MAP3K1, ANGPT1, AGK, TPK1, GTF2H4, MAPK13, P2RX7, SNRK, WEE1, TNIP2, CAMK4, TAOK2, CCM2, KRAS, PTPN6, CAMK1, TEK]
GO:0016311;dephosphorylation;5.0;0.6835726970475526;0.6320273603846966;8.32924126836186;24.405590426795786;4.076630054289783;8.168331479794688E-4;0.4987200624199847;[PPP1R15A, PNKP, PTEN, PTPN22, PPP2R2A, PTPRK, MTMR6, PPM1G, DUSP14, MTM1, PPP1CB, POLB, PPP2CA, PPP1CC, PPP6C, PDPR, PPP4C, NT5DC2, ACP2, SBF1, DUSP5, PPP1R12A, EYA2, SSU72, DUSP28, PPP2R5D, SSH3, SGPP2, CDC25A, SSH1, PTP4A1, DUSP22, DUSP23, MINPP1, G6PC3, SYNJ1, UBLCP1, PTPRA, CTDSP2, IMPAD1, PTPN6, ACPP]
GO:0045071;negative regulation of viral genome replication;8.0;0.8933024483968273;0.8216512241984136;9.474373572664863;85.23964546052278;5.8067817141283475;0.0028528942228632634;0.6719590869034888;[ILF3, CCNK, APOBEC3F, VAPA, TNIP1, APOBEC3H, CCL5, ZC3HAV1, APOBEC3A]
GO:0030833;regulation of actin filament polymerization;10.0;0.7043150770688792;0.76739855039536;9.223059144383958;153.53192706736982;4.665085839323926;0.005138575429181248;0.6538137186326234;[VASP, MTPN, NCKAP1, ACTR2, GMFB, GSN, WIPF2, ARPC1A, TWF2, WAS, WASL, IQGAP2, SPTB, CORO1A, VIL1, PREX1, BAG4, ARPC2, CAPZB, CDC42EP4, MYADM, NCKAP1L, ARFIP1]
GO:0030837;negative regulation of actin filament polymerization;11.0;0.8436909121759173;0.8542744084176208;9.536150932361107;433.7598075732239;5.8067817141283475;0.014517550400993206;0.7293880392331511;[VIL1, GSN, CAPZB, MYADM, TWF2, SPTB]
GO:0006509;membrane protein ectodomain proteolysis;7.0;0.8933024483968273;0.7975705894556142;9.446202695698167;50.748517158788495;6.781341354126479;0.0016985071986044009;0.6977174774718518;[P2RX7, MYH9]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[NCF1, NCF2, DEFB1, IL27, LYST, PIK3CG, PPP6C, C1QBP, HAVCR2, MAP3K5, FGA, MAP4K2, FCER1G, ANXA1, DTX3L, SYK, WRNIP1, RNASE3, IRAK4, TMEM173, SIRT2, IL23A, ELF4, PSPC1, TRIM14, TLR7, HIST1H2BC, ANKRD17, COLEC12, HIST1H2BJ, CFH, CEBPG, NLRC4, ZC3HAV1, LILRA2, CORO1A, AGER, RELA, C2, C3, RNF135, CLEC7A, PRDX1, NLRP2, ABL1, SLAMF7, NLRP3, CSK, APOL1, XRCC6, PPP1R14B, APOBEC3F, APOBEC3H, XRCC5, NONO, MX2, NFKB1, ANKHD1, CYLD, ITCH, POLR3B, POLR3C, FES, TREML4, POLR3E, PTX3, PTPN6, SERINC3, TRIM32, CD244, APOBEC3A, C1QC]
GO:0006749;glutathione metabolic process;6.0;0.8436909121759173;0.7449657686781032;9.360260265897443;147.28945980206763;5.71663061713405;0.0049296456676673804;0.6154690682008903;[GSTK1, G6PD, GSTA5, ALDH5A1, CTNS, CHAC2, PARK7, MMACHC, CNDP2]
GO:0097711;ciliary basal body-plasma membrane docking;5.0;1.0;0.7902410118609202;9.628524252492122;21.38880323109876;5.223196736079928;7.158639954716971E-4;0.5573555358475362;[DCTN2, RAB3IP, DCTN3, TUBG1, CKAP5, RAB11A, ACTR1A, CENPJ, CEP70, FGFR1OP, MAPRE1, CLASP1, PAFAH1B1]
GO:0006508;proteolysis;5.0;0.5517781253862416;0.5661300745540411;7.338517941704937;47.85814540089318;2.5985281439167696;0.001601769057033345;0.42312986198474045;[CYFIP2, PDCD6, CCNF, PREP, BUB1B, UBE3A, PARK7, UBE2Z, UBE2L3, CNDP2, YY1, PSMD8, NPEPPS, PSMD7, PSMD4, PSMD2, CDC26, MYC, CPNE1, LONP2, PMPCB, CAPN1, SKP2, C18orf25, ATXN7L3, USP8, RNF44, FBXO18, ARRDC1, KCTD2, TRPC4AP, KCTD5, CDC25A, RNF40, SFRP1, KCTD10, TBL1XR1, PSME2, CHMP4B, ANAPC5, UBR4, COPS7B, COPS7A, ANAPC11, C2, HSP90B1, C3, VCPIP1, CCNB1, RHOT1, RNF213, DPP8, UBD, UBR5, NLRP3, USP51, RIPK1, AMZ2, CTSA, XBP1, UBE2I, TOR1A, SDF2L1, UBE2B, KLHL25, WFS1, RHBDD2, EDEM1, RHBDD1, LNPEP, ERLIN2, BTBD6, PGA3, MARCH6, PGA5, NFKB1, NFKBIA, NSFL1C, CYLD, COPS5, RNF103, NPLOC4, CDC16, FBXL3, TPP1, USP36, USP37, WDR48, USP38, PPP1R11, USP32, USP34, KIF14, PTEN, OTUD7B, BRCA1, ECE2, USP39, SENP6, POLB, TRIM9, CTSO, SCRN1, CASP3, CTSK, CASP2, CTSH, CTSE, USP46, FGA, SEC13, PDCD6IP, DTX3L, RHBDF2, FGG, RAD23A, VPS37A, SENP2, JOSD1, SIRT2, TGFBR1, DDB1, PSMA1, ESPL1, MMP23A, MYH9, PIK3C3, MAN1B1, USP41, THOP1, MPND, BECN1, STOML2, DERL3, GPS1, VPS4B, RNF38, USP12, DERL2, NEDD8, LRP8, TANK, PARL, PSMB10, PSMA7, RELA, ARNTL, TFPT, CLN3, FZR1, ADAM28, PSMB5, TP53INP2, PERP, PSMB1, ADAM23, UBQLN1, RFFL, SEC11A, SEC11C, RNF20, MBD6, LRRC29, SYVN1, FBXL15, FBXL16, CAPN13, P2RX7, KBTBD4, ITCH, SPSB1, SPCS2, XPNPEP1, FAP, TNIP1, TNIP2, PSMC1, ASXL2, TRIM32, OTUD1, C1QC, MAD2L1, METAP2]
GO:0030838;positive regulation of actin filament polymerization;11.0;0.7866048967936545;0.8257314007264895;9.456673995565463;459.92540939869633;5.2552850506314295;0.01539328954657896;0.7011844742147011;[VASP, NCKAP1, ACTR2, GSN, WIPF2, ARPC1A, WAS, WASL, IQGAP2, VIL1, BAG4, ARPC2, CDC42EP4, NCKAP1L]
GO:0045088;regulation of innate immune response;6.0;0.4673148936341128;0.556777759407201;6.780712109014753;42.469229973879315;3.8881956693475885;0.0014214069074002054;0.52196281994017;[GFI1, ITGB2, PTPN22, GPATCH3, RPS6KA5, AP1G1, SIN3A, C1QBP, EP300, IL12A, HRAS, HAVCR2, IFNAR2, FGA, LAG3, FCER1G, SYK, FCRL3, FGG, IRAK4, TMEM173, VAV1, PSPC1, IRF4, PIK3C3, TLR7, CARD11, ANKRD17, COLEC12, CLEC12B, GPS2, NLRC4, LILRA2, TANK, RELA, HSP90B1, RNF135, CLEC7A, CCL5, UBQLN1, RIPK1, A2M, CD300LF, CREBBP, XRCC6, MAP3K1, CADM1, XRCC5, NONO, CAV1, NFKB1, PUM2, NFKBIA, CYLD, ITCH, NPLOC4, CNOT7, POLR3B, TNIP1, POLR3C, TNIP2, TREML4, KRAS, PTPN6, LSM14A]
GO:0071347;cellular response to interleukin-1;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.446340287394138;0.0027327542132076126;0.6016464081682054;[UPF1, CD40, ABCC2, CCL20, FGG, RORA, TANK, NFKB1, RELA, MAPK13, YY1, SFRP1, NLRP7, CCL5, HYAL2, CCL19]
GO:0072678;T cell migration;7.0;0.7140352122741334;0.7079369713942671;8.8813098506619;30.235634434558513;6.686031174322154;0.001011959474220325;0.692843310444282;[CCL20, MSN, PIK3CG, CCR2]
GO:0070498;interleukin-1-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.845247994956144;0.00101047745553359;0.6498456195510879;[NFKBIA, RPS6KA4, MAP3K3, RPS6KA5, TNIP2, IRAK4, NFKB1, RELA]
GO:0071345;cellular response to cytokine stimulus;5.0;0.6729672293956388;0.6267246265587396;8.214830917184116;61.59823360834823;3.805811787890007;0.0020616374440603005;0.48487040368196277;[CD40, RPL3, TFRC, DOCK8, CIB1, RORA, DDX41, BRCA1, YY1, RAB43, TUBA1B, HYAL2, JARID2, NEFH, HLA-DPA1, MAP3K5, TLE4, UPF1, ACTR2, ABCC2, FGG, TMEM173, SFRP1, PIGA, CDC42EP4, MTF2, GAPDH, MCM2, WAS, VPS26B, THBS1, TANK, CORO1A, RELA, SRM, BCLAF1, BAG4, RAB20, NLRP7, RNF138, CCL5, TPR, ADAM23, RIPK1, CCL19, IL12RB1, XBP1, GSN, PMM1, CCL20, XRCC5, NFKB1, BSPRY, MAPK13, CDK9, CD4, NLRP12, IMPDH2, PTPN6]
GO:0071346;cellular response to interferon-gamma;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.266214121163619;0.0027327542132076126;0.5924347476504533;[ACTR2, GSN, CCL20, WAS, VPS26B, RAB43, RAB20, CCL5, CDC42EP4, CCL19, IL12RB1, GAPDH, HLA-DPA1]
GO:1904691;negative regulation of type B pancreatic cell proliferation;7.0;1.0;0.8509193652572005;9.628524252492122;87.0726066655688;9.777073627680469;0.0029142417848381673;0.8509193652572005;[WDR13]
GO:0021955;central nervous system neuron axonogenesis;9.0;0.7043150770688792;0.7483981637147287;8.801845679307654;65.99544162831262;6.375876246018314;0.0022088080392582156;0.722303232910233;[C12orf57, NFIB, PTEN, PAFAH1B1]
GO:1902036;regulation of hematopoietic stem cell differentiation;7.0;0.8933024483968273;0.7975705894556142;9.474373572664863;97.61516402498306;6.558197802812269;0.003267091691972132;0.6863059058804069;[ITCH, ABL1, RUNX1]
GO:1903364;positive regulation of cellular protein catabolic process;8.0;0.7248374789738407;0.7374187394869203;9.303101852057495;870.9707591387623;4.821246570079209;0.029150607485581233;0.6215587738047448;[XBP1, ZFAND2A, EDEM1, CAV1, ATPIF1, PTEN, MSN, RAD23A, SIRT2, RNF40, RNF138, PSMC1, VPS11, UBQLN1, TRIB3, RNF166, DACT1]
GO:2001171;positive regulation of ATP biosynthetic process;11.0;0.8653626801206646;0.8651102923899945;9.574457031221845;2732.5785771167416;6.481236761676141;0.09145694581504019;0.7638797017301124;[P2RX7, ARNT, TAZ]
GO:0015031;protein transport;7.0;0.4793097133439409;0.590574221929171;6.989466922876863;54.45792783373929;2.578890050578526;0.0018226578356421344;0.4828039223744382;[VPS29, AHCYL1, RPL3, NUP107, TFRC, ZDHHC6, RPS15, LONP2, ARFIP1, HOMER3, TBC1D22A, SIL1, VPS18, GSTK1, ARRDC1, COG4, COG3, AP1B1, ATG10, COG1, MYO7A, SCAMP1, SYTL3, SCAMP3, BCR, RUFY1, NUP93, DOPEY2, UNC50, KIF20A, RPL29, ACOT4, VPS26B, ABCB9, VPS8, VPS11, ATP6V0A2, SSR1, VPS16, BBS2, CTSA, XBP1, PMM1, RAB3IP, PMM2, RAB27B, POLA2, NPLOC4, HYOU1, CD24, ARF3, ARF4, TRAM1, AHCTF1, DENND1A, SRP54, ARHGAP1, CLTA, MIA3, LYST, TRAM2, XPO5, KIF13B, TMED2, TMED1, AP3S2, TMED7, RAB8B, TMED4, GRIPAP1, TMED9, SEC13, ANXA1, SYK, SSR2, ZDHHC12, BTN3A2, COMMD1, ZDHHC17, RHOB, VAMP8, AFTPH, LSG1, GAL, AGPS, EXOC3, SLU7, VAMP5, ARF5, PAFAH1B1, EXOC1, RABGAP1, TOMM40, ZDHHC23, HSD17B4, ZDHHC24, DERL2, TRAK1, RGPD1, NAPG, STX11, ARNTL, GGA3, SNX25, LMNA, AP2S1, HEATR3, STX5, MFN2, CCL19, BID, RAE1, RPL19, PEX16, MON2, PEX19, AGK, SYVN1, SNX22, RAB11A, YIF1A, ARCN1, CENPF, SPCS2, SNX19, GPAM, SNX17, SNX14, TAOK2, RAB3GAP2, APBA3, RAB3B, STEAP3, SYS1, DGKD, NCF1, PDCD6, RAB3D, TBC1D3C, PARK7, IPO4, RAB43, RPH3A, EIF4ENIF1, IPO8, IPO9, LAMP2, KPNA4, RPS9, RPS7, VPS33A, VPS33B, TOMM34, TBC1D2B, RINT1, RAB35, CHMP4B, RAB38, SLC27A2, KPNB1, PPID, CARD11, RTN2, COPB2, COPA, SUCNR1, RAB5C, HSP90B1, MTM1, NCKIPSD, CLTCL1, NLRP3, ECT2, RAB6A, TBC1D15, ATP6V1F, AP1M1, TOR1A, RAB4B, VTA1, NUP153, TIMM44, NFKBIA, PAN3, CDK5, TMEM115, BCL3, PLEKHM1, SFT2D3, YWHAB, GPR89B, SEC61A2, AP1G2, AP1G1, NUP62, ITGAV, EVI5L, TNPO1, TNPO2, SNAP29, ARL5A, TNPO3, PDCD6IP, DTX3L, RHBDF2, FGG, TBC1D8, VPS13B, VPS37A, VPS37B, SENP2, ARFGAP1, DNM2, ACOX2, CAT, MYH9, LCP2, CHMP6, SEC22C, VPS4B, RAB1B, GOSR1, RRBP1, NLRC4, RAB21, AP3M1, RAB20, RAB40C, VPS52, VPS54, RAB28, TIMM8B, ARFGEF2, MX2, RPL23A, MCM3AP, VPS41, RAB13, RAB18, RUNDC1, VPS45, SEC24C]
GO:0045920;negative regulation of exocytosis;8.0;0.7140352122741334;0.7320176061370667;9.004369943419128;172.2069348332117;6.375876246018314;0.005763611132688151;0.701062607729944;[BCR, RAP1B, TRIM9, ABR, ANXA1, VPS4B, CCR2]
GO:0007409;axonogenesis;8.0;0.6873818243518346;0.7186909121759173;8.667113085337498;64.60914726719044;4.956792062075433;0.0021624100145753813;0.6284905765689417;[TOP2B, C12orf57, RYK, MAP1S, OMG, PTEN, LRFN4, ALS2, CDK5, NFIB, TAOK2, NPTX1, NEFH, PAFAH1B1, PICALM]
GO:0019886;antigen processing and presentation of exogenous peptide antigen via MHC class II;5.0;1.0;0.7902410118609202;9.628524252492122;42.20009821028515;5.192106149009898;0.0014123993094755708;0.5557655617789146;[DCTN6, DCTN5, DCTN2, DCTN4, DCTN3, CLTA, KLC1, KIF15, HLA-DMA, ACTR1A, HLA-DMB, ACTR1B, KIF3B, CAPZB, AP1G1, AP2S1, CTSE, HLA-DQA1, HLA-DPA1, AP1M1, LAG3, SEC13, FCER1G, AP1B1, KIF23, DYNLL2, DNM2, CENPE, KIF4A, HLA-DPB1, KIF2C, HLA-DRB3, SEC24C, HLA-DQB1]
GO:0051127;positive regulation of actin nucleation;12.0;0.9326813400603323;0.9144609826203107;9.59953671561887;617.551681028286;6.943860283624253;0.02066889900358683;0.8032296504172152;[NCKAP1, GSN, WIPF2, WAS, WASL]
GO:1902042;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;10.0;0.9326813400603323;0.8815816818910864;9.589303539338841;425.73912115989816;6.193554689224359;0.014249105244888325;0.731979686697602;[FGA, TRADD, FGG, TMBIM1, TNFRSF10B, RIPK1, TNFRSF10A, BRCA1, PARK7, RFFL]
GO:0090503;RNA phosphodiester bond hydrolysis, exonucleolytic;8.0;0.8436909121759173;0.7968454560879586;9.466005322994347;231.13671471601307;6.166155715036245;0.007735937832006836;0.6903374900225189;[CNOT6, PAN3, CNOT7, XRN1, CNOT1, XRN2, ISG20L2, CNOT8, EXOSC3, DCPS, DCP2]
GO:0060074;synapse maturation;4.0;1.0;0.75;9.628524252492122;25.433288066812054;7.697632086000634;8.512292631229848E-4;0.6436572628545723;[NFIA, PTEN]
GO:1902045;negative regulation of Fas signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;187.41437209568753;9.777073627680469;0.006272590372058239;0.8509193652572005;[TMBIM1]
GO:0045930;negative regulation of mitotic cell cycle;6.0;0.5833093054345528;0.6147749653074209;7.836764783264067;61.236897459641845;4.271742091748107;0.0020495438483445192;0.5415774018184651;[TOP2B, BTG2, CDKN1A, BTG1, ZWILCH, PTEN, BUB1B, BRCA1, PKD2, GPR132, ZNF207, TIMP2, CASP2, EP300, KNTC1, TOPBP1, GTSE1, HRAS, CDK5RAP3, DACT1, TIPIN, TFDP1, RBL1, TFDP2, CTDSP2, MCPH1, PCNA, XPC, CCNB1, RAD21, TPR, ABL1, E2F7, E2F8, FANCI, INTS3, DONSON, MAD2L1BP, CNOT10, ZWINT, CNOT4, CNOT6, CENPF, WEE1, CNOT7, FAP, CNOT1, RFWD3, CNOT3, TAOK2, CDK2, CNOT8, EZH2, MAD2L1]
GO:0006334;nucleosome assembly;7.0;0.8653626801206646;0.7836007053175329;9.474373572664863;104.51542930890014;4.99795013456894;0.0034980373611892576;0.6065147675675062;[HIST1H2BO, TSPYL1, HIST1H2BJ, H2AFY, H3F3A, IPO4, CHAF1B, CHAF1A, CENPH, UBN1, CENPK, POLE3, CENPL, OIP5, RBBP7, TSPYL6, CENPP, ITGB3BP, MCM2, HIST1H2BC, ASF1B]
GO:0007416;synapse assembly;4.0;0.8436909121759173;0.6718454560879586;9.117698628726131;35.85243951974866;5.500407508664414;0.0011999488856252476;0.5312910957882058;[DBNL, CDK5, RYK, PTEN]
GO:1990138;neuron projection extension;4.0;0.811012628672052;0.655506314336026;9.223059144383958;50.60479478960687;5.69953618377475;0.0016936969402496266;0.5414745454937787;[CYFIP2, ITGB1, SLC9A6, CDK5, CPNE1, ULK1, SPG11, C9orf72]
GO:0016126;sterol biosynthetic process;6.0;0.7980440201809971;0.722142322680643;9.292052015870908;224.1590834480148;5.885253329569843;0.007502402792927377;0.6240924415566148;[ACLY, SQLE, CYB5R1, EBP, NSDHL, G6PD, CYB5R3, GGPS1]
GO:0045948;positive regulation of translational initiation;9.0;0.7586651285174919;0.775573189439035;9.39368466141472;1253.3709905068713;6.409777797693995;0.04194919909160693;0.7240369598395108;[PPP1R15A, CDC123, RXRA, YTHDF3, CCL5, POLR2G]
GO:0045947;negative regulation of translational initiation;9.0;0.7508913569872202;0.7716863036738992;9.377209824211215;1335.4538949630598;6.832634648514029;0.044696440033937586;0.7456618788553018;[TPR, EIF2AK3, RARA, EIF2S1]
GO:0043523;regulation of neuron apoptotic process;7.0;0.7043150770688792;0.7030769037916401;8.763526815005518;34.538657273781794;4.5143834387755835;0.0011559777761799947;0.581785144256483;[TFAP2A, PRNP, BTG2, G6PD, EGLN2, ANGPT1, WFS1, NONO, KIF14, PARK7, CORO1A, CLN3, CDK5, ADORA2A, CASP3, CASP2, KRAS, HYOU1, ADNP, SNCB, HRAS, CPEB4]
GO:0045944;positive regulation of transcription by RNA polymerase II;11.0;0.5461734764479651;0.7055156905536448;8.363590748376499;1463.8556817380634;2.718315475161805;0.048993932283191266;0.5714437321440341;[CRTC2, ZNF175, CCNK, MAML1, CCNH, GFI1, ZNF292, ARID4A, RORA, YEATS4, UBE3A, IKZF1, PARK7, IKZF2, ELK1, YY1, RPS6KA4, RPS6KA5, MYC, DPF2, EP300, SOX8, SOX6, IER5, ZNF564, IER2, CDK5RAP3, DDX17, MEF2B, FLT3LG, MED6, RUNX2, PIAS2, RUNX1, ARMCX3, IL23A, TBL1XR1, RFX4, HOXB4, PAXIP1, MAX, RLF, SUPT6H, BCL2L12, HSPH1, RAD21, HLTF, SCAP, NLRP3, HOXC4, ZBED1, RIPK1, CYTL1, TFAP2A, ZBTB17, ZNF143, DR1, CREBBP, XBP1, XRCC6, JUP, PBX3, EAF2, ERLIN2, FLI1, NFKB1, SETX, CDK9, NFKBIA, IL6, STAG1, TFCP2, COPS5, CNOT7, SP1, SP3, MAFF, BCL3, MNAT1, NFE2L1, ARF4, CIITA, CD40, SETD3, BMPR2, ONECUT2, ELL, CHD8, CHD7, DDX41, HOXC13, BRCA1, LDB2, AATF, PKD2, MED12, FLCN, NIPBL, SIN3A, HYAL2, MLX, HRAS, TEAD2, ZNF485, KLF13, RBM15, PPP1R12A, PEG3, NCOA6, MKL1, ARNT, SENP2, SAFB, TMEM173, PPRC1, SIRT2, GNL3, CREB3, GAL, TFDP1, RBL1, TFDP2, ELF4, IRF4, MTF2, TFEC, RARA, EAPP, MET, HDAC3, ZNF350, HDAC1, WBP2, CEBPG, GPS2, RELA, ARNTL, RXRA, PLAGL2, MTA2, E2F7, E2F8, TBX1, ZNF462, NFYC, ATAD2, ARID3B, GRHL1, USF2, KLF6, NFIA, TNIP1, NFIB, TNIP2, TTC5, NFIC, PSMC1, ASXL2, TAF7, CAMK1, TAF4, MIXL1]
GO:0040018;positive regulation of multicellular organism growth;6.0;1.0;0.8231203125901445;9.628524252492122;145.45792876686207;6.280566066213989;0.004868345972189967;0.6443087532925187;[BBS2, VIL1, NIPBL, GPAM, CHD7, SH3PXD2B]
GO:0007628;adult walking behavior;4.0;1.0;0.75;9.628524252492122;34.938319875750295;6.518977089658987;0.0011693541237948906;0.5833807915285978;[CHD7, CTNS]
GO:0051384;response to glucocorticoid;7.0;0.7671156992804218;0.7344772148974115;9.223059144383958;62.73690238121479;4.800339885259895;0.00209974766315278;0.5964089702280253;[ERRFI1, USP8, CDKN1A, ABCC2, PCNA, ANXA1, ABCA3, SERPINF1, ABCB4, CAD, UBE2L3, AQP1, IL6, CASP3, DDIT4, SDC1, KRAS, PAM]
GO:0097105;presynaptic membrane assembly;5.0;1.0;0.7902410118609202;9.628524252492122;57.45028169597201;7.474488534686424;0.001922809226467428;0.6724867031240476;[PTEN]
GO:0097107;postsynaptic density assembly;6.0;1.0;0.8231203125901445;9.628524252492122;79.48995662447987;8.390779266560578;0.00266045731190491;0.7522251544931926;[PTEN]
GO:0038128;ERBB2 signaling pathway;9.0;0.8653626801206646;0.8289219652406215;9.36615998802463;32.38857880465376;6.343086423195323;0.0010840165847632744;0.7206263598461826;[CPNE3, HBEGF]
GO:0016358;dendrite development;6.0;0.8259837884571596;0.7361122068187242;9.260799472366804;32.63417926892749;6.343086423195323;0.0010922366112764486;0.647506047256038;[MAP1S, LST1, SCARF1]
GO:0016579;protein deubiquitination;9.0;0.7307253602413294;0.7616033053009538;9.151600180401813;202.59641706362558;4.174954806800768;0.0067807197541817285;0.6097480081553338;[USP36, USP37, WDR48, USP38, USP32, USP34, PTEN, OTUD7B, BRCA1, USP39, YY1, PSMD8, POLB, PSMD7, PSMD4, PSMD2, MYC, SKP2, ATXN7L3, USP46, USP8, RAD23A, JOSD1, CDC25A, TGFBR1, PSMA1, PSME2, USP41, BECN1, USP12, NEDD8, PSMB10, PSMA7, VCPIP1, TFPT, RHOT1, PSMB5, PSMB1, NLRP3, USP51, RIPK1, MBD6, NFKBIA, CYLD, COPS5, TNIP1, TNIP2, PSMC1, ASXL2, OTUD1]
GO:0120009;intermembrane lipid transfer;6.0;0.8653626801206646;0.7558016526504768;9.36615998802463;36.254519839839105;7.697632086000634;0.00121340615208988;0.7167775754447168;[GLTP]
GO:0043534;blood vessel endothelial cell migration;8.0;0.8653626801206646;0.8076813400603323;9.34084218004034;26.070480469920426;6.599019797332524;8.725555194190899E-4;0.712474179321389;[ITGB1, SCARB1, MYH9, EPHB4]
GO:0006555;methionine metabolic process;9.0;0.7140352122741334;0.7532582313173557;9.094441766561864;190.74552811891832;6.7325511899570465;0.006384081166309989;0.740543606130341;[MSRA, AHCYL1, MTHFD1, MTHFD2L]
GO:0010803;regulation of tumor necrosis factor-mediated signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.446202695698167;58.00234281560482;5.734022359845919;0.001941286215318787;0.64415753539903;[CYLD, HIST1H2BJ, SYK, SPHK1, TRADD, MADD, CPNE1, GPS2, RIPK1, RFFL, TRIM32]
GO:0019852;L-ascorbic acid metabolic process;6.0;0.8259837884571596;0.7361122068187242;9.405380701177911;115.66137206117003;7.379178354882098;0.003871082034410502;0.7004918368257019;[SLC23A2, CYB5R3]
GO:0060044;negative regulation of cardiac muscle cell proliferation;10.0;1.0;0.9152410118609203;9.628524252492122;721.615529104109;7.292166977892469;0.02415182234730172;0.7881627702307852;[PTEN, JARID2]
GO:0018108;peptidyl-tyrosine phosphorylation;9.0;0.811012628672052;0.801746939516315;9.414950152194063;338.33129968976414;4.530049555519983;0.011323644122215096;0.627907570118429;[IL5RA, TESK2, IGF1R, ZMYM2, TRIM24, ABL1, NEK1, CSK, EPHB4, PDGFRB, SYK, ERLIN2, CLK4, CLK3, CLK1, BCR, WEE1, FES, KIT, FGFR1OP, PTPN6, TEK, EPHA1, MET, HBEGF]
GO:1902230;negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage;10.0;0.9326813400603323;0.8815816818910864;9.596775554177542;831.2496569477559;6.409777797693995;0.02782117794191935;0.7430373465201421;[BCL2L12, CDKN2D, ING2, BID, TRIM32]
GO:0022604;regulation of cell morphogenesis;5.0;0.5326392268888578;0.5565606253053492;7.3549266963713285;31.055921926933518;3.6012063575747084;0.001039413758379302;0.47440687246051283;[BMPR2, WDR1, SH3KBP1, WIPF2, LST1, ITGB2, PTEN, CIB1, WASL, PREX1, ZMYM2, CAPZB, C1QBP, CFL1, KIF13B, SEMA6B, FGA, ACTR2, TBCCD1, ANXA1, TNFRSF12A, FGG, OMG, VRK1, VRK2, RHOC, UNC13D, RHOB, DNM2, OLFM1, CFDP1, RUFY3, CDC42EP4, KIT, MYADM, MYH9, RHOU, ADNP, ALDOA, CSNK1G2, PAFAH1B1, CSNK1G1, EPB41, TWF2, WAS, TRAK1, LRP8, CORO1A, RAB21, FXR1, ABL1, DVL3, MARK2, S100A10, SEMA4D, RCC2, SEMA4B, MSN, CDC7, SSH3, RAB11A, SSH1, VIL1, MKLN1, ARPC2, CDK5, FES, CAPRIN1, TAOK2, LIMS1]
GO:0060043;regulation of cardiac muscle cell proliferation;9.0;0.8933024483968273;0.8428918493787028;9.517298617381897;128.59890602933217;6.166155715036245;0.004304089653300247;0.711578115202808;[CCNB1, PTEN, JARID2, TGFBR1]
GO:0006366;transcription by RNA polymerase II;10.0;0.6039883530135606;0.7172351883677006;8.613793447804714;583.8786478812184;3.2909128387363804;0.01954189288791682;0.5835384474769965;[TCERG1, ZNF175, CCNK, CCNH, ZNF292, ARID4A, ELK1, MYC, TRIM24, EP300, IER2, GTF2I, MEF2B, ZBTB32, RUNX1, RFX4, MAX, RPAP1, SUPT6H, GTF2E2, RAD21, HLTF, HIVEP1, HOXC4, ZBED1, HIVEP2, TFAP2A, ZBTB17, ZNF143, XBP1, INTS3, PBX3, EAF2, NFXL1, FLI1, NFKB1, CDK9, STAG1, TFCP2, COPS5, SP1, MAFF, NFE2L3, INTS4, INTS7, INTS6, MNAT1, ZNF136, INTS8, NFE2L1, BMPR2, ONECUT2, ELL, INTS10, HOXC13, BRCA1, AFF4, HYAL2, ZNF768, KLF11, TBP, KLF13, MKL1, ARNT, CREB3, NCOR1, TFDP1, TFDP2, ELF4, IRF4, NFX1, TFEC, MED20, ZNF516, LCOR, WBP2, CEBPG, RELA, ARNTL, POLR2B, TAF1A, POLR2E, PLAGL2, POLR2G, TCFL5, POLR2J3, NFYC, ARID3B, DEK, GRHL1, USF2, GTF2H4, GFI1B, KLF6, NFIA, NFIB, NFIC, TAF7, TAF5, TAF4, MIXL1]
GO:0008542;visual learning;8.0;1.0;0.875;9.628524252492122;51.65827414420079;5.970411137910149;0.00172895594617802;0.6803271032452366;[RIC8A, ITGB1, CDK5, HRH2, KIT, DDHD2, CTNS, KRAS]
GO:0006364;rRNA processing;9.0;0.6347111282356054;0.7135961892980918;8.681142933547935;356.38664419027253;4.478756261132433;0.01192794025389202;0.6252844286580675;[DDX27, POP4, SUV39H1, EIF4A3, HEATR1, CHD7, ISG20L2, NOLC1, NAT10, WDR43, RRP9, RPS15, PES1, EXOSC3, DDX17, RPS9, WDR37, RPS7, WDR18, IMP4, BYSL, BOP1, LAS1L, RPL7L1, MRTO4, XRN2]
GO:0006367;transcription initiation from RNA polymerase II promoter;9.0;1.0;0.896240625180289;9.628524252492122;477.15162764714074;4.629579150867016;0.015969835568764485;0.6329975182530758;[CDKN1A, MAML1, CCNH, RORA, ZNF45, GTF2E2, MED12, RXRA, MED30, POLR2B, NPPA, POLR2E, POLR2G, TEAD2, GTF2I, CREBBP, TBP, GTF2H4, MED6, RUNX2, CDK9, MED20, RARA, TAF7, TAF5, MNAT1, TAF4]
GO:0048167;regulation of synaptic plasticity;7.0;0.6729672293956388;0.6874029799550199;8.567652291806858;39.259689615435484;4.623782033182691;0.0013139864800018823;0.5873797934620173;[PRNP, MCTP1, PTEN, AGER, RAB11A, SSH1, CDK5, ADORA2A, HRH2, KIT, ABL1, RARA, KRAS, HRAS, RAB3GAP1]
GO:0030220;platelet formation;5.0;1.0;0.7902410118609202;9.628524252492122;33.79744107268718;6.832634648514029;0.0011311699369806302;0.639662265535933;[WDR1, VPS33A, CASP3, EP300, MYH9, CIB1, PTPN6]
GO:0060291;long-term synaptic potentiation;8.0;1.0;0.875;9.628524252492122;145.7697243391103;5.948432231191374;0.004878781489395318;0.6792031009335148;[PTEN]
GO:0060292;long term synaptic depression;8.0;1.0;0.875;9.628524252492122;145.80791725818347;7.004484905440688;0.004880059772025301;0.7332096838060964;[PTEN]
GO:0030224;monocyte differentiation;6.0;1.0;0.8231203125901445;9.628524252492122;69.52661413212034;7.004484905440688;0.0023269932051117304;0.6813299963962409;[SP3, MT1G, MYH9]
GO:0032402;melanosome transport;8.0;1.0;0.875;9.628524252492122;154.03816563912218;6.686031174322154;0.005155518778592664;0.7169239451870815;[BBS2, DCTN2, RAB27B, RAB11A]
GO:0060271;cilium assembly;6.0;0.8653626801206646;0.7558016526504768;9.405380701177911;137.68250629835126;4.347727998726029;0.00460810957959482;0.5454633246350222;[BBS2, SPAG16, ACTR2, GALNT11, SEPT11, GSN, ONECUT2, IFT122, FNBP1L, WDR34, DYNLL2, SEPT2, TTLL3, TMEM138, RFX4, CENPJ, TMEM107, NEK1, CCDC65, SNAP29, CLUAP1]
GO:1904668;positive regulation of ubiquitin protein ligase activity;12.0;1.0;0.9481203125901445;9.628524252492122;754.3373369627636;7.212124270218933;0.025246991808615726;0.8169486831672182;[FZR1, PTEN, MASTL]
GO:1902004;positive regulation of amyloid-beta formation;8.0;1.0;0.875;9.628524252492122;442.71613466832366;7.474488534686424;0.01481731060869512;0.7572456912631272;[ROCK2, PICALM]
GO:0009404;toxin metabolic process;3.0;0.5720181185523628;0.484129371866326;7.2867184463447945;27.61873557695172;6.686031174322154;9.243742245122942E-4;0.5400442577772261;[PAM]
GO:0030217;T cell differentiation;6.0;0.657518819034173;0.651879722107231;8.679443697794976;65.04859315339479;5.132682728539097;0.00217711787291102;0.5856059460217904;[PTGER4, FCER1G, ANXA1, RIPK3, CHD7, RORA, PTPN22, RUNX2, VAV1, RC3H2, PREX1, CD4, SP3, BCL3, KIT, ABL1, ATP7A]
GO:0010629;negative regulation of gene expression;6.0;0.471430776349301;0.558835700764795;6.738152494595957;59.04642522059629;2.349334787147576;0.001976230713800692;0.44326540286011196;[TCERG1, ZNF175, RPL3, RNH1, GFI1, EIF4A3, PPP2R2A, IKZF1, IKZF2, RPS15, RPS6KA5, MYC, SAP130, DPF2, TRIM24, CPNE1, SOX8, DIP2A, SOX6, DDX17, ZNF282, SLC35C2, SFMBT2, SERPINF1, ZNF12, HCFC2, SND1, RUNX2, THAP1, RUNX1, EID1, SFRP1, XRN1, HOXB4, TRIB3, RPL29, FOXG1, MEPCE, GLG1, MTDH, FXR1, DHX34, HIVEP1, HESX1, A2M, BBS2, CREBBP, XRCC6, ZNF263, XRCC5, BCL11A, H3F3A, EIF2AK3, QARS, PKIA, DCP1A, RCOR3, ZNF136, EZH2, CPEB4, CDKN1C, HBS1L, BTG2, CDKN1A, SMG1, TCF25, SUV39H1, OTUD7B, BRCA1, PTPRK, SMG5, NIPBL, C1QBP, MLX, CIC, JARID2, HRAS, HAVCR2, UPF2, ZNF485, UPF1, TSC22D4, HELLS, HBZ, TSC22D3, SIRT7, SIRT2, NME1, NCOR2, NCOR1, NFX1, PTRH2, CSDE1, MTF2, DEPDC1, RARA, DCP2, ZNF350, GPS2, RELA, ARNTL, PPP2CA, BCLAF1, RXRA, EXOSC3, DCPS, RPL19, YTHDF3, NFYC, PER2, CENPF, GFI1B, HIST3H2A, NFIA, NFIB, NFIC, LIMS1, NAB1, GMNN, ARID4A, UBP1, ZBTB20, CASC3, PARK7, UBE2Z, YY1, EIF4ENIF1, WWC3, EP300, ZNF564, TLE4, RPS9, IGFBP5, RPS7, ZBTB32, SARS, RNF40, ERN1, OLFM1, ILF3, BRMS1, ZNF93, TBL1XR1, PSPC1, CCNE1, MRTO4, TIMELESS, MYADM, ADNP, PPID, MAX, SUPT6H, BCL2L12, CCNB1, NLRP7, BAG3, TPR, SUDS3, BPTF, TFAP2A, PRNP, DR1, UBE2I, CBX4, WFS1, NONO, CAV1, NFXL1, CNOT10, HELZ, LSM5, EIF2S1, NFKB1, CDK9, CNOT4, CNOT6, PAN3, CNOT7, CDK5, YEATS2, CNOT1, CAPRIN1, SP3, BCL3, CNOT3, CDK2, ZNF658, NFE2L3, SKIV2L, CNOT8, PHF19, PICALM, USP36, CIITA, YWHAB, CHD8, PTPN22, LDB2, FLCN, PTBP1, SIN3A, LRRFIP1, HIF1AN, DACT1, KLF11, KLF12, PEG3, RFC1, H2AFY, PAPD4, ARID1A, ZFP90, DUSP22, RBL1, TFDP2, LCOR, ETF1, BIRC6, EIF4E2, EAPP, GAPDH, MCPH1, HDAC3, HDAC1, NLRC4, LRP8, THBS1, U2AF2, DNAJB5, TP53INP1, SAP18, POLR2G, RBBP7, MTA2, E2F7, ZNF189, E2F8, TCFL5, IRX1, RNF20, SPEN, SEMA4D, RPL23A, PNRC1, TAF7, TNRC6A, TRIM33]
GO:0030216;keratinocyte differentiation;6.0;0.8933024483968273;0.7697715367885581;9.377209824211215;25.58801435984686;5.486614186532078;8.564078129062366E-4;0.6037060172430475;[CSTA, ANXA1, CASP3, STK4]
GO:0050482;arachidonic acid secretion;12.0;1.0;0.9481203125901445;9.628524252492122;224.85573033724626;6.599019797332524;0.007525718937368459;0.7855944919115336;[PLA2G12A, ANXA1]
GO:0051572;negative regulation of histone H3-K4 methylation;11.0;0.9326813400603323;0.8987696223598284;9.59953671561887;804.8473500351352;8.390779266560578;0.026937516490087493;0.8615337942327104;[H2AFY, BRCA1]
GO:0010628;positive regulation of gene expression;6.0;0.4705935272257725;0.5584170762030307;6.666693530613812;58.797024432214236;2.2471302570788807;0.001967883493859682;0.43803865843940215;[ZNF175, CCNK, MAML1, CCNH, GFI1, ZNF292, EIF4A3, IKZF1, GPATCH3, IKZF2, ELK1, RPS6KA4, RPS6KA5, MYC, ZXDC, DPF2, TRIM24, SOX8, SOX6, IER5, ATXN7L3, IER2, CDK5RAP3, DDX17, MEF2B, SECISBP2, FLT3LG, PRKAB1, MED6, RUNX2, RUNX1, SFRP1, KARS, IL23A, RFX4, HOXB4, PAXIP1, NOLC1, C3, FXR1, HSPH1, DHX34, RAD21, HLTF, SCAP, HOXC4, ZBED1, ZNF143, CREBBP, XBP1, XRCC6, JUP, PBX3, EIF2AK3, EAF2, ERLIN2, FLI1, SETX, STAG1, CDKN1C, ARF4, CD40, SETD3, ELL, HOXC13, BRCA1, AATF, WDR43, MED12, NIPBL, ING2, C1QBP, HYAL2, SH3PXD2B, MLX, TMED2, CTSH, HRAS, TEAD2, ZNF485, SEC13, NCOA6, SIRT7, TMEM173, PPRC1, SIRT2, GNL3, NCOR2, GAL, NCOR1, MTF2, TFEC, KIT, RARA, MAPRE3, CDC123, ZNF350, HEATR1, GPS2, RELA, ARNTL, SERTAD3, BCLAF1, RXRA, SERTAD2, LMNA, PLAGL2, GPBP1L1, SF3B1, ZNF462, GSN, YTHDF3, NFYC, ATAD2, GRHL1, NFIA, NFIB, TTC5, NFIC, CAMK4, MARS, PSMC1, CAMK1, RAB3GAP1, MIXL1, LIMS1, CRTC2, NCF1, CD80, ARID4A, RORA, YEATS4, UBE3A, PARK7, YY1, EP300, ZNF564, MAP3K5, RPS9, RPS7, PIAS2, ERN1, ARMCX3, OLFM1, ILF3, TBL1XR1, CCNE1, MAX, RLF, SUPT6H, BCL2L12, CCNB1, MED30, UBR5, DVL3, NLRP3, RIPK1, CYTL1, BPTF, TFAP2A, ZBTB17, DR1, RHBDD1, CAV1, MSN, NFKB1, CDK9, NFKBIA, IL6, TFCP2, COPS5, CNOT7, SP1, SP3, MAFF, BCL3, CDK2, NFE2L3, MNAT1, NFE2L1, PHF19, PICALM, CIITA, BMPR2, ONECUT2, CHD8, CHD7, PTEN, PTPN22, DDX41, LDB2, PKD2, CKS1B, RBM3, FLCN, LBH, SIN3A, NUP62, ARHGEF11, TBP, KLF13, RBM15, PPP1R12A, PEG3, DTX3L, RFC1, H2AFY, ITGA2, MKL1, ARNT, SENP2, SAFB, ARID1A, ZFP90, TGFBR1, DNM2, CREB3, TFDP1, RBL1, TFDP2, ELF4, IRF4, ZNF516, POLR1E, MYH9, EAPP, MET, PPP1R15A, HDAC3, HDAC1, WBP2, ROCK2, POLDIP3, CEBPG, THBS1, CLEC3B, U2AF2, TP53INP2, CCL5, TP53INP1, TAF1A, POLR2E, POLR2G, MTA2, E2F7, E2F8, TBX1, RNF20, CHURC1, ARID3B, DEK, USF2, P2RX7, CD4, KLF6, TNIP1, TNIP2, ASXL2, TAF7, KRAS, FAM98A, TAF4]
GO:0001914;regulation of T cell mediated cytotoxicity;8.0;0.7763722522362496;0.7631861261181248;9.32314260294094;59.92129984876392;6.250713103064308;0.0020055119802694153;0.6946617587785947;[P2RX7, RIPK3, IL23A, HLA-C, IL12A, HLA-A, HLA-F, IL12RB1, AGER]
GO:0071169;establishment of protein localization to chromatin;8.0;0.9326813400603323;0.8413406700301662;9.55953138100517;126.96280394857794;7.697632086000634;0.004249330789053679;0.7686572628545723;[NIPBL, H2AFY]
GO:0018345;protein palmitoylation;8.0;0.811012628672052;0.780506314336026;9.370695143190021;306.991636675669;6.311337724880743;0.010274733804998895;0.6977621047576203;[ZDHHC23, ZDHHC5, ZDHHC12, ZDHHC24, ZDHHC6, ZDHHC17]
GO:0018105;peptidyl-serine phosphorylation;9.0;0.7369933605727446;0.7647373054666613;9.207310787415818;338.73676479787366;4.61801832846594;0.011337214674488616;0.6324062972578516;[SMG1, MAST3, ROCK2, STK4, RPS6KA4, CCNB1, RPS6KA5, STK38, MKNK2, STK38L, RIPK1, MARK2, SYK, EIF2AK3, CDC7, VRK1, VRK2, MASTL, TGFBR1, MAPK13, CLK1, ERN1, CDK5, CAMK4, CDK2, ULK1, CAMK1, CSNK1G2, CSNK1G1]
GO:0018107;peptidyl-threonine phosphorylation;9.0;0.7671156992804218;0.7797984748205;9.305750860229072;337.99482745314367;5.395046993006588;0.011312382699260763;0.6721435792979885;[CLK1, CSNK2A1, CDK5, ROCK2, CAD, VRK1, ULK1, CAMK1, OXSR1, MARK2, TGFBR1]
GO:0010862;positive regulation of pathway-restricted SMAD protein phosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;1012.5567145242198;5.905872616772578;0.033889361993245395;0.7172676121338334;[TWSG1, BMPR2, TGFBR1]
GO:0030214;hyaluronan catabolic process;8.0;1.0;0.875;9.628524252492122;501.2795327383162;6.8867018697843045;0.01677737483846132;0.7271862538851576;[HYAL2, GUSB]
GO:1901164;negative regulation of trophoblast cell migration;8.0;1.0;0.875;9.628524252492122;362.8566342195128;8.16763571524637;0.012144484997557702;0.7926932703116032;[ARHGDIB, TIMP1]
GO:0045907;positive regulation of vasoconstriction;8.0;0.8933024483968273;0.8216512241984136;9.57973408832269;103.52331479149503;6.280566066213989;0.003464832181136806;0.6961884407023742;[FGA, OXTR, TBXA2R, HRH2, CAV1, FGG]
GO:0006580;ethanolamine metabolic process;8.0;0.8933024483968273;0.8216512241984136;9.523163736834295;154.04867005222826;9.777073627680469;0.005155870351845966;0.875;[CHKA]
GO:0006342;chromatin silencing;11.0;0.7763722522362496;0.820615078447787;9.454170865347344;1752.5176526080036;5.433268205826786;0.058655188669300654;0.7102865410484548;[HELLS, HIST3H2A, H2AFY, HDAC1, SUV39H1, H3F3A, SUPT6H, SIRT2]
GO:0032869;cellular response to insulin stimulus;8.0;1.0;0.875;9.628524252492122;462.69925393661634;5.334422371190153;0.015486127626965131;0.6478026081386739;[ERRFI1, XBP1, SP1, MARS, PPAT, RAB13, PTEN, TRIB3, RAB8B]
GO:0032868;response to insulin;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;74.03337757263446;4.800339885259895;0.0024778305216419678;0.5964089702280253;[ERRFI1, XBP1, MAX, CAD, PTEN, RELA, GAL, SP1, MARS, PPAT, NPPA, RAB13, CAT, SCAP, TRIB3, RAB8B]
GO:0060070;canonical Wnt signaling pathway;8.0;0.6729672293956388;0.7114836146978194;8.391761625343195;31.415129658942366;5.233778845410465;0.0010514361179036673;0.6426556935498979;[MED12, SFRP1, UBE2B, RYK, MYC, CHD8, PTEN, DVL3, SDC1]
GO:0060071;Wnt signaling pathway, planar cell polarity pathway;9.0;0.7436939687323844;0.7680876095464813;9.094441766561864;99.0414819593438;5.825829909099042;0.0033148292696323837;0.694173837660411;[MED12, SFRP1, RYK, AP2S1, DVL3]
GO:0031532;actin cytoskeleton reorganization;6.0;1.0;0.8231203125901445;9.628524252492122;32.01253927882412;5.788089581116195;0.001071430880247358;0.6191234829421188;[MKLN1, ANXA1, PARVG, KIT, MYH9]
GO:1903351;cellular response to dopamine;8.0;1.0;0.875;9.628524252492122;545.6259493406901;7.138016298065211;0.018261609492958953;0.7400384854347593;[SIN3A, ABL1, SULT1A3, DNM2]
GO:0038168;epidermal growth factor receptor signaling pathway via I-kappaB kinase/NF-kappaB cascade;11.0;1.0;0.9324289523296623;9.628524252492122;34.468020346337084;9.777073627680469;0.0011536136217875279;0.9324289523296623;[RASSF2]
GO:1904681;response to 3-methylcholanthrene;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;32.41369733281489;9.777073627680469;0.0010848572792956199;0.8231203125901445;[CHKA]
GO:0042407;cristae formation;7.0;1.0;0.8509193652572005;9.628524252492122;41.98985797947654;6.343086423195323;0.0014053627581543302;0.6753050999230941;[APOO, ATP5J, ATP5I, ATP5O, ATP5F1, TAZ, ATP5L]
GO:1900087;positive regulation of G1/S transition of mitotic cell cycle;9.0;0.9326813400603323;0.8625812952104552;9.577230958104572;354.40743100732976;6.409777797693995;0.011861697769835146;0.7240369598395108;[ANKRD17, ANXA1, MEPCE]
GO:0006351;transcription, DNA-templated;9.0;0.5708408884191841;0.6816610693898811;8.449869256150476;581.393741231429;1.9872050686257638;0.019458725298619164;0.49786638480429696;[TCERG1, ZNF175, CCNK, CCNH, GFI1, ZNF292, IKZF1, GPATCH3, IKZF2, ELK1, UBE2L3, MYC, SAP130, ZXDC, DPF2, TRIM24, CPNE1, SOX8, SOX6, IER5, ATXN7L3, IER2, DDX17, ZNF18, SAP30BP, MEF2B, CSNK2A1, ZNF282, RFX1, ZNF12, SND1, THAP1, RUNX1, EID1, EWSR1, RFX4, HOXB4, TRIB3, BCORL1, ASF1B, SF1, ZNF276, ZNF395, ZNF274, ZNF394, PAXIP1, FOXG1, MYCBP2, ZNF20, CDCA7, RPAP1, ZNF25, COMMD9, RAD21, HLTF, HIVEP1, HESX1, HOXC4, ZBED1, HIVEP2, ZNF264, ZNF143, XBP1, XRCC6, ZNF263, SETDB1, ZNF260, XRCC5, BCL11A, INTS3, PBX3, EAF2, ZNF35, FLI1, SOX30, STAG1, ZNF30, INTS4, INTS7, INTS6, RCOR3, ZNF136, INTS8, EZH2, PHF3, SETD5, BTG2, SETD3, ELL, ZNF250, TCF25, SUV39H1, INTS10, ATF7IP2, HOXC13, BRCA1, WASL, WDR43, NIPBL, CHAF1B, ING2, ZMYM2, SCML1, C1QBP, HYAL2, MLX, CIC, JARID2, ZNF485, BRD3, TSC22D4, HELLS, COMMD3, BAZ1A, COMMD1, SIRT7, PPRC1, ZFX, MED29, SIRT2, MED28, NCOR2, NCOR1, NFX1, TFEC, MED20, DEPDC1, VGLL4, ZNF350, HEATR1, GPS2, ZNF2, ZNF69, RELA, ARNTL, SERTAD3, BCLAF1, SERTAD2, TCEAL3, PLAGL2, GPBP1L1, DEDD, ZNF101, ZNF462, ZNF581, NFYC, ATAD2, GRHL1, GTF2H4, PER2, GFI1B, NFIA, NFIB, NFIC, MARS, ZNF213, ZNF696, MIXL1, ZNF212, ZNF331, CRTC2, NAB1, ARID4A, UBP1, ZBTB20, YEATS4, YY1, EP300, ZNF326, ZNF688, ZNF564, GTF2I, TLE4, ZNF441, ZNF680, ZBTB32, SARS, PIAS2, ERN1, ILF3, BRMS1, ZNF93, TBL1XR1, PSPC1, TIMELESS, ADNP, ZNF550, MAX, RLF, SUPT6H, GTF2E2, ZNF549, ZNF548, NLRP3, SUDS3, ZNF544, BPTF, TRAPPC2, TFAP2A, ZBTB17, DR1, CBX4, NONO, NFXL1, CNOT10, NFKB1, CDK9, CNOT6, IRAK1BP1, TFCP2, COPS5, CNOT7, CNOT1, SP1, SP3, MAFF, BCL3, CNOT3, ZFP64, ZNF658, NFE2L3, ZNF777, CNOT8, TMEM18, MNAT1, ZNF654, ZNF532, ZNF410, NFE2L1, ZSCAN2, PHF19, NFKBIB, PHTF2, CIITA, BMPR2, ONECUT2, CHD9, CHD8, CHD7, CHD1, AFF4, LBH, SIN3A, ZNF407, NUP62, ZNF768, ZNF525, ZNF524, ZNF766, LRRFIP1, HIF1AN, KLF11, KLF12, TBP, KLF13, RFC1, BUD31, MKL1, ARNT, SAFB, ARID1A, ZFP90, CREB3, TFDP1, RBL1, ZNF519, TFDP2, ELF4, IRF4, ZNF516, LCOR, ZNF511, ZNF630, ITGB3BP, GTF3C1, SMARCD2, HDAC3, HDAC1, WBP2, CEBPG, TFPT, POLR2B, RBBP5, TP53INP2, FAM120B, TP53INP1, TAF1A, POLR2E, SAP18, POLR2G, ASCC3, RBBP7, E2F7, ZNF189, E2F8, TCFL5, TBX1, POLR2J3, SPEN, CHURC1, EYA2, ARID3B, DEK, USF2, PNRC1, MAPK13, KLF6, POLR3B, POLR3C, TNIP2, POLR3E, ASXL2, TAF7, MNDA, TAF5, TAF4, TRIM33]
GO:1900086;positive regulation of peptidyl-tyrosine autophosphorylation;11.0;1.0;0.9324289523296623;9.628524252492122;1786.9389585583017;8.16763571524637;0.05980723880229299;0.8501222226412654;[SYK]
GO:0006355;regulation of transcription, DNA-templated;9.0;0.4043225613388953;0.5984019058497367;6.838723401371219;245.35026186902695;1.5478292109445575;0.008211652463856259;0.4753966830094131;[ZNF175, NUP107, MAML1, ZNF292, GPATCH3, ELK1, MYC, ZXDC, IER5, IER2, CDK5RAP3, DDX17, ZNF18, SAP30BP, MEF2B, CSNK2A1, ZNF282, RFX1, ZNF12, HCFC2, SND1, MED6, RC3H2, EID1, EWSR1, RFX4, HOXB4, ASF1B, SF1, ZNF276, ZNF395, ZNF274, ZNF394, MEPCE, ZNF20, CDCA7, NOLC1, ZNF25, MTDH, HSPH1, RAD21, HESX1, HOXC4, ZNF264, ZNF143, CREBBP, ZNF263, JUP, ZNF260, H3F3A, PBX3, EIF2AK3, ERLIN2, ZNF35, FLI1, SOX30, SETX, CYLD, QARS, PKIA, ZNF30, ZNF136, PAM, EZH2, CDKN1C, SETD5, ARF4, BTG2, CDKN1A, SETD3, BTG1, ELL, ZNF250, TCF25, ATF7IP2, HOXC13, ZNF45, WDR43, MED12, NIPBL, CHAF1B, ING2, CIC, JARID2, TEAD2, HAVCR2, ZNF485, BRD3, HELLS, RIPK3, SPHK1, BAZ1A, SIRT7, TMEM173, MED29, SIRT2, MED28, GNL3, NCOR2, NCOR1, MTF2, MED20, RARA, ZNF350, GPS2, ZNF69, BCLAF1, UBN1, PLAGL2, DEDD, ZNF101, ZNF462, EGLN2, ZNF581, ATAD2, GTF2H4, CENPF, NFIA, NFIB, NFIC, PSMC1, ZNF213, ZNF696, MIXL1, ZNF212, LIMS1, ZNF331, NCF1, NAB1, GMNN, UBP1, ZBTB20, RORA, YEATS4, PARK7, YY1, ADORA3, ZNF207, ZNF326, ZNF688, FADS1, ZNF564, GTF2I, MAP3K5, TLE4, ZNF441, ZNF680, ZBTB32, SARS, LEMD3, PIAS2, ARMCX3, ILF3, ADNP, ZNF550, MAX, RLF, GTF2E2, BCL2L12, MED30, BAG3, TPR, ZNF549, ZNF548, ABL1, DVL3, ZNF544, TRAPPC2, ZBTB17, DR1, WFS1, NFKB1, CDK9, CNOT6, IRAK1BP1, TFCP2, COPS5, CNOT7, CDK5, YEATS2, CNOT1, SP1, SP3, MAFF, BCL3, CNOT3, CDK2, ZFP64, ZNF658, NFE2L3, ZNF777, CNOT8, MNAT1, ZNF654, ZNF532, ZNF410, NFE2L1, CIITA, BMPR2, ONECUT2, TRADD, ITGB2, PTEN, LBH, SIN3A, ZNF407, ZNF768, ZNF525, ZNF524, ZNF766, HIF1AN, PPP1R12A, PEG3, DTX3L, RFC1, ZFP91, ARNT, ZFP90, DUSP22, TFDP1, ZNF519, TFDP2, ADORA2A, ZNF516, LCOR, ZNF511, MET, ZNF630, GTF3C1, MTPN, SMARCD2, HDAC3, HDAC1, WBP2, CEBPG, NLRC4, LRP8, RBBP5, DNAJB5, TP53INP2, TP53INP1, SAP18, ASCC3, ZNF622, RBBP7, E2F7, E2F8, IRX1, TBX1, RNF20, SEMA4D, FBXL15, PNRC1, KLF6, POLR3C, ASXL2, MNDA, TRIM32, TRIM33, TCERG1, CCNK, CCNH, GFI1, IKZF1, IKZF2, UBE2L3, TIAL1, RPS6KA4, RPS6KA5, SAP130, DPF2, TRIM24, CPNE1, SOX8, FBXO5, SOX6, ATXN7L3, SFMBT2, FLT3LG, RUNX2, THAP1, RUNX1, THAP6, SFRP1, TWSG1, KARS, IL23A, BOLA3, XRN2, TRIM14, TRIB3, ANKRA2, BCORL1, PAXIP1, FOXG1, MYCBP2, GMCL1, COMMD9, HLTF, HIVEP1, SCAP, ZBED1, HIVEP2, XBP1, XRCC6, SETDB1, XRCC5, BCL11A, EAF2, STAG1, GOLGB1, RCOR3, AHCTF1, CD40, SUV39H1, OTUD7B, BRCA1, WASL, PTPRK, AATF, ZMYM2, SCML1, C1QBP, HYAL2, MLX, HRAS, TSC22D4, HBZ, SEC13, SYK, NCOA6, TSC22D3, PRMT3, TSC22D2, COMMD3, COMMD1, PPRC1, ZFX, VAV1, MLF2, TOX4, GAL, NFX1, CSDE1, TFEC, KIT, DEPDC1, MAPRE3, VGLL4, ARHGEF5, PCNA, HEATR1, NEDD8, ZNF2, TRAK1, RELA, ARNTL, PPP2CA, SERTAD3, RXRA, SERTAD2, TCEAL3, GPBP1L1, SCAND1, APBB3, NFYC, GRHL1, PER2, ITCH, NLRP12, GFI1B, HIST3H2A, TTC5, CAMK4, MARS, CAMK1, CRTC2, CD80, ARID4A, CIB1, UBE3A, WWC3, EP300, SNIP1, SSU72, ERN1, BRMS1, ZNF93, TBL1XR1, PSPC1, CCNE1, TIMELESS, PPID, CARD11, SUPT6H, AGER, STK3, NLRP2, NLRP3, RIPK1, CYTL1, SUDS3, BPTF, TFAP2A, PRNP, UBE2I, CBX4, NONO, CAV1, NFXL1, CNOT10, NFKBIA, IL6, ZSCAN2, PHF19, PICALM, USP36, PHTF2, YWHAB, CHD9, CHD8, CHD7, DDX41, LDB2, PKD2, CHD1, AFF4, CKS1B, FLCN, NUP62, GATAD1, LRRFIP1, DACT1, ARHGEF11, KLF11, KLF12, TBP, KLF13, RBM15, H2AFY, BUD31, MKL1, IRAK4, SENP2, SAFB, ARID1A, TGFBR1, DNM2, CREB3, RBL1, SETBP1, ELF4, IRF4, CAT, EAPP, ITGB3BP, MCPH1, TFPT, FAM120B, TAF1A, MTA2, ZNF189, TCFL5, SPEN, CHURC1, EYA2, ARID3B, DEK, USF2, MAPK13, CD4, TNIP1, TNIP2, TAF7, KRAS, TAF5, TAF4]
GO:0006353;DNA-templated transcription, termination;8.0;0.7980440201809971;0.7740220100904985;9.413412872875176;475.54218973470665;5.433268205826786;0.015915969130235397;0.6528575887187926;[TBP, CCNH, CPSF3, CPSF2, SSU72, GTF2H4, SETX, PABPN1, PCF11, TAF1A, XRN2, SNRPG, POLR2E, POLR1E, MNAT1]
GO:0006357;regulation of transcription by RNA polymerase II;10.0;0.43649654099988644;0.6334892823608635;7.109131426632953;248.56913769389934;1.8913682364374496;0.008319385340914571;0.5119656714299493;[TCERG1, ZNF175, CCNK, MAML1, CCNH, GFI1, ZNF292, IKZF1, IKZF2, ELK1, TIAL1, RPS6KA4, RPS6KA5, MYC, SAP130, ZXDC, DPF2, SOX8, SOX6, IER5, ATXN7L3, IER2, CDK5RAP3, DDX17, ZNF18, MEF2B, ZNF282, FLT3LG, RFX1, ZNF12, HCFC2, MED6, RUNX2, RC3H2, THAP1, RUNX1, EID1, THAP6, SFRP1, TWSG1, IL23A, RFX4, BOLA3, HOXB4, TRIB3, ANKRA2, ZNF276, ZNF395, ZNF274, ZNF394, PAXIP1, FOXG1, MEPCE, ZNF20, ZNF25, MTDH, HSPH1, RAD21, HLTF, HIVEP1, HESX1, SCAP, HOXC4, ZBED1, HIVEP2, ZNF264, ZNF143, CREBBP, XBP1, XRCC6, ZNF263, JUP, ZNF260, BCL11A, PBX3, EAF2, ERLIN2, ZNF35, FLI1, SOX30, SETX, STAG1, PKIA, ZNF30, RCOR3, ZNF136, PAM, EZH2, ARF4, AHCTF1, BTG2, CDKN1A, CD40, SETD3, ELL, ZNF250, TCF25, SUV39H1, OTUD7B, HOXC13, ZNF45, BRCA1, AATF, MED12, NIPBL, ZMYM2, C1QBP, HYAL2, MLX, CIC, JARID2, HRAS, TEAD2, HAVCR2, ZNF485, BRD3, TSC22D4, HBZ, NCOA6, TSC22D3, TSC22D2, SIRT7, TMEM173, PPRC1, ZFX, SIRT2, GNL3, TOX4, NCOR2, GAL, NCOR1, NFX1, MTF2, TFEC, MED20, KIT, RARA, ZNF350, GPS2, NEDD8, ZNF2, TRAK1, ZNF69, RELA, ARNTL, RXRA, TCEAL3, UBN1, PLAGL2, ZNF101, ZNF462, EGLN2, ZNF581, NFYC, ATAD2, GRHL1, GTF2H4, PER2, GFI1B, NFIA, NFIB, TTC5, NFIC, PSMC1, CAMK1, ZNF213, ZNF696, MIXL1, ZNF212, ZNF331, CRTC2, ARID4A, UBP1, ZBTB20, RORA, YEATS4, UBE3A, PARK7, YY1, WWC3, EP300, ZNF564, GTF2I, TLE4, ZNF441, ZNF680, SSU72, ZBTB32, SARS, LEMD3, PIAS2, ARMCX3, BRMS1, ZNF93, TBL1XR1, PSPC1, CCNE1, TIMELESS, ADNP, PPID, ZNF550, MAX, RLF, SUPT6H, BCL2L12, MED30, BAG3, TPR, ZNF549, ZNF548, ABL1, NLRP3, RIPK1, CYTL1, SUDS3, ZNF544, BPTF, TFAP2A, ZBTB17, DR1, UBE2I, CBX4, WFS1, NONO, CAV1, NFXL1, NFKB1, CDK9, NFKBIA, IL6, TFCP2, COPS5, CNOT7, YEATS2, CNOT1, SP1, SP3, MAFF, BCL3, CDK2, ZFP64, ZNF658, NFE2L3, ZNF777, MNAT1, ZNF654, ZNF532, ZNF410, NFE2L1, ZSCAN2, CIITA, BMPR2, ONECUT2, CHD8, CHD7, DDX41, LDB2, PKD2, CHD1, FLCN, SIN3A, ZNF407, GATAD1, ZNF768, ZNF525, ZNF524, ZNF766, LRRFIP1, HIF1AN, DACT1, KLF11, KLF12, TBP, KLF13, RBM15, PPP1R12A, PEG3, RFC1, H2AFY, BUD31, MKL1, ZFP91, ARNT, SENP2, SAFB, ARID1A, ZFP90, DUSP22, CREB3, TFDP1, RBL1, ZNF519, TFDP2, SETBP1, ELF4, IRF4, ZNF516, LCOR, ZNF511, EAPP, MET, MCPH1, SMARCD2, HDAC3, HDAC1, WBP2, CEBPG, LRP8, DNAJB5, SAP18, ZNF622, RBBP7, MTA2, E2F7, ZNF189, E2F8, TCFL5, IRX1, TBX1, SPEN, SEMA4D, FBXL15, ARID3B, DEK, USF2, KLF6, TNIP1, TNIP2, ASXL2, TAF7, TAF4, TRIM33]
GO:0098884;postsynaptic neurotransmitter receptor internalization;9.0;1.0;0.896240625180289;9.628524252492122;106.27993511699428;8.390779266560578;0.00355709378263404;0.8253454670833372;[SYNJ1, DNM2]
GO:0051353;positive regulation of oxidoreductase activity;5.0;0.6873818243518346;0.6339319240368375;8.560683622490766;68.71016387165909;5.905872616772578;0.002299667349651622;0.5922676121338333;[SCARB1, CCS, RIPK3, ABL1, KRAS, PARK7, ATP7A]
GO:0010848;regulation of chromatin disassembly;9.0;1.0;0.896240625180289;9.628524252492122;25.33440588765447;9.083926447120524;8.479197655747641E-4;0.8607930461318132;[MAP1S]
GO:0051351;positive regulation of ligase activity;5.0;0.7763722522362496;0.6784271379790451;8.866384200445225;31.72101275389926;7.8311634786251565;0.0010616737498149616;0.6907270763441554;[RIPK3]
GO:0051593;response to folic acid;7.0;0.8653626801206646;0.7836007053175329;9.446202695698167;113.95729645358138;7.379178354882098;0.003814048157392989;0.728290889492758;[GSN]
GO:0000738;DNA catabolic process, exonucleolytic;8.0;1.0;0.875;9.628524252492122;682.1166149099337;8.16763571524637;0.022829829235937557;0.7926932703116032;[XRN2]
GO:1904179;positive regulation of adipose tissue development;6.0;1.0;0.8231203125901445;9.628524252492122;84.15966440839325;8.16763571524637;0.0028167482289683326;0.7408135829017477;[SH3PXD2B]
GO:0045401;positive regulation of interleukin-3 biosynthetic process;8.0;1.0;0.875;9.628524252492122;833.6113263844036;9.777073627680469;0.027900220892599446;0.875;[SYK]
GO:0051091;positive regulation of DNA binding transcription factor activity;11.0;0.811012628672052;0.8379352666656883;9.431813958246067;277.8307104044464;4.2636448815154875;0.00929874384583087;0.650471949850128;[MTPN, CRTC2, CD40, TRADD, ITGB2, CEBPG, PTEN, CIB1, NLRC4, PARK7, LRP8, AGER, RELA, STK3, MTDH, RPS6KA4, RPS6KA5, EP300, NLRP3, RIPK1, CYTL1, UBE2I, JUP, RIPK3, BUD31, SPHK1, IRAK4, TMEM173, PPRC1, NFKB1, IL6, COPS5, KIT, CAT, TRIM14, KRAS, TRIM32, ARHGEF5, CARD11]
GO:0000731;DNA synthesis involved in DNA repair;8.0;0.7671156992804218;0.7585578496402109;9.369013057007038;574.6870345922199;5.8067817141283475;0.019234257863048946;0.6719590869034888;[RFC5, CDKN2D, RFC3, WRN, NPLOC4, RFC4, PCNA, RFC1, POLE2, WRNIP1]
GO:0051092;positive regulation of NF-kappaB transcription factor activity;12.0;0.9326813400603323;0.9144609826203107;9.587702257971866;279.4401483168805;4.8283137373023015;0.009352610284359957;0.6950405016553352;[MTPN, CD40, RIPK3, SPHK1, TRADD, ITGB2, CIB1, NLRC4, IRAK4, AGER, NFKB1, RELA, MTDH, RPS6KA4, RPS6KA5, CAT, TRIM14, NLRP3, RIPK1, KRAS, TRIM32, CARD11]
GO:0051090;regulation of DNA binding transcription factor activity;10.0;0.7192862368539868;0.7748841302879137;9.223059144383958;255.33763090554476;3.793137346993279;0.00854592071745993;0.6092222321850824;[CRTC2, CD40, GFI1, TRADD, ITGB2, PTEN, CIB1, PARK7, PKD2, RPS6KA4, RPS6KA5, ADORA3, EP300, CDK5RAP3, HAVCR2, RIPK3, SYK, BUD31, SPHK1, COMMD1, IRAK4, TMEM173, PPRC1, BRMS1, KIT, CAT, TRIM14, ARHGEF5, CARD11, MTPN, CEBPG, NLRC4, LRP8, AGER, RELA, STK3, MTDH, NLRP2, NLRP3, RIPK1, CYTL1, PRNP, UBE2I, JUP, WFS1, NFKB1, NFKBIA, CYLD, ITCH, NLRP12, IL6, COPS5, KRAS, TRIM32, EZH2]
GO:0045893;positive regulation of transcription, DNA-templated;10.0;0.5159906454948852;0.673236334608363;8.141425192250265;1208.1179641469014;2.4745772039531437;0.04043462102441837;0.5417910051506925;[ZNF175, CCNK, MAML1, CCNH, GFI1, ZNF292, IKZF1, GPATCH3, IKZF2, ELK1, RPS6KA4, RPS6KA5, MYC, ZXDC, DPF2, TRIM24, SOX8, SOX6, IER5, ATXN7L3, IER2, CDK5RAP3, DDX17, MEF2B, FLT3LG, MED6, RUNX2, RUNX1, SFRP1, KARS, IL23A, RFX4, HOXB4, PAXIP1, NOLC1, HSPH1, RAD21, HLTF, SCAP, HOXC4, ZBED1, ZNF143, CREBBP, XBP1, XRCC6, JUP, PBX3, EIF2AK3, EAF2, ERLIN2, FLI1, SETX, STAG1, CDKN1C, ARF4, CD40, SETD3, ELL, HOXC13, BRCA1, AATF, WDR43, MED12, NIPBL, ING2, HYAL2, MLX, HRAS, TEAD2, ZNF485, SEC13, NCOA6, SIRT7, TMEM173, PPRC1, SIRT2, GNL3, GAL, MTF2, TFEC, RARA, MAPRE3, ZNF350, HEATR1, GPS2, RELA, ARNTL, SERTAD3, BCLAF1, RXRA, SERTAD2, PLAGL2, GPBP1L1, ZNF462, NFYC, ATAD2, GRHL1, NFIA, NFIB, TTC5, NFIC, CAMK4, MARS, PSMC1, CAMK1, MIXL1, CRTC2, NCF1, CD80, ARID4A, RORA, YEATS4, UBE3A, PARK7, YY1, EP300, ZNF564, MAP3K5, PIAS2, ARMCX3, ILF3, TBL1XR1, CCNE1, MAX, RLF, SUPT6H, BCL2L12, MED30, DVL3, NLRP3, RIPK1, CYTL1, BPTF, TFAP2A, ZBTB17, DR1, NFKB1, CDK9, NFKBIA, IL6, TFCP2, COPS5, CNOT7, SP1, SP3, MAFF, BCL3, CDK2, NFE2L3, MNAT1, NFE2L1, PHF19, PICALM, CIITA, BMPR2, ONECUT2, CHD8, CHD7, DDX41, LDB2, PKD2, CKS1B, FLCN, LBH, SIN3A, NUP62, ARHGEF11, TBP, KLF13, RBM15, PPP1R12A, PEG3, DTX3L, RFC1, MKL1, ARNT, SENP2, SAFB, ARID1A, ZFP90, TGFBR1, DNM2, CREB3, TFDP1, RBL1, TFDP2, ELF4, IRF4, ZNF516, EAPP, MET, HDAC3, HDAC1, WBP2, CEBPG, TP53INP2, TP53INP1, MTA2, E2F7, E2F8, TBX1, RNF20, CHURC1, ARID3B, USF2, CD4, KLF6, TNIP1, TNIP2, ASXL2, TAF7, TAF4]
GO:0044320;cellular response to leptin stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;109.38485831558611;7.379178354882098;0.003661012767841448;0.7004918368257019;[PTEN]
GO:0018032;protein amidation;7.0;0.6954798709641801;0.6986593007392905;8.781226392104918;151.15475272427284;9.777073627680469;0.005059013543235805;0.8509193652572005;[PAM]
GO:0030148;sphingolipid biosynthetic process;7.0;0.6913464685778243;0.6965925995461126;8.992535485772125;238.8284648682076;5.288437257948329;0.007993373787475071;0.6213702925661609;[ELOVL5, SPHK2, AGK, SPHK1, ELOVL6, SGPP2, ALDH3A2, P2RX7, UGT8, SGPL1, VAPA, ALDH3B1, DEGS1, CSNK1G2]
GO:0065002;intracellular protein transmembrane transport;9.0;0.7763722522362496;0.7844267512984139;9.223059144383958;167.43526304983118;5.788089581116195;0.005603907572324205;0.6922437955322635;[PEX16, BCR, SEC61A2, RTN2, TOMM40, AGK, SRP54, TIMM44, HYOU1]
GO:0045652;regulation of megakaryocyte differentiation;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;68.9575807315309;5.845247994956144;0.0023079481692908138;0.6498456195510879;[HDAC1, RBBP5, SIN3A, H3F3A, EP300, CIB1, THBS1, TNRC6A, RUNX1]
GO:0075044;autophagy of host cells involved in interaction with symbiont;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;40.524811843842954;8.16763571524637;0.0013563289824505948;0.7408135829017477;[ULK1, ATG5]
GO:0002924;negative regulation of humoral immune response mediated by circulating immunoglobulin;10.0;0.8933024483968273;0.861892236059334;9.592156608321247;508.9965303178644;7.9853141584524145;0.017035655802601874;0.8236103492792612;[PTPN6]
GO:0045429;positive regulation of nitric oxide biosynthetic process;8.0;1.0;0.875;9.628524252492122;658.6394256443023;6.166155715036245;0.02204406883931546;0.6903374900225189;[P2RX4, ITGB2, PTX3, PKD2, DNM2]
GO:1905049;negative regulation of metallopeptidase activity;10.0;0.8933024483968273;0.861892236059334;9.59573442966913;499.6307270806722;7.9853141584524145;0.016722190796928726;0.8236103492792612;[TIMP2, TIMP1, PICALM]
GO:0038095;Fc-epsilon receptor signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;78.4757768553383;4.989581884898423;0.002626513627734276;0.6301674496329921;[FCER1G, MAP3K1, SYK, LCP2, CALM1, NFKB1, VAV1, RELA, CARD11, VAV2]
GO:0008203;cholesterol metabolic process;6.0;0.7980440201809971;0.722142322680643;9.223059144383958;82.64786032185484;5.058574756385375;0.0027661495067272364;0.581816060879476;[HSD3B7, STARD3, SCARB1, G6PD, GGPS1, ERLIN2, ACLY, SQLE, EBP, NSDHL, RXRA, CYB5R3, SOAT1, SNX17, CAT, FDXR, SCAP, APOL1, SCARF1, NFE2L1]
GO:0045666;positive regulation of neuron differentiation;8.0;0.6181399273706679;0.684069963685334;8.712233520617966;337.32148776029015;3.9481280100702625;0.011289846625707336;0.576907450041722;[BMPR2, FOXG1, TWF2, PTEN, TRAK1, LRP8, CYB5D2, RAB21, NCKIPSD, CPNE1, TIMP2, DVL3, ECT2, SCARF1, MARK2, ACTR2, TMEM30A, SEMA4D, TNFRSF12A, SERPINF1, RAB11A, NME1, SETX, FES, RUFY3, CAPRIN1, RAPGEF1, RARA, CAMK1, ADNP, TRIM32, PAFAH1B1, EZH2]
GO:0045663;positive regulation of myoblast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;114.26328322821418;6.7325511899570465;0.00382428925936973;0.6674232935401965;[BTG1, FLT3LG, HIF1AN, MAP3K5]
GO:0007595;lactation;6.0;1.0;0.8231203125901445;9.628524252492122;25.956233089099676;5.9928839937622085;8.687317623989867E-4;0.6295966787287501;[OXTR, PPAT, CAV1, ABCB4, CAD, ATP7A, USF2, PAM, NME1]
GO:0038096;Fc-gamma receptor signaling pathway involved in phagocytosis;10.0;1.0;0.9152410118609203;9.628524252492122;384.64074149301706;4.886724499458715;0.01287357946357817;0.6651483300191682;[CYFIP2, NCKAP1, ACTR2, SYK, WIPF2, ARPC1A, WAS, WASL, VAV1, VAV2, NCKIPSD, ARPC2, ELMO1, ABL1, NCKAP1L]
GO:0045669;positive regulation of osteoblast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.56398573135455;169.86351353303945;5.734022359845919;0.005685178930713632;0.6163584827319739;[IL6, BMPR2, TMEM119, FAM20C, RUNX2]
GO:0045667;regulation of osteoblast differentiation;5.0;0.8259837884571596;0.7032329060895001;9.405380701177911;40.22549681874724;5.067543426368135;0.001346311177926675;0.5493954183502558;[HEMGN, BMPR2, IGFBP5, SEMA4D, RUNX2, PIAS2, SFRP1, TWSG1, IL6, CDK6, RASSF2, TMEM119, FAM20C]
GO:0048935;peripheral nervous system neuron development;5.0;1.0;0.7902410118609202;9.628524252492122;34.232648149996464;7.474488534686424;0.0011457359261972313;0.6724867031240476;[ONECUT2, RUNX1]
GO:0045425;positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process;8.0;1.0;0.875;9.628524252492122;833.6113263844036;9.083926447120524;0.027900220892599446;0.839552420951524;[SYK, CD80]
GO:0110053;regulation of actin filament organization;8.0;0.6281612110245125;0.6890806055122563;8.465373442686442;54.28302931840981;4.22799754278525;0.0018168041397325012;0.5912199909600306;[PTGER4, MTPN, NCKAP1, GMFB, WDR1, ROCK2, WIPF2, ARPC1A, TWF2, WAS, WASL, IQGAP2, CORO1A, PREX1, BAG4, CAPZB, CFL1, SH3PXD2B, PPFIA1, ABL1, NCKAP1L, ARFIP1, CLASP1, S100A10, VASP, ACTR2, GSN, SWAP70, SSH3, SPTB, TGFBR1, CIT, SSH1, VIL1, SFRP1, ARPC2, CDC42EP4, MYADM, EPHA1, MET, ARHGEF5, C9orf72]
GO:0043249;erythrocyte maturation;4.0;0.8933024483968273;0.6966512241984136;9.377209824211215;39.55885145263534;7.138016298065211;0.0013239991574647877;0.6150384854347593;[HBZ, G6PD]
GO:0043491;protein kinase B signaling;6.0;1.0;0.8231203125901445;9.628524252492122;26.42836680105094;6.250713103064308;8.845336528452411E-4;0.6427820713687392;[SETX, CD40, CCL5, PTEN, SIRT2]
GO:0045670;regulation of osteoclast differentiation;8.0;0.8259837884571596;0.7879918942285797;9.485423408851448;139.67875005531917;5.587418885654044;0.0046749220616377945;0.6607408616538982;[SFRP1, RASSF2, IL23A, CAMK4, GPR55, LILRB3]
GO:0043011;myeloid dendritic cell differentiation;6.0;0.8933024483968273;0.7697715367885581;9.4949928598676;91.1712242271392;6.8867018697843045;0.003051418826107602;0.6753065664753021;[IRF4, CAMK4, UBD, LTBR]
GO:0033630;positive regulation of cell adhesion mediated by integrin;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;34.61675044652454;6.943860283624253;0.0011585914843924019;0.6453503496879909;[SYK, CCL5, CIB1, NCKAP1L, PTPN6]
GO:0035810;positive regulation of urine volume;5.0;0.9326813400603323;0.7565816818910864;9.510741216835738;23.90496242438734;7.138016298065211;8.000775792748091E-4;0.6552794972956795;[ADORA2A, HYAL2]
GO:0048709;oligodendrocyte differentiation;5.0;0.8933024483968273;0.736892236059334;9.34084218004034;23.145667324477426;6.518977089658987;7.746646556020492E-4;0.623621803389518;[CDKN2C, CDK5, SOX8, TSPAN2, CSK]
GO:0044344;cellular response to fibroblast growth factor stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;97.48528473772916;6.444869117505266;0.003262744749111514;0.6527112189764278;[SETX, TBX1, SFRP1, CCL5, HYAL2]
GO:0038083;peptidyl-tyrosine autophosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;522.6399477532146;5.905872616772578;0.017492288705884526;0.7172676121338334;[SYK, FES, ABL1, CSK, IGF1R]
GO:0048701;embryonic cranial skeleton morphogenesis;6.0;1.0;0.8231203125901445;9.628524252492122;46.18089108149027;6.280566066213989;0.0015456328643938164;0.6443087532925187;[TBX1, TFAP2A, EIF4A3, RUNX2, TGFBR1]
GO:0009306;protein secretion;8.0;0.5696777571895439;0.659838878594772;7.923776160253697;130.2874189859313;4.786641040901733;0.004360602662394617;0.6197890454332871;[RAB3B, STEAP3, SUCNR1, ANXA1, RAB3D, FGG, MIA3, NLRC4, BTN3A2, PARK7, GAL, SNX19, GPAM, NLRP3, LCP2, ITGAV, CCL19, CARD11, PAFAH1B1, RAB8B]
GO:0044351;macropinocytosis;7.0;0.8653626801206646;0.7836007053175329;9.405380701177911;29.536082298666074;7.8311634786251565;9.88546093788053E-4;0.7514054297404357;[DOCK2, DNM2]
GO:1990314;cellular response to insulin-like growth factor stimulus;8.0;1.0;0.875;9.628524252492122;388.66587636398185;7.57984905034425;0.013008297105323164;0.7626338329336335;[PTEN]
GO:0002902;regulation of B cell apoptotic process;9.0;0.7369933605727446;0.7647373054666613;9.117698628726131;22.875998380894767;6.8867018697843045;7.656390787466303E-4;0.7484268790654467;[PTEN]
GO:0030593;neutrophil chemotaxis;9.0;1.0;0.896240625180289;9.628524252492122;130.2972973825895;5.382624473008031;0.004360933283440787;0.671508291047556;[CXCL6, PREX1, FCER1G, SYK, CCL20, CCL5, ITGB2, NCKAP1L, CCL19, VAV1, PIK3CG]
GO:0032532;regulation of microvillus length;8.0;0.8653626801206646;0.8076813400603323;9.446202695698167;49.286089413540054;7.8311634786251565;0.0016495610580704579;0.7754860644832351;[VIL1, TWF2]
GO:0010764;negative regulation of fibroblast migration;8.0;0.9326813400603323;0.8413406700301662;9.567899630675686;202.31180315966054;7.8311634786251565;0.006771193982951902;0.7754860644832351;[HYAL2]
GO:0030111;regulation of Wnt signaling pathway;6.0;0.5902001590945054;0.6182203921373972;7.99439372746765;41.8512380110395;4.069963362931594;0.0014007232725606145;0.5312584282431182;[HDAC1, CHD8, USP34, KLHL12, APCDD1, STK4, ARNTL, STK3, PPP2CA, MED12, RNF213, UBR5, ABL1, DVL3, EMD, DACT1, TLE4, USP8, CSNK2A1, JUP, CAV1, SENP2, NFKB1, RUNX1, CYLD, DEPDC1B, SFRP1, TBL1XR1, GNAQ, RAPGEF1, TAX1BP3]
GO:0033622;integrin activation;5.0;1.0;0.7902410118609202;9.628524252492122;40.42272244673708;7.57984905034425;0.0013529121422039536;0.6778748447945537;[TLN1]
GO:0032534;regulation of microvillus assembly;8.0;0.8933024483968273;0.8216512241984136;9.461470167828956;72.33391722527347;7.9853141584524145;0.00242095111323081;0.7833693374183408;[PLD1]
GO:1905461;positive regulation of vascular associated smooth muscle cell apoptotic process;10.0;1.0;0.9152410118609203;9.628524252492122;149.5070754231924;7.9853141584524145;0.005003867266781941;0.8236103492792612;[MFN2, STK4]
GO:0061099;negative regulation of protein tyrosine kinase activity;11.0;0.8653626801206646;0.8651102923899945;9.55953138100517;2158.5537617243776;6.481236761676141;0.07224485183265184;0.7638797017301124;[ERRFI1, SH3BP5L, CAV1, HYAL2, FGFR1OP, CHMP6]
GO:0007179;transforming growth factor beta receptor signaling pathway;8.0;0.7586651285174919;0.754332564258746;9.05316010758856;29.903672154863813;5.2552850506314295;0.0010008489954655988;0.6437555218850388;[DUSP22, TWSG1, FUT8, COL1A2, BMPR2, PTPRK, TGFBR1]
GO:0045600;positive regulation of fat cell differentiation;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;114.26328322821418;5.71663061713405;0.00382428925936973;0.6154690682008903;[SFRP1, XBP1, ASXL2, SH3PXD2B, STK4, METRNL, STK3]
GO:0051291;protein heterooligomerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;5.113634533568402;0.00140677858073304;0.5846318204451575;[HBZ, RRM1, SEPT11, XRCC6, CPSF6, JUP, RIPK3, YWHAB, TRADD, IKZF1, HSD17B8, PRKAB1, GCHFR, BAG4, COL1A2, NUP62, RIPK1, HRAS, S100A10]
GO:0009117;nucleotide metabolic process;7.0;0.4444416221570314;0.5731401763357162;7.314889323311491;170.44217484987414;3.7109655375767217;0.005704546204226714;0.5406983154264199;[GPI, ADPGK, ADK, RORA, PARK7, NADSYN1, NUDT3, GPHN, AQP1, HK3, NNT, FLAD1, PPAT, NPPA, TK2, NUDT15, G6PD, TPI1, ACOT7, DCAKD, DCXR, CAD, TALDO1, BPGM, ATP5F1, COASY, NME1, ACLY, KARS, MTHFD1, ADORA2A, IMPAD1, MTHFD2L, FAM20C, ALDOC, ALDOA, ACPP, GAPDH, CARD11, PRPS2, STOML2, PNKP, AK2, ADCY4, ATP5J, AK3, ATP5I, COX5B, ATP5O, ATP5L, UNG, PRPSAP1, SULT1A1, ATP6V0A2, PDE6B, CYC1, SULT1A3, RRM1, DUT, IDH2, CTNS, NMNAT3, RPIA, SMUG1, UCK2, IMPDH1, IMPDH2, TJP2]
GO:0051289;protein homotetramerization;7.0;1.0;0.8509193652572005;9.628524252492122;85.45061507946225;5.433268205826786;0.002859955186148837;0.6287769539759931;[VASP, CRTC2, GPX3, DCXR, ATPIF1, PKD2, ACACA, GLS, RXRA, ALDH5A1, IMPDH2, PPAT, CAT, ALDOA, ACPP]
GO:0051045;negative regulation of membrane protein ectodomain proteolysis;9.0;1.0;0.896240625180289;9.628524252492122;966.2736676900156;7.697632086000634;0.032340310067742455;0.7898978880348613;[TIMP2, LRIG2, TIMP1]
GO:0010592;positive regulation of lamellipodium assembly;9.0;1.0;0.896240625180289;9.628524252492122;310.04759849733875;6.8867018697843045;0.010377014096983099;0.7484268790654467;[NCKAP1, ARPC2, TWF2, ATP7A, DNM2]
GO:0033690;positive regulation of osteoblast proliferation;6.0;1.0;0.8231203125901445;9.628524252492122;63.05258358394898;7.379178354882098;0.0021103132289136558;0.7004918368257019;[ABL1, TMEM119, SOX8, ITGAV]
GO:0045618;positive regulation of keratinocyte differentiation;8.0;0.9326813400603323;0.8413406700301662;9.57973408832269;360.6004015365146;7.069023426578259;0.012068970920135338;0.7365101867784198;[H2AFY]
GO:0010591;regulation of lamellipodium assembly;8.0;0.8933024483968273;0.8216512241984136;9.461470167828956;72.62159929772238;6.343086423195323;0.0024305795732986186;0.6993857346658935;[NCKAP1, BIN3, ARPC2, CAPZB, TWF2, WAS, ATP7A, SSH3, SSH1, DNM2]
GO:0006094;gluconeogenesis;7.0;1.0;0.8509193652572005;9.628524252492122;174.6088252776196;5.926926025970411;0.005844000244301424;0.6540226378555745;[PER2, GPI, CRTC2, TPI1, G6PC3, SLC25A10, ALDOC, BPGM, ALDOA, GAPDH]
GO:0045616;regulation of keratinocyte differentiation;7.0;0.8259837884571596;0.7639112594857803;9.461470167828956;71.48722327515921;6.113511981550823;0.002392613028695569;0.663564652301091;[ERRFI1, H2AFY, ROCK2, CTSK, GRHL1, AQP3, RUNX1]
GO:0007186;G-protein coupled receptor signaling pathway;5.0;0.5508212674310002;0.5656516455764204;7.20077601654407;23.17027026302992;2.605416804911955;7.75488093814194E-4;0.4234821484283897;[CXCL6, OXTR, AHCYL1, DGKD, DGKA, DEFB1, PIK3CG, HEBP1, AKAP13, PREX1, GPR132, GNAT2, RGS1, ADORA3, NPPA, OR56B1, HOMER3, CCR2, PDGFRB, ARHGEF11, ANXA1, SPHK2, SPHK1, RHOC, VAV1, VAV2, RHOB, SFRP1, GAL, ADORA2A, SPNS1, ARHGEF1, DAGLB, GPRC5D, ARHGEF5, XPR1, PTGER4, SUCNR1, RGS19, ROCK2, ADCY4, IQGAP2, CRHR1, RIC8A, C3, ABR, GNG2, TBXA2R, HRH2, CCL5, GRK6, CCL19, ECT2, NTSR1, CCR10, SULT1A3, SLC12A2, CCL20, CAV1, GPR55, TSHR, BAIAP3, GPR180, GNAQ, GNB2, PNOC, NMUR1, CALM3, PTPN6, CALM1, CALM2]
GO:0006098;pentose-phosphate shunt;11.0;1.0;0.9324289523296623;9.628524252492122;549.7873240273956;7.212124270218933;0.018400886958728914;0.8012573229067359;[RPIA, G6PD, TALDO1]
GO:0030182;neuron differentiation;4.0;0.5833093054345528;0.5416546527172764;7.212610474191073;21.066225782797595;4.296434704338478;7.050676185779127E-4;0.4697198705845162;[MTPN, PIGT, RYK, ROM1, PAPD4, RORA, RUNX2, RUNX1, PPP1CC, SFRP1, HERC1, CDK5, CASP3, DDIT4, XRN2, SOX8, ATP7A, IER2, PAFAH1B1]
GO:0007187;G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger;6.0;0.6997970393407541;0.6730188322605215;8.578702127993445;26.976932752798508;4.347727998726029;9.028936615729279E-4;0.5454633246350222;[PTGER4, ANXA1, ADCY4, CRHR1, TSHR, RIC8A, AKAP13, GNG2, GNAT2, ADORA2A, RGS1, TBXA2R, HRH2, GNAQ]
GO:0061086;negative regulation of histone H3-K27 methylation;11.0;0.9326813400603323;0.8987696223598284;9.59953671561887;804.8473500351352;8.390779266560578;0.026937516490087493;0.8615337942327104;[H2AFY, MTF2, SUPT6H]
GO:0031274;positive regulation of pseudopodium assembly;9.0;0.9326813400603323;0.8625812952104552;9.571365838652174;200.71212349518538;7.212124270218933;0.006717654144200148;0.7650689957573628;[CDC42EP4, KIT]
GO:0031032;actomyosin structure organization;6.0;0.7192862368539868;0.682763431017138;8.763526815005518;32.01253927882412;5.16195311083921;0.001071430880247358;0.5871028347338303;[PDGFRB, ITGB1, PDCD6IP, RTKN, WDR1, EPB41, MYH9, KIF23]
GO:0008277;regulation of G-protein coupled receptor protein signaling pathway;6.0;0.5383299095163034;0.5922852673482962;7.5335785242763205;41.8512380110395;4.8942717050940985;0.0014007232725606145;0.5734135951955668;[PDE6H, MGRN1, YWHAB, RASGRP4, C3, RGS1, CCL5, GRK6, PDE6B, CALM1, ACPP, MET, MGLL, METAP2]
GO:0042102;positive regulation of T cell proliferation;9.0;0.7763722522362496;0.7844267512984139;9.424925297250882;564.8543510249671;5.212725436212633;0.018905166792893686;0.6628196464047262;[TFRC, CD80, EBI3, CORO1A, AGER, HLA-DMB, CCL5, NCKAP1L, IL12A, CCL19, IL12RB1, CCR2, HLA-DPA1, HAVCR2, ANXA1, SYK, PDCD1LG2, CCDC88B, CD4, IL6, GPAM, IL23A, HLA-DPB1, CD24, CARD11]
GO:0000302;response to reactive oxygen species;4.0;0.7090535922965819;0.604526796148291;8.781226392104918;25.335607989987928;4.595290077388384;8.479599988580431E-4;0.4850033482604845;[BECN1, PCNA, NCF1, PARK7, PTPRK, PKD2, RELA, AQP1, CASP3, HYAL2, ABL1, KPNA4, CCL19, ECT2, MAP3K5, PDGFRB, ANXA1, TXNRD1, RHOB, MAPK13, DNM2, SETX, IL6, PXMP2, CDK2, CAT, PPIF, SDC1, EZH2]
GO:0043434;response to peptide hormone;6.0;0.6696747006330769;0.657957662906683;8.712233520617966;71.32532737153224;4.149452513989832;0.0023871945184980284;0.5353235071248601;[ERRFI1, BTG2, OXTR, BTG1, MAX, ABCB4, ADCY4, PTEN, CRHR1, RELA, RAP1B, PPAT, NPPA, SCAP, CSK, CYC1, TIMP1, RAB8B, EIF2B4, XBP1, ABCC2, ANXA1, IGFBP5, CAV1, CAD, TSHR, NFKB1, RNF40, GAL, SP1, MARS, RAB13, CAT, TRIB3, TEK]
GO:0033209;tumor necrosis factor-mediated signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.510741216835738;30.19135422731818;5.395046993006588;0.00101047745553359;0.6268223193749;[CD40, TNFRSF12A, CD70, TRADD, TNFRSF10B, TNFRSF10A, RELA, NFKBIA, BAG4, KARS, RIPK1, LTBR, LIMS1]
GO:0045860;positive regulation of protein kinase activity;10.0;0.6281612110245125;0.7293216173731766;9.003430535177193;1094.9224192180604;3.5309668621989068;0.03664606800502658;0.5958148214005239;[CDKN1A, CD40, CCNK, NCF1, CCNH, ITGB3, KIF14, CIB1, PARK7, PKD2, PIK3CG, CKS1B, AKAP13, RASSF2, NEK1, HRAS, MAP3K5, PDGFRB, DUSP5, MAP4K2, DBNL, RIPK3, SYK, ZFP91, OXSR1, MAPK8IP3, TGFBR1, ERN1, KARS, ALS2, IL23A, KIT, MADD, RAPGEF1, JTB, MTCP1, LCP2, MAPRE3, ADNP, ARHGEF5, STK4, LRP8, THBS1, AGER, STK3, PPP2CA, CCNB1, HSPH1, CCL5, ABL1, DVL3, NCKAP1L, RIPK1, CSK, CCL19, ECT2, MARK2, MAP3K3, PRNP, XRCC6, MAP3K1, PDE6H, ANGPT1, XRCC5, TNFRSF10B, TNFRSF10A, PILRB, P2RX7, CENPE, CCDC88A, CD4, CDK5, TAOK2, KRAS, CALM3, CAMK1, CALM1, MNAT1, CD24, CALM2, EZH2]
GO:0051056;regulation of small GTPase mediated signal transduction;7.0;0.6799073451904818;0.6908730378524415;8.647694999480395;45.070113835906206;4.018171853803189;0.001508456149618737;0.5564088607247961;[ITGB1, DENND1A, KIF14, ARHGAP1, FLCN, AKAP13, PREX1, RASGEF1A, PSD4, NUP62, ARHGDIB, TIMP2, HRAS, PDGFRB, ARHGEF11, RHOC, GMIP, VAV1, VAV2, RHOB, DNM2, BCR, ITPKB, DEPDC1B, ALS2, MADD, RAPGEF1, ARHGEF1, RHOU, MET, ARHGEF5, RASGRP4, ABR, ARHGAP21, RHOT2, RHOT1, ABL1, MFN2, ECT2, A2M, ARFGEF2, STARD13, GPR55, MYO9B, ARHGAP26, ARHGAP25, ARHGAP30, KRAS, SPRY1]
GO:0051295;establishment of meiotic spindle localization;7.0;0.9326813400603323;0.8172600352873667;9.577230958104572;112.08033072751472;8.16763571524637;0.0037512278037010217;0.7686126355688037;[MYH9]
GO:0032355;response to estradiol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;74.25476231829794;4.940791720728991;0.0024852400698459885;0.542913330229313;[PDGFRB, OXTR, ENDOG, PCNA, ANXA1, ITGA2, ABCB4, PTEN, CD4, SFRP1, CASP3, CAT, RARA, PAM, EZH2]
GO:0030178;negative regulation of Wnt signaling pathway;7.0;0.6835726970475526;0.6927057137809769;8.781226392104918;188.91844949246428;4.7018998124466425;0.006322930488946581;0.591374740326424;[TLE4, HDAC1, CAV1, CHD8, KLHL12, APCDD1, STK4, STK3, MED12, CYLD, SFRP1, RNF213, RAPGEF1, DVL3, TAX1BP3, EMD, DACT1]
GO:0035627;ceramide transport;6.0;0.8436909121759173;0.7449657686781032;9.223059144383958;35.67391733827648;7.379178354882098;0.0011939739088709061;0.7004918368257019;[GLTP, ABCA12]
GO:0046718;viral entry into host cell;7.0;0.7671156992804218;0.7344772148974115;8.935377071932177;28.374411874040543;5.346256828837156;9.496660301113433E-4;0.6243271881103005;[ITGB1, VPS18, SCARB1, GYPA, TFRC, SIVA1, ITGB3, ITGA2, CD80, NUP153, VAMP8, ITCH, CLDN9, HYAL2, NCAM1, ITGAV, XPR1]
GO:0045629;negative regulation of T-helper 2 cell differentiation;13.0;1.0;0.9625549647676366;9.628524252492122;2589.4439345822343;8.390779266560578;0.08666635814222527;0.8916598066706847;[ANXA1]
GO:0042119;neutrophil activation;6.0;0.8933024483968273;0.7697715367885581;9.4949928598676;20.951462914457938;3.578594911188161;7.012266086544604E-4;0.5061298227699893;[SERPINA3, PYGB, CXCL6, GPI, SIGLEC9, FRMPD3, RAB3D, ITGB2, HK3, PREX1, PSMD7, ACTR1B, PSMD2, LAMP2, CPNE1, TIMP2, CTSH, ITGAV, CPNE3, CAPN1, GUSB, SNAP29, CAP1, ACTR2, SERPINB1, FCER1G, DBNL, SYK, PLAUR, COMMD3, RNASE3, TMEM173, SCAMP1, UNC13D, SERPINB6, VAMP8, ACLY, CAT, TMBIM1, ALDOC, DOCK2, ALDOA, ACPP, SLC27A2, DNASE1L3, KPNB1, CSTB, PDXK, RAB5C, CLEC12A, UBR4, IQGAP2, LILRA2, PLD1, C3, RAP1B, COMMD9, CYB5R3, CCL5, ALDH3B1, PSMB1, NCKAP1L, RAB6A, AP1M1, CTSA, XRCC6, TMEM30A, RAB4B, GSN, JUP, XRCC5, HSPA6, SURF4, LILRB3, NFKB1, FABP5, VAPA, IMPDH1, IMPDH2, RAB18, PTX3, MNDA, DEGS1, MAN2B1, PTPN6]
GO:0045627;positive regulation of T-helper 1 cell differentiation;13.0;1.0;0.9625549647676366;9.628524252492122;2605.164725512912;7.9853141584524145;0.08719251886688177;0.8709243021859774;[ANXA1, CD80, CCL19]
GO:0006068;ethanol catabolic process;7.0;1.0;0.8509193652572005;9.628524252492122;292.83912655610527;7.292166977892469;0.009801062027729285;0.7238411236270654;[SULT1A1, ALDH3B1, SULT1A3]
GO:1905007;positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation;8.0;1.0;0.875;9.628524252492122;277.7728422204446;8.16763571524637;0.009296807049790315;0.7926932703116032;[TGFBR1]
GO:0043687;post-translational protein modification;7.0;0.6467165523344657;0.6742776414244334;8.507933057105237;151.15475272427284;3.8799197600437285;0.005059013543235805;0.5493386422205575;[PRKCSH, SERPINA10, CCNF, MIA3, MSLN, PSMD8, PSMD7, PSMD4, PSMD2, TIMP1, SKP2, FGA, IGFBP5, ESCO1, FGG, COMMD1, RABGGTA, SUMF1, DDB1, PSMA1, PSME2, FAM20C, RAB38, ITIH2, GPS1, RAB1B, COPS7B, NEDD8, COPS7A, PSMB10, PSMA7, HSP90B1, C3, TGOLN2, PSMB5, RBBP5, UBD, PSMB1, RBBP7, APOL1, ATG5, KLHL25, WFS1, FEM1B, RHBDD1, FBXL15, FBXL16, BTBD6, RAB11A, IL6, SPSB1, COPS5, PSMC1, ASB8, RAB13, STT3A, CALU, FBXL3, ASB3, KBTBD8]
GO:0097264;self proteolysis;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;49.64990487012002;7.697632086000634;0.001661737633989536;0.7167775754447168;[CAPN1]
GO:0035855;megakaryocyte development;5.0;1.0;0.7902410118609202;9.628524252492122;66.38585475831493;7.069023426578259;0.0022218748153703875;0.6517511986393402;[KIT, EP300, PTPN6, FLI1]
GO:0006071;glycerol metabolic process;7.0;0.7866048967936545;0.7442218136540277;9.303101852057495;71.14030572701571;6.832634648514029;0.0023810020105647298;0.7003406189322132;[COQ3, COQ2, TPI1]
GO:1903077;negative regulation of protein localization to plasma membrane;8.0;0.8436909121759173;0.7968454560879586;9.4949928598676;218.53196919702376;6.686031174322154;0.007314068343020746;0.7169239451870815;[TMBIM1, PPFIA1, CSK, PICALM]
GO:0009101;glycoprotein biosynthetic process;6.0;0.7436939687323844;0.6949672969563367;9.223059144383958;293.39385102615995;6.015873511986907;0.009819628156522405;0.6307723637598831;[EXTL2, BMPR2, TNIP1, CYTL1, ATP7A]
GO:0045630;positive regulation of T-helper 2 cell differentiation;13.0;1.0;0.9625549647676366;9.628524252492122;2538.1941708228874;7.8311634786251565;0.08495107467099283;0.8630410292508717;[IL4R, RARA, NLRP3]
GO:0019370;leukotriene biosynthetic process;8.0;0.8653626801206646;0.8076813400603323;9.488762310116963;324.40599840797483;6.781341354126479;0.010857576820271119;0.7217981122146513;[SYK]
GO:0035606;peptidyl-cysteine S-trans-nitrosylation;10.0;1.0;0.9152410118609203;9.628524252492122;309.9752588804085;9.083926447120524;0.010374592955105871;0.8797934328124444;[GAPDH]
GO:2000504;positive regulation of blood vessel remodeling;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;73.90018610244502;8.67846133901236;0.002473372722999268;0.7669372290569613;[TMBIM1]
GO:0042130;negative regulation of T cell proliferation;9.0;0.7763722522362496;0.7844267512984139;9.424925297250882;581.9323154417883;5.734022359845919;0.01947675089275457;0.6894787953221185;[PRNP, ITCH, TWSG1, CD80, CASP3, GLMN, CTLA4, PTPN6, PDCD1LG2, HAVCR2]
GO:0010569;regulation of double-strand break repair via homologous recombination;9.0;0.8436909121759173;0.8180860812682478;9.523163736834295;184.48234756552796;6.221725566191056;0.00617445814968456;0.7144199599751273;[RAD51AP1, POLQ, RAD51, PPP4C, FBXO18, USP51, ZNF365]
GO:0032331;negative regulation of chondrocyte differentiation;7.0;0.8933024483968273;0.7975705894556142;9.567899630675686;230.26794502196225;6.781341354126479;0.007706860892188918;0.6977174774718518;[TGFBR1]
GO:0071901;negative regulation of protein serine/threonine kinase activity;11.0;0.7369933605727446;0.8009256326160346;9.385578073881732;1262.8536775520981;4.8942717050940985;0.0422665760931464;0.6827222349350845;[CDKN1C, CDKN1A, GPS1, PTEN, GPS2, CIB1, PTPN22, DUSP14, PPP2CA, CASP3, HYAL2, NUP62, STK38, ABL1, CDK5RAP3, CDKN2D, DUSP5, CDKN2C, H2AFY, CAV1, PAQR3, DUSP22, SFRP1, CDK6, PKIA, SPRY1, PTPN6]
GO:0031087;deadenylation-independent decapping of nuclear-transcribed mRNA;7.0;0.9326813400603323;0.8172600352873667;9.56398573135455;114.44564401843101;7.9853141584524145;0.0038303927109042315;0.7592887026755414;[DCP1A, PNRC1]
GO:0008064;regulation of actin polymerization or depolymerization;9.0;0.6729672293956388;0.7327242398781084;9.05316010758856;119.88573797499163;4.556717802602145;0.004012467759863614;0.6292713855144111;[MTPN, NCKAP1, GMFB, WDR1, WIPF2, ARPC1A, TWF2, WAS, WASL, IQGAP2, CORO1A, PREX1, BAG4, CAPZB, CFL1, NCKAP1L, ARFIP1, VASP, ACTR2, GSN, SWAP70, SSH3, SPTB, CIT, SSH1, VIL1, ARPC2, CDC42EP4, MYADM]
GO:0048515;spermatid differentiation;4.0;1.0;0.75;9.628524252492122;60.59721651971341;8.16763571524637;0.002028134302960584;0.6676932703116032;[RHBDD1, TMEM119]
GO:0046579;positive regulation of Ras protein signal transduction;9.0;0.8259837884571596;0.8092325194088689;9.394909401310617;287.86983276338884;5.905872616772578;0.009634744236561129;0.6982672254532021;[PDGFRB, ITPKB, AKAP13, ALS2, RASGEF1A, GPR55, KRAS, HRAS, RASGRP4]
GO:0009157;deoxyribonucleoside monophosphate biosynthetic process;9.0;0.7763722522362496;0.7844267512984139;9.478992518521158;899.5024035803052;7.379178354882098;0.030105535948226757;0.7736121494158466;[DUT, TK2]
GO:0090050;positive regulation of cell migration involved in sprouting angiogenesis;11.0;1.0;0.9324289523296623;9.628524252492122;645.2358217485536;6.7325511899570465;0.021595462279385098;0.7767319332797141;[MAP3K3, ANXA1, ABL1, CIB1]
GO:1903923;positive regulation of protein processing in phagocytic vesicle;10.0;1.0;0.9152410118609203;9.628524252492122;819.0285373556242;9.083926447120524;0.027412148067464264;0.8797934328124444;[GSN, MYH9]
GO:0061734;parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization;11.0;1.0;0.9324289523296623;9.628524252492122;1245.9766177902136;8.16763571524637;0.0417017160912838;0.8501222226412654;[MFN2]
GO:1903917;positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;1202.2252293636348;9.777073627680469;0.04023739649433943;0.9152410118609203;[PPP1R15A]
GO:0001666;response to hypoxia;5.0;0.811012628672052;0.6957473261969462;9.117698628726131;21.16160540946;4.1860866471696125;7.082598888462125E-4;0.5043176776701113;[BECN1, SUV39H1, ABCB4, PTEN, ITPR2, RORA, THBS1, AQP3, AGER, TM9SF4, HSP90B1, AQP1, NPEPPS, ALKBH5, CCNB1, MYC, FUNDC1, CASP3, NPPA, LMNA, UBQLN1, EP300, SCAP, ATP7A, CREBBP, EGLN2, ENDOG, ITGA2, CAV1, ARNT, SIRT2, SFRP1, TBL2, DDIT4, CAT, HYOU1, TEK, CD24, PAM, KCNK3]
GO:0046580;negative regulation of Ras protein signal transduction;9.0;0.8259837884571596;0.8092325194088689;9.394909401310617;288.24654468039586;5.885253329569843;0.009647352445404638;0.6972127541467594;[ITGB1, FLCN, NUP62, RAPGEF1, TIMP2, MFN2, SPRY1, MET]
GO:0002755;MyD88-dependent toll-like receptor signaling pathway;12.0;0.8933024483968273;0.8947715367885583;9.5544162803384;412.6549923027037;6.280566066213989;0.013811191226989502;0.7693087532925187;[MAP3K1, TNIP1, TLR7, IRAK4]
GO:1903919;negative regulation of actin filament severing;6.0;1.0;0.8231203125901445;9.628524252492122;41.94029430001795;9.777073627680469;0.0014037039064072668;0.8231203125901445;[MYH9]
GO:0045010;actin nucleation;12.0;0.8933024483968273;0.8947715367885583;9.572954401337311;481.27193714664344;6.250713103064308;0.016107738619675037;0.7677820713687393;[VIL1, ACTR2, GSN, ARPC2, ARPC1A, IQGAP2]
GO:0050832;defense response to fungus;6.0;0.8653626801206646;0.7558016526504768;9.387362195675234;69.94032091756767;6.193554689224359;0.002340839598908718;0.6398589874268261;[GAPDH]
GO:0071539;protein localization to centrosome;9.0;0.9326813400603323;0.8625812952104552;9.541512875502493;37.378778991281564;6.781341354126479;0.0012510340941211122;0.7430387373949403;[DCTN2, GOLGB1, MCPH1]
GO:0010390;histone monoubiquitination;11.0;0.8933024483968273;0.8790801765280758;9.589303539338841;498.95626046972137;6.375876246018314;0.016699617006440744;0.7584915600596062;[DDB1, RNF20, DTX3L, ATXN7L3, RNF40]
GO:0031076;embryonic camera-type eye development;7.0;1.0;0.8509193652572005;9.628524252492122;37.007636568074005;7.212124270218933;0.0012386122912228506;0.7197477358342742;[RARA]
GO:0009165;nucleotide biosynthetic process;8.0;0.5302988655260388;0.6401494327630194;8.295339716686179;725.1038699111774;4.326035174114769;0.024268573974811393;0.5962336399854383;[PRPS2, GPI, STOML2, ADPGK, ADK, AK2, ADCY4, ATP5J, ATP5I, COX5B, ATP5O, NADSYN1, ATP5L, AQP1, PRPSAP1, HK3, FLAD1, PPAT, NPPA, ATP6V0A2, TK2, CYC1, RRM1, DUT, TPI1, ACOT7, DCAKD, IDH2, CAD, NMNAT3, BPGM, ATP5F1, COASY, NME1, UCK2, KARS, MTHFD1, ADORA2A, IMPDH1, IMPDH2, MTHFD2L, ALDOC, ALDOA, GAPDH]
GO:1902600;proton transmembrane transport;8.0;0.7586651285174919;0.754332564258746;9.117698628726131;95.86613314633948;4.835431205071165;0.0032085532024895276;0.6222841766978864;[SLC36A1, SLC25A3, STOML2, COX15, COX4I1, ATP5J, ATP5I, COX5B, ATP5O, COX6A1, CLCN3, ATP5F1, ATP5L, COX7A2L, SLC9A6, NDUFS7, NNT, SLC9A8, ATP6V0A2, CYC1, ATP6V1F]
GO:0046104;thymidine metabolic process;9.0;0.8933024483968273;0.8428918493787028;9.541512875502493;399.2486070631531;8.390779266560578;0.013362491577985136;0.8253454670833372;[DPYD, TK2]
GO:0001676;long-chain fatty acid metabolic process;8.0;0.6835726970475526;0.7167863485237763;8.866384200445225;93.73125239075797;5.049685808968129;0.0031371006648681556;0.6332411671050352;[ACOT7, ELOVL5, ACSL6, HSD17B4, ELOVL6, DAGLB, SLC27A2, PAM, FADS1, ACOT4, MGLL]
GO:0046597;negative regulation of viral entry into host cell;8.0;0.9326813400603323;0.8413406700301662;9.548481544818586;84.95196338807416;6.832634648514029;0.002843265762795464;0.7244212536750128;[GSN, PTX3]
GO:0033004;negative regulation of mast cell activation;7.0;0.8653626801206646;0.7836007053175329;9.5544162803384;126.92306413003195;7.379178354882098;0.00424800073309046;0.728290889492758;[CD300LF]
GO:0035666;TRIF-dependent toll-like receptor signaling pathway;13.0;0.9326813400603323;0.9288956347978027;9.592156608321247;413.3481394832653;6.599019797332524;0.013834390239330937;0.8000291440890255;[RIPK1, CD300LF, TANK]
GO:0010389;regulation of G2/M transition of mitotic cell cycle;8.0;0.7369933605727446;0.7434966802863723;8.986670366319727;58.92720908338202;4.74012102526684;0.001972240656975688;0.6174100096703167;[DCTN2, VPS4B, DCTN3, KIF14, BRCA1, GPR132, CCNB1, ACTR1A, SIN3A, RAD21, CEP70, TOPBP1, CLASP1, CDK5RAP3, FANCI, RCC2, DONSON, CDC7, TUBG1, CKAP5, RAB11A, CDC25A, RINT1, CENPF, RAD51C, CDK6, PKIA, CENPJ, TAOK2, CDK2, FGFR1OP, MAPRE1, PAFAH1B1]
GO:0071526;semaphorin-plexin signaling pathway;6.0;0.811012628672052;0.7286266269261705;9.089527751759436;26.50247477320489;6.166155715036245;8.87013979980389E-4;0.6384578026126634;[SEMA6B, SEMA4D, SEMA4B, MET]
GO:0055072;iron ion homeostasis;9.0;0.811012628672052;0.801746939516315;9.292052015870908;38.23288616879122;5.395046993006588;0.0012796202927058053;0.6721435792979885;[STEAP3, TFRC, SLC22A17, MYC, HYAL2, ATP6V0A2, SFXN3, SFXN4, NEDD8, ACO1, PICALM]
GO:0090038;negative regulation of protein kinase C signaling;8.0;1.0;0.875;9.628524252492122;238.79440420981607;9.083926447120524;0.00799223380789131;0.839552420951524;[MYADM]
GO:0008286;insulin receptor signaling pathway;8.0;0.8653626801206646;0.8076813400603323;9.34084218004034;31.002284443533863;5.346256828837156;0.0010376185600805164;0.6484078228531001;[PTPRA, ATP6V0A2, SH2B2, ATP6V1F, IGF1R, APPL1]
GO:0008285;negative regulation of cell proliferation;5.0;0.5619039856592722;0.5711930046905564;7.31175452450612;43.614270733588945;3.2818080717434612;0.0014597303911579066;0.4580728292695636;[CDKN1C, BTG2, CDKN1A, BMPR2, BTG1, CD80, LST1, SIRPG, PTEN, CIB1, PTPRK, COMT, PKD2, FLCN, ING2, ADORA3, RPS6KA2, MYC, CASP3, FNTB, NUP62, TRIM24, TIMP2, CTLA4, IL12A, JARID2, HRAS, EMD, RBM5, HAVCR2, KLF11, KLF13, IGFBP5, SERPINF1, ATPIF1, EMP3, PDCD1LG2, SIRT2, TGFBR1, NME1, SFRP1, TWSG1, GAL, TFDP1, KARS, ADORA2A, RAPGEF1, RARA, TAX1BP3, B4GALT7, SF1, BECN1, STK4, THBS1, STK3, TMEM127, TP53INP1, LMNA, MFN2, CSK, E2F7, TFAP2A, CDKN2D, ZBTB17, PRNP, CDKN2C, CAV1, IDH2, GLMN, EAF2, IFT122, WDR13, PER2, ITCH, IL6, CDK6, CNOT7, FAP, TMEM115, NFIB, CD9, MNDA, SPRY1, PTPN6, CNOT8, TRIM32]
GO:0008284;positive regulation of cell proliferation;5.0;0.5587538620495764;0.5696179428857084;7.270369308343265;43.45254999490143;2.9881018846882994;0.0014543177435732513;0.44305268120482816;[TFRC, CD80, PDCD6, SIRPG, CCNF, CIB1, IGF1R, AQP1, TIAL1, PPP1CC, MYC, FNTB, SOX8, IL12A, CAPN1, SKP2, MAP3K5, PDGFRB, RPS9, TIPIN, CSNK2A1, IGFBP5, FLT3LG, RUNX2, ERN1, SFRP1, CCNE2, IL23A, CCNE1, EPHA1, CARD11, FOXG1, EBI3, NOLC1, CORO1A, AGER, CCNB1, ABL1, SSR1, NCKAP1L, XBP1, CDC7, CCDC88B, CNOT6, IL6, CDK6, CNOT7, SP1, CDK2, TMEM119, FGFR1OP, CNOT8, MNAT1, CD24, CCNJL, ITGB1, CDKN1A, CD40, WDR48, BMPR2, ITGB3, KIF14, PTEN, LBH, CTSH, ITGAV, TIMP1, ATP7A, HRAS, CCR2, HLA-DPA1, HAVCR2, ANXA1, SYK, SPHK2, ITGA2, SPHK1, FCRL3, TBC1D8, ARNT, PDCD1LG2, IRAK4, TGFBR1, NME1, KIT, RARA, BIRC6, EAPP, HBEGF, CDC123, HDAC1, DERL2, CRIP2, THBS1, RELA, FZR1, HLA-DMB, CCL5, MFN2, CCL19, IL12RB1, TBX1, MAP3K3, TSHR, PDCL3, CD4, GPAM, HLA-DPB1, KRAS, PTPN6, FAM98A, TEK]
GO:0048538;thymus development;5.0;1.0;0.7902410118609202;9.628524252492122;35.890675140737365;6.039404009397101;0.0012012285974499148;0.5990964137624962;[TBX1, RIPK3, ABL1, JARID2, TGFBR1]
GO:1902856;negative regulation of non-motile cilium assembly;10.0;1.0;0.9152410118609203;9.628524252492122;402.0466438491823;8.67846133901236;0.013456139351143913;0.8590579283277371;[DNM2]
GO:0050850;positive regulation of calcium-mediated signaling;8.0;0.7763722522362496;0.7631861261181248;9.283683766200392;239.92176968958296;6.039404009397101;0.008029965715936047;0.6838554019015759;[PTBP1, CD4, P2RX4, SYK, CIB1, CALM3, CALM1, PKD2, CALM2]
GO:0050851;antigen receptor-mediated signaling pathway;9.0;0.8653626801206646;0.8289219652406215;9.533214072687796;218.73839564357212;4.31748811353631;0.007320977250414979;0.6170371680902661;[STOML2, WAS, PTPN22, RELA, ABL1, CTLA4, NCKAP1L, CSK, HRAS, HLA-DQA1, SH2B2, HLA-DPA1, EIF2B4, SYK, BTN2A1, BTN3A2, NFKB1, RC3H2, CD4, HLA-DPB1, MNDA, LCP2, PTPN6, HLA-DRB3, CARD11, HLA-DQB1]
GO:2000778;positive regulation of interleukin-6 secretion;10.0;1.0;0.9152410118609203;9.628524252492122;618.0674169630446;6.599019797332524;0.02068616022119099;0.7527151911823093;[XBP1, HYAL2, MBP]
GO:0043097;pyrimidine nucleoside salvage;9.0;0.811012628672052;0.801746939516315;9.507896264703508;2649.2611103990594;7.292166977892469;0.08866838518485125;0.769162383550154;[UCK2, TK2]
GO:0001649;osteoblast differentiation;4.0;1.0;0.75;9.628524252492122;21.066225782797595;5.171903441692378;7.050676185779127E-4;0.5144913825262545;[IGFBP5, H3F3A, HSD17B4, RRBP1, HSPE1, SND1, RUNX2, RPS15, SFRP1, TP53INP2, CAT, TMEM119, SOX8]
GO:0032147;activation of protein kinase activity;11.0;0.6799073451904818;0.7723826249249031;9.164951513576677;1096.8683293671154;4.034070439870987;0.03671119586651001;0.6387315022281249;[ITGB3, KIF14, PARK7, STK4, THBS1, STK3, ABL1, NEK1, NCKAP1L, RIPK1, CCL19, ECT2, MARK2, MAP3K5, MAP3K3, DUSP5, PRNP, MAP4K2, MAP3K1, DBNL, PDE6H, ANGPT1, RIPK3, SYK, ZFP91, TNFRSF10B, TNFRSF10A, PILRB, OXSR1, MAPK8IP3, TGFBR1, ERN1, P2RX7, CCDC88A, KARS, TAOK2, KIT, MADD, RAPGEF1, ADNP]
GO:0050859;negative regulation of B cell receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;309.61561130321576;7.9853141584524145;0.010362555874359037;0.7833693374183408;[FCRL3, GPS2, PTPN6]
GO:0071318;cellular response to ATP;7.0;1.0;0.8509193652572005;9.628524252492122;523.2473722673394;7.212124270218933;0.01751261865772571;0.7197477358342742;[P2RX4, HSP90B1, SSH1]
GO:0050855;regulation of B cell receptor signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;68.86251036091213;6.686031174322154;0.0023047662495439825;0.692843310444282;[FCRL3, GPS2, PTPN22, PTPN6, RUNX1]
GO:0050852;T cell receptor signaling pathway;10.0;1.0;0.9152410118609203;9.628524252492122;219.43154282413207;4.981283082083729;0.007344176262756358;0.6699840603320352;[EIF2B4, STOML2, BTN2A1, WAS, PTPN22, BTN3A2, NFKB1, RELA, RC3H2, CD4, HLA-DPB1, LCP2, CSK, HLA-DRB3, HRAS, HLA-DQA1, CARD11, HLA-DPA1, HLA-DQB1]
GO:0050853;B cell receptor signaling pathway;10.0;0.9326813400603323;0.8815816818910864;9.582004236857228;219.43154282413207;4.948759890378168;0.007344176262756358;0.6683208227957298;[SYK, ABL1, CTLA4, NCKAP1L, MNDA, PTPN6]
GO:0031295;T cell costimulation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;354.8971974647038;5.845247994956144;0.011878089812402261;0.6951668794741764;[CD80, CAV1, CTLA4, CSK, PTPN6, PDCD1, PDCD1LG2, CCL19, CD24, VAV1, CARD11]
GO:0008053;mitochondrial fusion;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;60.85147907762772;6.943860283624253;0.0020366442419525303;0.6453503496879909;[STOML2, MFN2]
GO:0008299;isoprenoid biosynthetic process;6.0;0.5673924682959377;0.6068165467381134;7.849668188099975;119.50302130477095;6.558197802812269;0.00399965857733397;0.6585068532133508;[COQ2, GGPS1]
GO:1903955;positive regulation of protein targeting to mitochondrion;10.0;0.9326813400603323;0.8815816818910864;9.597752593825367;662.5702871444865;6.311337724880743;0.022175631236180954;0.7380031166185408;[NPEPPS, USP36, UBL5, VPS11, RHOU, UBE2L3]
GO:0050860;negative regulation of T cell receptor signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.57973408832269;309.61561130321576;6.8867018697843045;0.010362555874359037;0.7271862538851576;[DUSP22, PRNP, PVRIG, PTPN22, PTPN6]
GO:0071300;cellular response to retinoic acid;6.0;1.0;0.8231203125901445;9.628524252492122;200.602279209425;5.54296712308321;0.006713977754809188;0.606587909038952;[SETX, TBX1, SERPINF1, TWF2, RARA, ZNF35, TEAD2, AQP1]
GO:0001657;ureteric bud development;8.0;1.0;0.875;9.628524252492122;36.921511297847346;6.139487467954083;0.0012357297559360753;0.6889736746265369;[SFRP1, CAT, RARA, SDC1, SPRY1]
GO:0035646;endosome to melanosome transport;6.0;1.0;0.8231203125901445;9.628524252492122;33.20429938101479;7.474488534686424;0.0011113180183532213;0.7053660038532718;[AP1G1, RAB38, AP1M1]
GO:2000785;regulation of autophagosome assembly;8.0;0.8933024483968273;0.8216512241984136;9.503361109538115;101.62596648496498;6.166155715036245;0.0034013296408198605;0.6903374900225189;[BECN1, RAB1B, CHMP4B, RAB3GAP2, ULK1, RAB3GAP1, MTM1, C9orf72]
GO:2000786;positive regulation of autophagosome assembly;9.0;1.0;0.896240625180289;9.628524252492122;594.8628679994155;7.379178354882098;0.019909524850116572;0.7736121494158466;[BECN1, RAB3GAP2, ULK1, RAB3GAP1]
GO:0030199;collagen fibril organization;5.0;1.0;0.7902410118609202;9.628524252492122;53.964823970696955;5.9928839937622085;0.0018061540931107725;0.5967173779995258;[COL1A2, COL5A1, ATP7A, TGFBR1]
GO:0070459;prolactin secretion;9.0;1.0;0.896240625180289;9.628524252492122;236.67564318465372;8.390779266560578;0.007921320783140251;0.8253454670833372;[ANXA1]
GO:0055012;ventricular cardiac muscle cell differentiation;7.0;1.0;0.8509193652572005;9.628524252492122;47.302935560632505;8.16763571524637;0.001583186683336236;0.7686126355688037;[RXRA, RARA]
GO:0046777;protein autophosphorylation;8.0;0.7763722522362496;0.7631861261181248;9.31486669363708;180.75330000196035;4.488806596985934;0.006049650283656873;0.604557778120715;[SMG1, STK4, IGF1R, MKNK2, TRIM24, ABL1, RIPK1, CSK, MARK2, EPHB4, PDGFRB, MAP3K3, RIPK3, SYK, CAD, EIF2AK3, VRK1, VRK2, CLK4, EIF2S1, CLK3, CLK1, ERN1, BCR, CDK5, FES, CAMK4, TAOK2, KIT, ULK1, TEK, EPHA1, CSNK1G2]
GO:0043029;T cell homeostasis;7.0;1.0;0.8509193652572005;9.628524252492122;22.00128503895464;6.444869117505266;7.363632103827933E-4;0.6805102716434839;[P2RX7, RIPK3, CASP3, NCKAP1L, CORO1A, RC3H2]
GO:0002554;serotonin secretion by platelet;10.0;1.0;0.9152410118609203;9.628524252492122;131.6544252072528;8.67846133901236;0.0044063551303965215;0.8590579283277371;[FCER1G, SYK]
GO:0006914;autophagy;4.0;0.6729672293956388;0.5864836146978194;8.39638057119949;37.75222312160081;4.39717627414001;0.001263532933085;0.4748717991491287;[BECN1, RGS19, CALCOCO2, ITGB4, EI24, VPS4B, RAB1B, CLEC16A, PTPN22, PARK7, FNBP1L, CLN3, FUNDC1, CTSK, LAMP2, VPS11, UBQLN1, ABL1, C6orf106, MFN2, MARK2, ATG5, VPS18, GABARAPL1, XBP1, MAP1S, VTA1, ATG10, VPS37A, VPS37B, PGA3, DYNLL2, PRKAB1, PGA5, SIRT2, TM9SF1, VPS41, PLEKHM1, CHMP4B, PIK3C3, ULK1, CHMP6, C9orf72]
GO:0071732;cellular response to nitric oxide;6.0;1.0;0.8231203125901445;9.628524252492122;346.50110413771324;7.004484905440688;0.011597080124741305;0.6813299963962409;[CDK2, AQP1, DNM2]
GO:2000310;regulation of NMDA receptor activity;9.0;0.8933024483968273;0.8428918493787028;9.541512875502493;200.74624271324296;6.8867018697843045;0.006718796083723233;0.7484268790654467;[CAPN1]
GO:0010193;response to ozone;5.0;0.9326813400603323;0.7565816818910864;9.541512875502493;79.59609566907567;7.9853141584524145;0.0026640096902085927;0.6986103492792611;[CAT]
GO:0043277;apoptotic cell clearance;7.0;1.0;0.8509193652572005;9.628524252492122;28.437470009997963;6.8867018697843045;9.517765291732001E-4;0.7031056191423581;[ITGB3, RARA, ITGAV]
GO:0045454;cell redox homeostasis;5.0;1.0;0.7902410118609202;9.628524252492122;31.944097044200298;5.572381008289503;0.0010691401802485107;0.5752128357670632;[EGLN2, NNT, TXNRD1, PRDX1, TXNDC11, GLRX]
GO:0000147;actin cortical patch assembly;7.0;1.0;0.8509193652572005;9.628524252492122;89.93282460404566;7.9853141584524145;0.0030099707052099636;0.7592887026755414;[WIPF2, WAS, WASL]
GO:0043280;positive regulation of cysteine-type endopeptidase activity involved in apoptotic process;12.0;0.811012628672052;0.8536266269261705;9.556203590912496;733.386781063286;4.956792062075433;0.024545795556936395;0.7016108891590862;[GSN, DIABLO, PDCD6, TRADD, EIF2AK3, TNFRSF10B, TNFRSF10A, NLRC4, HSPE1, BBC3, NLRP12, MYC, CASP3, ARL6IP5, NLRP2, NLRP3, CTSH, RIPK1, BID, MAP3K5]
GO:0003417;growth plate cartilage development;6.0;1.0;0.8231203125901445;9.628524252492122;33.90475965706645;8.16763571524637;0.001134761793419349;0.7408135829017477;[RARA, THBS3]
GO:1905075;positive regulation of occluding junction disassembly;6.0;1.0;0.8231203125901445;9.628524252492122;64.33223260552629;9.083926447120524;0.002153141930056498;0.7876727335416686;[TGFBR1]
GO:0090237;regulation of arachidonic acid secretion;9.0;0.8933024483968273;0.8428918493787028;9.485423408851448;83.13942816732954;7.9853141584524145;0.0027826018401329354;0.8046099625986299;[SYK, NTSR1]
GO:0033280;response to vitamin D;7.0;0.9326813400603323;0.8172600352873667;9.548481544818586;74.55580141320215;6.375876246018314;0.002495315577434836;0.6769819729871445;[CDKN2D, CD4, SFRP1, ABCB4, AQP3]
GO:1903903;regulation of establishment of T cell polarity;8.0;0.8933024483968273;0.8216512241984136;9.461470167828956;46.402126927956544;8.390779266560578;0.0015530374290757074;0.8041048419030481;[GSN, DOCK8]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[TCERG1, ZNF175, GFI1, ZBTB20, IKZF2, YY1, MYC, SAP130, WWC3, EP300, SOX8, SOX6, ZNF564, TLE4, ZBTB32, SARS, HCFC2, THAP1, RUNX1, EID1, BRMS1, TBL1XR1, CCNE1, HOXB4, TIMELESS, TRIB3, PPID, MAX, FOXG1, MEPCE, MTDH, BAG3, TPR, HIVEP1, HESX1, SUDS3, BPTF, TFAP2A, DR1, CREBBP, ZNF263, UBE2I, CBX4, WFS1, BCL11A, CAV1, NFXL1, NFKB1, CNOT7, YEATS2, CNOT1, PKIA, SP3, CDK2, NFE2L3, RCOR3, ZNF136, EZH2, CIITA, BTG2, TCF25, SUV39H1, CHD8, OTUD7B, LDB2, FLCN, NIPBL, SIN3A, C1QBP, MLX, LRRFIP1, HIF1AN, CIC, JARID2, DACT1, KLF11, HBZ, KLF12, PEG3, RFC1, H2AFY, TSC22D3, SIRT7, ARID1A, SIRT2, ZFP90, DUSP22, NCOR2, NCOR1, RBL1, NFX1, MTF2, RARA, LCOR, EAPP, MCPH1, HDAC3, ZNF350, HDAC1, GPS2, LRP8, RELA, RXRA, DNAJB5, RBBP7, MTA2, E2F7, ZNF189, E2F8, TCFL5, IRX1, SPEN, SEMA4D, PER2, GFI1B, NFIA, NFIB, NFIC, TAF7, TRIM33]
GO:0045471;response to ethanol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;69.73224034292265;5.006389003214805;0.0023338753293357085;0.5462679783062231;[ACTR2, G6PD, GSN, SETDB1, PTEN, ITPR2, AACS, POLB, EEF1B2, TBXA2R, TP53INP1, CAT, RARA, SDF4]
GO:1902807;negative regulation of cell cycle G1/S phase transition;8.0;0.7763722522362496;0.7631861261181248;9.303101852057495;106.39519485100838;5.202362649177086;0.003560951422204466;0.6410490678135203;[BTG2, CDKN1A, PCNA, PTEN, PKD2, CCNB1, CASP2, EP300, GTSE1, E2F7, E2F8, DACT1, CDKN2D, CNOT10, CNOT4, CNOT6, TFDP1, RBL1, CNOT7, TFDP2, CNOT1, CTDSP2, RFWD3, CNOT3, CDK2, CNOT8, EZH2]
GO:0045475;locomotor rhythm;4.0;1.0;0.75;9.628524252492122;28.705510431398622;7.474488534686424;9.607476008567623E-4;0.6322456912631272;[PTEN]
GO:0035459;cargo loading into vesicle;6.0;0.8259837884571596;0.7361122068187242;9.318369324188282;55.50506792578142;6.518977089658987;0.001857704672157885;0.6565011041187423;[SEC13, TBC1D20, TMED2, MIA3, SEC24C, PICALM]
GO:0034125;negative regulation of MyD88-dependent toll-like receptor signaling pathway;9.0;1.0;0.896240625180289;9.628524252492122;354.70667396235325;9.083926447120524;0.011871713162238609;0.8607930461318132;[CD300LF]
GO:0035690;cellular response to drug;4.0;0.5629771490299041;0.531488574514952;7.020557509946895;41.90713853914268;4.145861845859104;0.0014025942129290189;0.462019567599527;[ERRFI1, TFRC, PTEN, PTPN22, BRCA1, PARK7, AQP1, EFTUD2, SIN3A, PPAT, MYC, MAP3K5, USP8, ABCC2, PPP1R12A, ANXA1, SERPINF1, CAD, NME1, RHOB, DNM2, SFRP1, XRN1, DDIT4, TIMELESS, PPIF, BECN1, PCNA, ABCB4, ITPR2, RELA, HSP90B1, RAP1B, TP53INP1, ABL1, ECT2, DCPS, SULT1A3, PRNP, JUP, SLC31A1, NFKB1, MAPK13, SSH1, SETX, IL6, RAD51, P2RX4, CDK2, EZH2]
GO:0033031;positive regulation of neutrophil apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;300.80443177442305;8.390779266560578;0.010067653625077092;0.8253454670833372;[ANXA1]
GO:0046323;glucose import;10.0;0.8933024483968273;0.861892236059334;9.461470167828956;38.205824888540654;7.212124270218933;0.00127871457600939;0.7840693824379941;[RAB4B]
GO:1903906;regulation of plasma membrane raft polarization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;31.3480583497322;9.777073627680469;0.0010491913015446624;0.8231203125901445;[GSN]
GO:0001697;histamine-induced gastric acid secretion;7.0;1.0;0.8509193652572005;9.628524252492122;28.891725282277577;9.777073627680469;9.669800443331955E-4;0.8509193652572005;[HRH2]
GO:0001698;gastrin-induced gastric acid secretion;7.0;1.0;0.8509193652572005;9.628524252492122;28.891725282277577;9.777073627680469;9.669800443331955E-4;0.8509193652572005;[HRH2]
GO:0048752;semicircular canal morphogenesis;4.0;1.0;0.75;9.628524252492122;28.499391571831023;8.16763571524637;9.53848988121965E-4;0.6676932703116032;[TBX1, CHD7]
GO:0002548;monocyte chemotaxis;7.0;1.0;0.8509193652572005;9.628524252492122;125.46101547564297;6.039404009397101;0.004199067280386423;0.6597747671587765;[IL6, ANXA1, CCL20, CCL5, CCL19, CCR2]
GO:0046330;positive regulation of JNK cascade;12.0;0.8436909121759173;0.8699657686781033;9.567899630675686;1762.0380321839782;4.909539177224887;0.058973827205923174;0.6991943744303455;[MAP4K2, DBNL, NCF1, SYK, MAPK8IP3, AGER, STK3, ERN1, DUSP22, RASSF2, TAOK2, DVL3, RIPK1, ZNF622, CCL19, LTBR, HRAS, ARHGEF5, MAP3K5]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[CIB1, PARK7, UBE2Z, IGF1R, AQP1, MYC, CFL1, SOX8, EPHB4, IER3, PDGFRB, CSNK2A1, FLT3LG, THOC6, SFRP1, CFDP1, PPIF, VDAC2, ADNP, EPHA1, PPID, CORO1A, MTDH, HSP90B1, BCL2L12, BAG4, HSPH1, BAG3, BAG1, ABL1, NCKAP1L, RIPK1, NTSR1, ATG5, TFAP2A, PRNP, PRELID1, XBP1, UBE2B, CBX4, WFS1, NONO, RHBDD1, CAV1, TNFRSF10B, TNFRSF10A, NFKB1, SETX, VIL1, NFKBIA, IL6, SON, COPS5, QARS, BCL3, HYOU1, MNAT1, CPEB4, AVEN, ITGB1, ARF4, BTG2, CDKN1A, DOCK8, TRADD, KIF14, PTEN, BRCA1, AATF, PIK3CG, ING2, NNT, SIN3A, CASP3, NUP62, CASP2, CTSH, ITGAV, TIMP1, HRAS, TSC22D4, FGA, DFFA, FCER1G, ANXA1, SPHK2, SPHK1, TSC22D3, FGG, PLAUR, YWHAZ, TGFBR1, DDB1, ITPKB, CREB3, ADORA2A, PTRH2, KIT, CAT, TMBIM1, RARA, BIRC6, MET, BECN1, HDAC3, HDAC1, NLRC4, THBS1, RELA, UNG, CLN3, CCL5, LMNA, CCL19, RFFL, SNCB, BID, TBX1, CDKN2D, ANGPT1, SEMA4D, EYA2, RYK, SYVN1, ITCH, GPAM, TNIP2, KRAS, ERCC5, PDCD1, TEK, TRIM32, MAD2L1]
GO:0006904;vesicle docking involved in exocytosis;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;32.65265176272962;6.039404009397101;0.0010928548690198408;0.6319757144917204;[RAB3B, VPS18, VPS33A, RAB3D, VPS33B, VPS11, VPS45, RABEPK, RAB8B]
GO:0043065;positive regulation of apoptotic process;7.0;0.5587538620495764;0.6302962962819887;7.806911820114386;80.91235068524658;3.3969510907807043;0.0027080635610472266;0.5246396020141064;[PDCD6, PARK7, UBE2Z, PREX1, RASSF2, RPS6KA2, MYC, ARL6IP5, IL12A, MAP3K5, PDGFRB, ENDOG, FBXO18, RPS7, SFRP1, BRMS1, PPIF, PPID, DIABLO, STK4, STK3, ABR, UBD, TP53BP2, NLRP2, ABL1, NLRP3, RIPK1, SUDS3, ECT2, NTSR1, TFAP2A, PRNP, PRELID1, CAV1, EIF2AK3, TNFRSF10B, TNFRSF10A, EIF2S1, CYLD, IL6, CDK5, SERINC3, HRK, ITGB1, CD40, BTG1, YWHAB, TRADD, PTEN, BBC3, FLCN, AKAP13, C1QBP, CASP3, HYAL2, CASP2, CTSH, CTLA4, RBM5, ARHGEF11, KLF11, DFFA, C3orf38, ANXA1, TNFRSF12A, RIPK3, ATPIF1, PLAUR, YWHAZ, SIRT2, VAV1, TGFBR1, VAV2, RHOB, DNM2, GAL, TFDP1, TFDP2, ADORA2A, PTRH2, ARHGEF1, GAPDH, ARHGEF5, ITGB3BP, NLRC4, THBS1, BCLAF1, CCL5, TP53INP1, SAP18, PLAGL2, MFN2, ZNF622, BID, GSN, G0S2, HSPE1, P2RX7, NLRP12, FAP, MNDA, PDCD1, LTBR]
GO:1903909;regulation of receptor clustering;7.0;0.7763722522362496;0.7391054913753253;9.223059144383958;31.620112264749665;7.57984905034425;0.0010582967012476693;0.738553198190834;[GSN, SSH1]
GO:0006909;phagocytosis;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;28.437470009997963;5.618190544320798;9.517765291732001E-4;0.610434838299289;[ANXA1, ADORA2A, NCF2, ITGB3, RARA, CDC7, ITGAV, CORO1A, MET, TM9SF4, UNC13D, DNM2]
GO:0034599;cellular response to oxidative stress;4.0;0.7248374789738407;0.6124187394869203;8.935377071932177;68.67201153720991;4.519578255652688;0.0022983904253524798;0.48113144217596127;[BECN1, PCNA, NCF1, ATP2A2, PARK7, PTPRK, PKD2, RELA, AQP1, PRDX1, ALDH3B1, TP53INP1, ABL1, ECT2, MAP3K5, G6PD, ANXA1, GPX3, TXNRD1, GPX7, PYCR1, VRK2, EIF2S1, SIRT2, RHOB, MAPK13, DNM2, SETX, IL6, CCS, PXMP2, CDK2, CAT, PPIF, NFE2L1, EZH2]
GO:0034115;negative regulation of heterotypic cell-cell adhesion;8.0;1.0;0.875;9.628524252492122;130.132988179366;7.57984905034425;0.004355434002277579;0.7626338329336335;[MYADM, MBP]
